BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586-590. [PMID: 32125455 DOI: 10.1007/s00134-020-05985-9] [Cited by in Crossref: 1064] [Cited by in F6Publishing: 967] [Article Influence: 532.0] [Reference Citation Analysis]
Number Citing Articles
1 Mavrikou S, Tsekouras V, Hatziagapiou K, Tsalidou A, Bakakos P, Rovina N, Koutsoukou A, Michos A, Nikola O, Koniari E, Papaparaskevas J, Chrousos GP, Kanaka-gantenbein C, Kintzios S. Angiotensin-Converting Enzyme 2 (ACE2) As a Novel Biorecognition Element in A Cell-Based Biosensor for the Ultra-Rapid, Ultra-Sensitive Detection of the SARS-CoV-2 S1 Spike Protein Antigen. Chemosensors 2021;9:341. [DOI: 10.3390/chemosensors9120341] [Reference Citation Analysis]
2 Gilroy DW, De Maeyer RPH, Tepper M, O'Brien A, Uddin M, Chen J, Goldstein DR, Akbar AN. Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19. Pharmacol Ther 2021;221:107745. [PMID: 33188794 DOI: 10.1016/j.pharmthera.2020.107745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Vitiello A, La Porta R, Ferrara F. Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19. Med Hypotheses 2021;147:110486. [PMID: 33460992 DOI: 10.1016/j.mehy.2021.110486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
4 Abdel Moniem A, Radwan MA, Yousef AI. COVID-19 and cardiovascular disease: Manifestations, pathophysiology, vaccination, and long-term implication. Current Medical Research and Opinion. [DOI: 10.1080/03007995.2022.2078081] [Reference Citation Analysis]
5 Kim ES, Jeon MT, Kim KS, Lee S, Kim S, Kim DG. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells. Viruses 2021;13:2021. [PMID: 34696455 DOI: 10.3390/v13102021] [Reference Citation Analysis]
6 Jani V, Koulgi S, Uppuladinne VNM, Sonavane U, Joshi R. An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2-Spike complex of SARS-CoV-2 using computational methods. Chem Zvesti 2021;:1-24. [PMID: 33994655 DOI: 10.1007/s11696-021-01680-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chung MK, Karnik S, Saef J, Bergmann C, Barnard J, Lederman MM, Tilton J, Cheng F, Harding CV, Young JB, Mehta N, Cameron SJ, McCrae KR, Schmaier AH, Smith JD, Kalra A, Gebreselassie SK, Thomas G, Hawkins ES, Svensson LG. SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. EBioMedicine 2020;58:102907. [PMID: 32771682 DOI: 10.1016/j.ebiom.2020.102907] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 25.5] [Reference Citation Analysis]
8 Neurath MF. COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34188251 DOI: 10.1038/s41575-021-00480-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhao Y, Wang J, Kuang D, Xu J, Yang M, Ma C, Zhao S, Li J, Long H, Ding K, Gao J, Liu J, Wang H, Li H, Yang Y, Yu W, Yang J, Zheng Y, Wu D, Lu S, Liu H, Peng X. Susceptibility of tree shrew to SARS-CoV-2 infection. Sci Rep 2020;10:16007. [PMID: 32994418 DOI: 10.1038/s41598-020-72563-w] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
10 Adu-Amankwaah J, Mprah R, Adekunle AO, Ndzie Noah ML, Adzika GK, Machuki JO, Sun H. The cardiovascular aspect of COVID-19. Ann Med 2021;53:227-36. [PMID: 33345626 DOI: 10.1080/07853890.2020.1861644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
11 Ali A, Noman M, Guo Y, Liu X, Zhang R, Zhou J, Zheng Y, Zhang XE, Qi Y, Chen X, Men D. Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality. Sci Rep 2021;11:5975. [PMID: 33727641 DOI: 10.1038/s41598-021-85426-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Weiss C, Carriere M, Fusco L, Capua I, Regla-Nava JA, Pasquali M, Scott JA, Vitale F, Unal MA, Mattevi C, Bedognetti D, Merkoçi A, Tasciotti E, Yilmazer A, Gogotsi Y, Stellacci F, Delogu LG. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic. ACS Nano 2020;14:6383-406. [PMID: 32519842 DOI: 10.1021/acsnano.0c03697] [Cited by in Crossref: 173] [Cited by in F6Publishing: 121] [Article Influence: 86.5] [Reference Citation Analysis]
13 Gomaa AA, Mohamed HS, Abd-Ellatief RB, Gomaa MA, Hammam DS. Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial. Inflammopharmacology 2022. [PMID: 35233748 DOI: 10.1007/s10787-022-00939-7] [Reference Citation Analysis]
14 Sathler PC. Hemostatic abnormalities in COVID-19: A guided review. An Acad Bras Cienc 2020;92:e20200834. [PMID: 32844987 DOI: 10.1590/0001-3765202020200834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 da Silva da Costa FA, Soares MR, Malagutti-Ferreira MJ, da Silva GR, Lívero FADR, Ribeiro-Paes JT. Three-Dimensional Cell Cultures as a Research Platform in Lung Diseases and COVID-19. Tissue Eng Regen Med 2021. [PMID: 34080133 DOI: 10.1007/s13770-021-00348-x] [Reference Citation Analysis]
16 Saha RP, Sharma AR, Singh MK, Samanta S, Bhakta S, Mandal S, Bhattacharya M, Lee SS, Chakraborty C. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Front Pharmacol. 2020;11:1258. [PMID: 32973505 DOI: 10.3389/fphar.2020.01258] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
17 Ghanbari R, Teimoori A, Sadeghi A, Mohamadkhani A, Rezasoltani S, Asadi E, Jouyban A, Sumner SC. Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients. Future Microbiol 2020;15:1747-58. [PMID: 33404263 DOI: 10.2217/fmb-2020-0120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Ahmad I, Pawara R, Surana S, Patel H. The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19. Top Curr Chem (Cham) 2021;379:40. [PMID: 34623536 DOI: 10.1007/s41061-021-00353-7] [Reference Citation Analysis]
19 Lazari LC, Ghilardi FR, Rosa-Fernandes L, Assis DM, Nicolau JC, Santiago VF, Dalçóquio TF, Angeli CB, Bertolin AJ, Marinho CR, Wrenger C, Durigon EL, Siciliano RF, Palmisano G. Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19. Life Sci Alliance 2021;4:e202000946. [PMID: 34168074 DOI: 10.26508/lsa.202000946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Guruprasad L. Human SARS CoV-2 spike protein mutations. Proteins 2021;89:569-76. [PMID: 33423311 DOI: 10.1002/prot.26042] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
21 Balkrishna A, Solleti SK, Verma S, Varshney A. Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation. Molecules 2020;25:E5091. [PMID: 33147850 DOI: 10.3390/molecules25215091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Wicik Z, Eyileten C, Jakubik D, Simões SN, Martins DC Jr, Pavão R, Siller-Matula JM, Postula M. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. J Clin Med 2020;9:E3743. [PMID: 33233425 DOI: 10.3390/jcm9113743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
23 Hsieh TC, Edwards NC, Bhattacharyya SK, Nitschelm KD, Burnett AL. The Epidemic of COVID-19-Related Erectile Dysfunction: A Scoping Review and Health Care Perspective. Sex Med Rev 2021:S2050-0521(21)00077-9. [PMID: 34732316 DOI: 10.1016/j.sxmr.2021.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 [DOI: 10.1101/2020.04.03.20051722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Zhang L, Zetter MA, Guerra EC, Hernández VS, Mahata SK, Eiden LE. ACE2 in the second act of COVID-19 syndrome: Peptide dysregulation and possible correction with oestrogen. J Neuroendocrinol 2021;33:e12935. [PMID: 33462852 DOI: 10.1111/jne.12935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wu Y, Huang X, Yuan L, Wang S, Zhang Y, Xiong H, Chen R, Ma J, Qi R, Nie M, Xu J, Zhang Z, Chen L, Wei M, Zhou M, Cai M, Shi Y, Zhang L, Yu H, Hong J, Wang Z, Hong Y, Yue M, Li Z, Chen D, Zheng Q, Li S, Chen Y, Cheng T, Zhang J, Zhang T, Zhu H, Zhao Q, Yuan Q, Guan Y, Xia N. A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters. Sci Transl Med 2021;13:eabg1143. [PMID: 34285130 DOI: 10.1126/scitranslmed.abg1143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Serrano-castro P, Estivill-torrús G, Cabezudo-garcía P, Reyes-bueno J, Ciano Petersen N, Aguilar-castillo M, Suárez-pérez J, Jiménez-hernández M, Moya-molina M, Oliver-martos B, Arrabal-gómez C, Rodríguez de Fonseca F. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? Neurología (English Edition) 2020;35:245-51. [DOI: 10.1016/j.nrleng.2020.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 12.5] [Reference Citation Analysis]
28 Huang KY, Lin MS, Kuo TC, Chen CL, Lin CC, Chou YC, Chao TL, Pang YH, Kao HC, Huang RS, Lin S, Chang SY, Yang PC. Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection. EMBO Mol Med 2021;13:e12828. [PMID: 33159417 DOI: 10.15252/emmm.202012828] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
29 Mukherjee S, Bhattacharyya D, Bhunia A. Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain. Biophys Chem 2020;266:106452. [PMID: 32818817 DOI: 10.1016/j.bpc.2020.106452] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
30 Das A, Pandita D, Jain GK, Agarwal P, Grewal AS, Khar RK, Lather V. Role of phytoconstituents in the management of COVID-19. Chem Biol Interact 2021;341:109449. [PMID: 33798507 DOI: 10.1016/j.cbi.2021.109449] [Reference Citation Analysis]
31 Kouhpayeh S, Shariati L, Boshtam M, Rahimmanesh I, Mirian M, Esmaeili Y, Najaflu M, Khanahmad N, Zeinalian M, Trovato M, Tay FR, Khanahmad H, Makvandi P. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy. Int J Mol Sci 2021;22:5438. [PMID: 34064039 DOI: 10.3390/ijms22115438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Larrea J, Villota-deleu E, Fernández-vega B, Fernández-vega Sanz Á. Late retinal and optic nerve vascular complications due to COVID-19 in young individuals. American Journal of Ophthalmology Case Reports 2022;25:101327. [DOI: 10.1016/j.ajoc.2022.101327] [Reference Citation Analysis]
33 Guruprasad K. Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development. Curr Res Struct Biol 2022;4:41-50. [PMID: 35156058 DOI: 10.1016/j.crstbi.2022.01.002] [Reference Citation Analysis]
34 Edenfield RC, Easley CA 4th. Implications of testicular ACE2 and the renin-angiotensin system for SARS-CoV-2 on testis function. Nat Rev Urol 2021. [PMID: 34837081 DOI: 10.1038/s41585-021-00542-5] [Reference Citation Analysis]
35 Wang H, Saha AK, Sun X, Kon ND, Ferrario CM, Groban L. Atrial appendage angiotensin-converting enzyme-2, aging and cardiac surgical patients: a platform for understanding aging-related coronavirus disease-2019 vulnerabilities. Curr Opin Anaesthesiol 2021;34:187-98. [PMID: 33606395 DOI: 10.1097/ACO.0000000000000965] [Reference Citation Analysis]
36 Temiz MZ, Dincer MM, Hacibey I, Yazar RO, Celik C, Kucuk SH, Alkurt G, Doganay L, Yuruk E, Muslumanoglu AY. Investigation of SARS-CoV-2 in semen samples and the effects of COVID-19 on male sexual health by using semen analysis and serum male hormone profile: A cross-sectional, pilot study. Andrologia 2021;53:e13912. [PMID: 33244788 DOI: 10.1111/and.13912] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
37 Felsenstein S, Reiff AO. A hitchhiker's guide through the COVID-19 galaxy. Clin Immunol 2021;232:108849. [PMID: 34563684 DOI: 10.1016/j.clim.2021.108849] [Reference Citation Analysis]
38 Fishbein A, Wang W, Yang H, Yang J, Hallisey VM, Deng J, Verheul SML, Hwang SH, Gartung A, Wang Y, Bielenberg DR, Huang S, Kieran MW, Hammock BD, Panigrahy D. Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression. Proc Natl Acad Sci U S A 2020;117:21576-87. [PMID: 32801214 DOI: 10.1073/pnas.2007412117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
39 Arbeitman CR, Rojas P, Ojeda-May P, Garcia ME. The SARS-CoV-2 spike protein is vulnerable to moderate electric fields. Nat Commun 2021;12:5407. [PMID: 34518528 DOI: 10.1038/s41467-021-25478-7] [Reference Citation Analysis]
40 Motavalli R, Abdelbasset WK, Rahman HS, Achmad MH, Sergeevna NK, Zekiy AO, Adili A, Khiavi FM, Marofi F, Yousefi M, Ghoreishizadeh S, Shomali N, Etemadi J, Jarahian M. The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses. IUBMB Life 2021;73:1005-15. [PMID: 34118117 DOI: 10.1002/iub.2516] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Xia X, Yuan P, Liu Y, Wang Y, Cao W, Zheng JC. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword? Immunology 2021;163:416-30. [PMID: 33742451 DOI: 10.1111/imm.13329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Thomas N, Gurvich C, Kulkarni J. Sex Differences and COVID-19. Adv Exp Med Biol 2021;1327:79-91. [PMID: 34279830 DOI: 10.1007/978-3-030-71697-4_6] [Reference Citation Analysis]
43 Nagy B Jr, Fejes Z, Szentkereszty Z, Sütő R, Várkonyi I, Ajzner É, Kappelmayer J, Papp Z, Tóth A, Fagyas M. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient. Int J Infect Dis 2021;103:412-4. [PMID: 33249290 DOI: 10.1016/j.ijid.2020.11.184] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
44 Wallentin L, Lindbäck J, Eriksson N, Hijazi Z, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Yusuf S, Oldgren J, Siegbahn A. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Eur Heart J 2020;41:4037-46. [PMID: 32984892 DOI: 10.1093/eurheartj/ehaa697] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
45 Bhattacharjee S. Toward COVID-19 Therapeutics: A Viewpoint from the Nonprotein Amino Acid Based Synthetic Peptide Design Approach. ACS Chem Neurosci 2020;11:3701-3. [DOI: 10.1021/acschemneuro.0c00661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Gao YM, Xu G, Wang B, Liu BC. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. J Intern Med 2021;289:147-61. [PMID: 32696489 DOI: 10.1111/joim.13144] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 26.5] [Reference Citation Analysis]
47 Benameur N, Mahmoudi R, Zaid S, Arous Y, Hmida B, Bedoui MH. SARS-CoV-2 diagnosis using medical imaging techniques and artificial intelligence: A review. Clin Imaging 2021;76:6-14. [PMID: 33545517 DOI: 10.1016/j.clinimag.2021.01.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
48 Jaiswal S, Kumar M, Mandeep, Sunita, Singh Y, Shukla P. Systems Biology Approaches for Therapeutics Development Against COVID-19. Front Cell Infect Microbiol 2020;10:560240. [PMID: 33194800 DOI: 10.3389/fcimb.2020.560240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
49 Khoshkam Z, Aftabi Y, Stenvinkel P, Paige Lawrence B, Rezaei MH, Ichihara G, Fereidouni S. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res 2021;31:49-60. [PMID: 33520309 DOI: 10.1016/j.jare.2020.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
50 Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth 2020;125:912-25. [PMID: 32988604 DOI: 10.1016/j.bja.2020.08.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
51 Jacob G, Aharon A, Brenner B. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations. Front Physiol 2020;11:596057. [PMID: 33391014 DOI: 10.3389/fphys.2020.596057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr 2020;63:119-24. [PMID: 32252141 DOI: 10.3345/cep.2020.00493] [Cited by in Crossref: 162] [Cited by in F6Publishing: 131] [Article Influence: 81.0] [Reference Citation Analysis]
53 Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14-20. [PMID: 32336612 DOI: 10.1016/j.ejim.2020.04.037] [Cited by in Crossref: 450] [Cited by in F6Publishing: 407] [Article Influence: 225.0] [Reference Citation Analysis]
54 Tan S, Banwell MG, Ye WC, Lan P, White LV. The Inhibition of RNA Viruses by Amaryllidaceae Alkaloids: Opportunities for the Development of Broad-Spectrum Anti-Coronavirus Drugs. Chem Asian J 2022;:e202101215. [PMID: 35032358 DOI: 10.1002/asia.202101215] [Reference Citation Analysis]
55 Dai YJ, Zhang WN, Wang WD, He SY, Liang CC, Wang DW. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients. Int J Biol Sci 2020;16:3028-36. [PMID: 33061814 DOI: 10.7150/ijbs.51234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Renu K, Prasanna PL, Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci 2020;255:117839. [PMID: 32450165 DOI: 10.1016/j.lfs.2020.117839] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 37.5] [Reference Citation Analysis]
57 Elahi R, Karami P, Heidary AH, Esmaeilzadeh A. An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19). International Immunopharmacology 2022;105:108536. [DOI: 10.1016/j.intimp.2022.108536] [Reference Citation Analysis]
58 Widyasari N, Basuki H, Wahjuni CU. Associated Risk of Death from Covid-19 Infection in Patients with Hypertensive Co-Morbidities. JBE 2021;9:130. [DOI: 10.20473/jbe.v9i22021.130-139] [Reference Citation Analysis]
59 Khodaei F, Ahsan A, Chamanifard M, Zamiri MJ, Ommati MM. Updated information on new coronavirus disease 2019 occurrence, drugs, and prediction of a potential receptor. J Biochem Mol Toxicol 2020;34:e22594. [PMID: 32770858 DOI: 10.1002/jbt.22594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Sriram K, Loomba R, Insel PA. Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges. Proc Natl Acad Sci U S A 2020;117:29274-82. [PMID: 33203679 DOI: 10.1073/pnas.2009875117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
61 [DOI: 10.1101/2020.08.09.20170910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Street ME. HMGB1: A Possible Crucial Therapeutic Target for COVID-19? Horm Res Paediatr. 2020;1-3. [PMID: 32375153 DOI: 10.1159/000508291] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
63 Ghareeb DA, Saleh SR, Nofal MS, Kaddah MMY, Hassan SF, Seif IK, El-zahaby SA, Khedr SM, Kenawy MY, Masoud AA, Soudi SA, Sobhy AA, Sery JG, El-wahab MGA, Elmoneam AAA, Al-mahallawi AM, El-demellawy MA. Potential therapeutic and pharmacological strategies for SARS-CoV2. J Pharm Investig 2021;51:281-96. [DOI: 10.1007/s40005-021-00520-4] [Reference Citation Analysis]
64 Yang J, Zhang P, Cheng WX, Lu Y, Gang W, Ren G. Exposing structural variations in SARS-CoV-2 evolution. Sci Rep 2021;11:22042. [PMID: 34764391 DOI: 10.1038/s41598-021-01650-3] [Reference Citation Analysis]
65 Basu A, Sarkar A, Maulik U. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci Rep 2020;10:17699. [PMID: 33077836 DOI: 10.1038/s41598-020-74715-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 20.0] [Reference Citation Analysis]
66 Şenkal N, Meral R, Medetalibeyoğlu A, Konyaoğlu H, Kose M, Tukek T. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19. Anatol J Cardiol 2020;24:21-9. [PMID: 32628137 DOI: 10.14744/AnatolJCardiol.2020.57431] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
67 Shirbhate E, Pandey J, Patel VK, Kamal M, Jawaid T, Gorain B, Kesharwani P, Rajak H. Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention. Pharmacol Rep 2021. [PMID: 34176080 DOI: 10.1007/s43440-021-00303-6] [Reference Citation Analysis]
68 Paz LES, Bezerra BJDS, Pereira TMM, da Silva WE. COVID-19: the importance of physical therapy in the recovery of workers' health. Rev Bras Med Trab 2021;19:94-106. [PMID: 33986786 DOI: 10.47626/1679-4435-2021-709] [Reference Citation Analysis]
69 Yavarpour-Bali H, Ghasemi-Kasman M. Update on neurological manifestations of COVID-19. Life Sci 2020;257:118063. [PMID: 32652139 DOI: 10.1016/j.lfs.2020.118063] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
70 Kamel NA, El Wakeel LM, Aboshanab KM. Exploring SARS-CoV-2 Spikes Glycoproteins for Designing Potential Antiviral Targets. Viral Immunol 2021. [PMID: 34018828 DOI: 10.1089/vim.2021.0023] [Reference Citation Analysis]
71 Vofo G, Brodie R, Gross M. Nasal lavage containing Angiotensin-Converting Enzyme-2 agonist can prevent and reduce viral load in COVID-19. Med Hypotheses 2020;144:110207. [PMID: 33254514 DOI: 10.1016/j.mehy.2020.110207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Li M, Chen S, Xiang X, Wang Q, Liu X. Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system. Herz 2020;45:659-62. [PMID: 33025029 DOI: 10.1007/s00059-020-04989-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Gong Y, Ma TC, Xu YY, Yang R, Gao LJ, Wu SH, Li J, Yue ML, Liang HG, He X, Yun T. Early Research on COVID-19: A Bibliometric Analysis. Innovation (N Y) 2020;1:100027. [PMID: 32914141 DOI: 10.1016/j.xinn.2020.100027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
74 Saxena SK, Kumar S, Baxi P, Srivastava N, Puri B, Ratho RK. Chasing COVID-19 through SARS-CoV-2 spike glycoprotein. Virusdisease 2020;:1-9. [PMID: 33313362 DOI: 10.1007/s13337-020-00642-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
75 Nasiri M, Khodadadi J, Molaei S. Does vitamin D serum level affect prognosis of COVID-19 patients? Int J Infect Dis 2021;107:264-7. [PMID: 33940189 DOI: 10.1016/j.ijid.2021.04.083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
76 van Rensburg R, Pillay-Fuentes Lorente V, Decloedt EH. Current evidence for directed and supportive investigational therapies against COVID-19. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235422 DOI: 10.7196/AJTCCM.2020.v26i2.072] [Reference Citation Analysis]
77 Bhattacharya R, Dev K, Sourirajan A. Antiviral activity of bioactive phytocompounds against coronavirus: An update. J Virol Methods 2021;290:114070. [PMID: 33497729 DOI: 10.1016/j.jviromet.2021.114070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
78 Badeti S, Tseng HC, Romanienko P, Yehia G, Liu D. Development of a Novel Human CD147 Transgenic NSG Mouse Model to test SARS-CoV-2 Infection and Immune Responses. Res Sq 2021:rs. [PMID: 33851148 DOI: 10.21203/rs.3.rs-396257/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Bosso M, Thanaraj TA, Abu-Farha M, Alanbaei M, Abubaker J, Al-Mulla F. The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Mol Ther Methods Clin Dev 2020;18:321-7. [PMID: 32665962 DOI: 10.1016/j.omtm.2020.06.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
80 Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clin Rheumatol 2020;39:3245-54. [PMID: 32895747 DOI: 10.1007/s10067-020-05387-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
81 Parvez Y, AlZarooni F, Khan F. Optic Neuritis in a Child With COVID-19: A Rare Association. Cureus 2021;13:e14094. [PMID: 33927916 DOI: 10.7759/cureus.14094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Zehra Z, Luthra M, Siddiqui SM, Shamsi A, Gaur NA, Islam A. Corona virus versus existence of human on the earth: A computational and biophysical approach. Int J Biol Macromol 2020;161:271-81. [PMID: 32512089 DOI: 10.1016/j.ijbiomac.2020.06.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
83 Monserrat Villatoro J, Mejía-abril G, Díaz García L, Zubiaur P, Jiménez González M, Fernandez Jimenez G, Cancio I, Arribas JR, Suarez Fernández C, Mingorance J, García Rodríguez J, Villagrasa Ferrer JR, Carcas AJ, Frías J, Abad-santos F, Borobia AM, Ramírez E; on behalf of the COVID@HULP Working Group and Other Collaborators from Hospital Universitario de la Princesa. A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals 2022;15:78. [DOI: 10.3390/ph15010078] [Reference Citation Analysis]
84 Chen S, Zhou J, Ou X, Cheng W, Qin Y, Guo Y, Jiang Y. Alimentary system is directly attacked by SARS-COV-2 and further prevents immune dysregulation caused by COVID-19. Int J Clin Pract 2021;75:e13893. [PMID: 33289233 DOI: 10.1111/ijcp.13893] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry 2021;26:1044-59. [PMID: 33328588 DOI: 10.1038/s41380-020-00965-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
86 Murugan C, Ramamoorthy S, Kuppuswamy G, Murugan RK, Sivalingam Y, Sundaramurthy A. COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks. Int J Biol Macromol 2021:S0141-8130(21)02301-1. [PMID: 34710479 DOI: 10.1016/j.ijbiomac.2021.10.144] [Reference Citation Analysis]
87 Farahani M, Niknam Z, Mohammadi Amirabad L, Amiri-Dashatan N, Koushki M, Nemati M, Danesh Pouya F, Rezaei-Tavirani M, Rasmi Y, Tayebi L. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. Biomed Pharmacother 2022;145:112420. [PMID: 34801852 DOI: 10.1016/j.biopha.2021.112420] [Reference Citation Analysis]
88 Xu F, Gao J, Bergmann S, Sims AC, Ashbrook DG, Baric RS, Cui Y, Jonsson CB, Li K, Williams RW, Schughart K, Lu L. Genetic Dissection of the Regulatory Mechanisms of Ace2 in the Infected Mouse Lung. Front Immunol 2020;11:607314. [PMID: 33488611 DOI: 10.3389/fimmu.2020.607314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Feng F, Chen J, Zhao J, Li Y, Li M, Sun C. Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection. Viruses 2021;13:2243. [PMID: 34835049 DOI: 10.3390/v13112243] [Reference Citation Analysis]
90 Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H, Bassetti S, Leuppi JD, Cathomas G, Tolnay M, Mertz KD, Tzankov A. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198-209. [PMID: 32364264 DOI: 10.1111/his.14134] [Cited by in Crossref: 493] [Cited by in F6Publishing: 466] [Article Influence: 246.5] [Reference Citation Analysis]
91 Jafarpour R, Pashangzadeh S, Dowran R. Host factors: Implications in immunopathogenesis of COVID-19. Pathol Res Pract 2021;228:153647. [PMID: 34749207 DOI: 10.1016/j.prp.2021.153647] [Reference Citation Analysis]
92 Ma C, Nikiforov A, De Geyter N, Dai X, Morent R, Ostrikov KK. Future antiviral polymers by plasma processing. Prog Polym Sci 2021;118:101410. [PMID: 33967350 DOI: 10.1016/j.progpolymsci.2021.101410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Eleuteri D, Montini L, Cutuli SL, Rossi C, Alcaro F, Antonelli M. Renin-angiotensin system dysregulation in critically ill patients with acute respiratory distress syndrome due to COVID-19: a preliminary report. Crit Care 2021;25:91. [PMID: 33648544 DOI: 10.1186/s13054-021-03507-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
94 Khusid JA, Becerra AZ, Gallante B, Sadiq AS, Atallah WM, Badani KK, Gupta M. Cancer, Mortality, and Acute Kidney Injury among Hospitalized Patients with SARS-CoV-2 Infection. Asian Pac J Cancer Prev 2021;22:517-22. [PMID: 33639668 DOI: 10.31557/APJCP.2021.22.2.517] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Bhatia R, Ganti SS, Narang RK, Rawal RK. Strategies and Challenges to Develop Therapeutic Candidates against COVID-19 Pandemic. TOVJ 2020;14:16-21. [DOI: 10.2174/1874357902014010016] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
96 Golabi S, Adelipour M, Mobarak S, Piri M, Seyedtabib M, Bagheri R, Suzuki K, Ashtary-Larky D, Maghsoudi F, Naghashpour M. The Association between Vitamin D and Zinc Status and the Progression of Clinical Symptoms among Outpatients Infected with SARS-CoV-2 and Potentially Non-Infected Participants: A Cross-Sectional Study. Nutrients 2021;13:3368. [PMID: 34684369 DOI: 10.3390/nu13103368] [Reference Citation Analysis]
97 Gelman R, Bayatra A, Kessler A, Schwartz A, Ilan Y. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents. Emerg Microbes Infect 2020;9:1397-406. [PMID: 32490731 DOI: 10.1080/22221751.2020.1776161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
98 Kali SK, Dröge P, Murugan P. Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection. Microb Pathog 2021;158:105105. [PMID: 34311016 DOI: 10.1016/j.micpath.2021.105105] [Reference Citation Analysis]
99 Engin AB, Engin ED, Engin A. Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection. Environ Toxicol Pharmacol 2020;79:103436. [PMID: 32562764 DOI: 10.1016/j.etap.2020.103436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
100 Casel MAB, Rollon RG, Choi YK. Experimental Animal Models of Coronavirus Infections: Strengths and Limitations. Immune Netw 2021;21:e12. [PMID: 33996168 DOI: 10.4110/in.2021.21.e12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Younis JS, Skorecki K, Abassi Z. The Double Edge Sword of Testosterone's Role in the COVID-19 Pandemic. Front Endocrinol (Lausanne) 2021;12:607179. [PMID: 33796068 DOI: 10.3389/fendo.2021.607179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
102 Carpenter A, Chambers OJ, El Harchi A, Bond R, Hanington O, Harmer SC, Hancox JC, James AF. COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2. Front Cardiovasc Med 2020;7:85. [PMID: 32432127 DOI: 10.3389/fcvm.2020.00085] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
103 Swärd P, Edsfeldt A, Reepalu A, Jehpsson L, Rosengren BE, Karlsson MK. Age and sex differences in soluble ACE2 may give insights for COVID-19. Crit Care 2020;24:221. [PMID: 32410690 DOI: 10.1186/s13054-020-02942-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 23.0] [Reference Citation Analysis]
104 Harisna AH, Nurdiansyah R, Syaifie PH, Nugroho DW, Saputro KE, Firdayani, Prakoso CD, Rochman NT, Maulana NN, Noviyanto A, Mardliyati E. In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis. Biochem Biophys Rep 2021;26:100969. [PMID: 33681482 DOI: 10.1016/j.bbrep.2021.100969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
105 Angeli F, Verdecchia P, Reboldi G. Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patients. Expert Opin Pharmacother 2021;:1-8. [PMID: 34634987 DOI: 10.1080/14656566.2021.1990264] [Reference Citation Analysis]
106 Kreutz R, Algharably EAE, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer TG, Wang JG, Burnier M. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. Cardiovasc Res 2020;116:1688-99. [PMID: 32293003 DOI: 10.1093/cvr/cvaa097] [Cited by in Crossref: 169] [Cited by in F6Publishing: 148] [Article Influence: 84.5] [Reference Citation Analysis]
107 Taylor BES, Khandelwal P, Rallo MS, Patel P, Smith L, Sun H, Nanda A, Singla A, Roychowdhury S, Cheng RC, Lee K, Gupta G, Johnson SA. Outcomes and Spectrum of Major Neurovascular Events Among COVID-19 Patients: A 3-Center Experience. Neurosurg Open 2020;1:okaa008. [PMID: 34632389 DOI: 10.1093/neuopn/okaa008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
108 Sandoval F, Julio K, Méndez G, Valderas C, Echeverría AC, Perinetti MJ, Suarez NM, Barraza G, Piñera C, Alarcón M, Samaniego F, Quesada-Rios P, Robles C, Izquierdo G. Neurologic Features Associated With SARS-CoV-2 Infection in Children: A Case Series Report. J Child Neurol 2021;:883073821989164. [PMID: 33646895 DOI: 10.1177/0883073821989164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
109 Cipriano M, Ruberti E, Giacalone A. Gastrointestinal Infection Could Be New Focus for Coronavirus Diagnosis. Cureus 2020;12:e7422. [PMID: 32351807 DOI: 10.7759/cureus.7422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
110 Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D'Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.J Infect Dis. 2020;222:1807-1815. [PMID: 32914853 DOI: 10.1093/infdis/jiaa578] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
111 Lotfi F, Akbarzadeh-Khiavi M, Lotfi Z, Rahbarnia L, Safary A, Zarredar H, Baghbanzadeh A, Naghili B, Baradaran B. Micronutrient therapy and effective immune response: a promising approach for management of COVID-19. Infection 2021. [PMID: 34160789 DOI: 10.1007/s15010-021-01644-3] [Reference Citation Analysis]
112 Hembram P. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021;45:123. [PMID: 34257504 DOI: 10.1186/s42269-021-00582-2] [Reference Citation Analysis]
113 Sanchez-Ramirez DC, Mackey D. Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis. Respir Med 2020;171:106096. [PMID: 32763754 DOI: 10.1016/j.rmed.2020.106096] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
114 Bastos GAN, Azambuja AZ, Polanczyk CA, Gräf DD, Zorzo IW, Maccari JG, Haygert LS, Nasi LA, Gazzana MB, Bessel M, Pitrez PM, Oliveira RP, Scotta MC. Clinical characteristics and predictors of mechanical ventilation in patients with COVID-19 hospitalized in Southern Brazil. Rev Bras Ter Intensiva 2020;32:487-92. [PMID: 33263703 DOI: 10.5935/0103-507X.20200082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
115 Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos DA, Aaseth J, Tsatsakis A, Tinkov AA. Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review). Int J Mol Med 2020;46:17-26. [PMID: 32319538 DOI: 10.3892/ijmm.2020.4575] [Cited by in Crossref: 76] [Cited by in F6Publishing: 117] [Article Influence: 38.0] [Reference Citation Analysis]
116 Lopez Santi R, Piskorz DL, Marquez MF, Ramirez Ramos C, Renna NF, Ibarrola M, Wyss FS, Naranjo Dominguez A, Perez GE, Farina JM, Forte E, Juarez Lloclla JP, Flores de Espinal E, Puente Barragan A, Ruise MG, Delgado D, Baranchuk A; CorCOVID LATAM Study Investigators. Impact of the Pandemic on NonInfected Cardiometabolic Patients: A Survey in Countries of Latin America-Rationale and Design of the CorCOVID LATAM Study. CJC Open 2020;2:671-7. [PMID: 32904407 DOI: 10.1016/j.cjco.2020.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
117 Laney DA, Germain DP, Oliveira JP, Burlina AP, Cabrera GH, Hong GR, Hopkin RJ, Niu DM, Thomas M, Trimarchi H, Wilcox WR, Politei JM, Ortiz A. Fabry disease and COVID-19: international expert recommendations for management based on real-world experience. Clin Kidney J 2020;13:913-25. [PMID: 33391734 DOI: 10.1093/ckj/sfaa227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
118 Di Salvo E, Di Gioacchino M, Tonacci A, Casciaro M, Gangemi S. Alarmins, COVID-19 and comorbidities. Ann Med 2021;53:777-85. [PMID: 34042528 DOI: 10.1080/07853890.2021.1921252] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? J Clin Med. 2020;9. [PMID: 32403217 DOI: 10.3390/jcm9051417] [Cited by in Crossref: 185] [Cited by in F6Publishing: 191] [Article Influence: 92.5] [Reference Citation Analysis]
120 Hong J, Jhun H, Choi YO, Taitt AS, Bae S, Lee Y, Song CS, Yeom SC, Kim S. Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target. Immune Netw 2021;21:e8. [PMID: 33728101 DOI: 10.4110/in.2021.21.e8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Li J, Wang X, Chen J, Zhang H, Deng A. Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China. JAMA Cardiol. 2020;5:825-830. [PMID: 32324209 DOI: 10.1001/jamacardio.2020.1624] [Cited by in Crossref: 297] [Cited by in F6Publishing: 273] [Article Influence: 148.5] [Reference Citation Analysis]
122 Alfaleh MA, Zawawi A, Al-Amri SS, Hashem AM. David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors. MAbs 2022;14:2057832. [PMID: 35380919 DOI: 10.1080/19420862.2022.2057832] [Reference Citation Analysis]
123 Arnold RH, Tideman PA, Devlin GP, Carroll GE, Elder A, Lowe H, Macdonald PS, Bannon PG, Juergens C, McGuire M, Mariani JA, Coffey S, Faddy S, Brown A, Inglis S, Wang WYS. Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement. Heart Lung Circ 2020;29:e88-93. [PMID: 32487432 DOI: 10.1016/j.hlc.2020.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
124 Spaccarotella C, Mazzitelli M, Migliarino S, Curcio A, De Rosa S, Torti C, Indolfi C. Therapy with RAS inhibitors during the COVID-19 pandemic. J Cardiovasc Med (Hagerstown) 2021;22:329-34. [PMID: 33795584 DOI: 10.2459/JCM.0000000000001160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
125 Turkia M. COVID-19 As An Endothelial Disease and Its Relationship to Vascular Endothelial Growth Factor (VEGF) and Iodide. SSRN Journal. [DOI: 10.2139/ssrn.3604987] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
126 Wang M, Qin K, Zhai X. Combined Network Pharmacology, Molecular Docking, and Experimental Verification Approach to Investigate the Potential Mechanisms of Polydatin Against COVID-19. Natural Product Communications 2022;17:1934578X2210953. [DOI: 10.1177/1934578x221095352] [Reference Citation Analysis]
127 Zimmer MA, Zink AK, Weißer CW, Vogt U, Michelsen A, Priebe HJ, Mols G. Hypernatremia-A Manifestation of COVID-19: A Case Series. A A Pract 2020;14:e01295. [PMID: 32909725 DOI: 10.1213/XAA.0000000000001295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
128 Crimi E, Benincasa G, Figueroa-Marrero N, Galdiero M, Napoli C. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review. Br J Anaesth 2020;125:1002-17. [PMID: 32828489 DOI: 10.1016/j.bja.2020.06.060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
129 Sanchez-Vazquez R, Guío-Carrión A, Zapatero-Gaviria A, Martínez P, Blasco MA. Shorter telomere lengths in patients with severe COVID-19 disease. Aging (Albany NY) 2021;13:1-15. [PMID: 33428591 DOI: 10.18632/aging.202463] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
130 Behl T, Kaur I, Bungau S, Kumar A, Uddin MS, Kumar C, Pal G, Sahil, Shrivastava K, Zengin G, Arora S. The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions. Life Sci 2020;257:118075. [PMID: 32653522 DOI: 10.1016/j.lfs.2020.118075] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 20.5] [Reference Citation Analysis]
131 Roncati L, Gallo G, Manenti A, Palmieri B. Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2. Med Hypotheses 2020;140:109686. [PMID: 32220710 DOI: 10.1016/j.mehy.2020.109686] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
132 Awadasseid A, Wu Y, Tanaka Y, Zhang W. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. Int J Biol Sci 2020;16:1846-60. [PMID: 32398954 DOI: 10.7150/ijbs.45018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
133 Sun H, Su X, Huang L, Mu D, Qu Y. Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection. Biomolecules 2021;11:196. [PMID: 33573324 DOI: 10.3390/biom11020196] [Reference Citation Analysis]
134 Haşlak F, Yıldız M, Adrovic A, Barut K, Kasapçopur Ö. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon. Balkan Med J 2020;37:184-8. [PMID: 32264666 DOI: 10.4274/balkanmedj.galenos.2020.2020.4.43] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
135 Thota SM, Balan V, Sivaramakrishnan V. Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19. Phytother Res 2020;34:3148-67. [PMID: 32881214 DOI: 10.1002/ptr.6794] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
136 Dowran R, Nabavi SF, Habtemariam S, Banach M, Shahmohamadnejad S, Cismaru CA, Berindan-Neagoe I, Sahebnasagh A, Nabavi SM. Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon? Biochimie 2020;177:50-2. [PMID: 32805303 DOI: 10.1016/j.biochi.2020.08.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
137 Hossein-Khannazer N, Shokoohian B, Shpichka A, Aghdaei HA, Timashev P, Vosough M. Novel therapeutic approaches for treatment of COVID-19. J Mol Med (Berl) 2020;98:789-803. [PMID: 32494931 DOI: 10.1007/s00109-020-01927-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
138 Syed A, Khan A, Gosai F, Asif A, Dhillon S. Gastrointestinal pathophysiology of SARS-CoV2 - a literature review. J Community Hosp Intern Med Perspect. 2020;10:523-528. [PMID: 33194122 DOI: 10.1080/20009666.2020.1811556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
139 Giordano G, Petrolini C, Corradini E, Campanini N, Esposito S, Perrone S. COVID-19 in pregnancy: placental pathological patterns and effect on perinatal outcome in five cases. Diagn Pathol 2021;16:88. [PMID: 34602071 DOI: 10.1186/s13000-021-01148-6] [Reference Citation Analysis]
140 Hozhabri H, Piceci Sparascio F, Sohrabi H, Mousavifar L, Roy R, Scribano D, De Luca A, Ambrosi C, Sarshar M. The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting. Int J Environ Res Public Health 2020;17:E5648. [PMID: 32764417 DOI: 10.3390/ijerph17165648] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
141 Schmitt CA, Bergey CM, Jasinska AJ, Ramensky V, Burt F, Svardal H, Jorgensen MJ, Freimer NB, Grobler JP, Turner TR. ACE2 and TMPRSS2 variation in savanna monkeys (Chlorocebus spp.): Potential risk for zoonotic/anthroponotic transmission of SARS-CoV-2 and a potential model for functional studies. PLoS One 2020;15:e0235106. [PMID: 32574196 DOI: 10.1371/journal.pone.0235106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
142 Yildiz H, Alp HH, Ekin S, Arisoy A, Gunbatar H, Asker S, Cilingir BM, Sunnetcioglu A, Celikel M, Esen N, Bedirhanoglu S, Baykal ND, Haylu M. Analysis of endogenous oxidative damage markers and association with pulmonary involvement severity in patients with SARS-CoV-2 pneumonia. Infect Dis Now 2021;51:429-34. [PMID: 34146758 DOI: 10.1016/j.idnow.2021.06.302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
143 Nicola M, O'Neill N, Sohrabi C, Khan M, Agha M, Agha R. Evidence based management guideline for the COVID-19 pandemic - Review article. Int J Surg. 2020;77:206-216. [PMID: 32289472 DOI: 10.1016/j.ijsu.2020.04.001] [Cited by in Crossref: 119] [Cited by in F6Publishing: 94] [Article Influence: 59.5] [Reference Citation Analysis]
144 Ou T, Mou H, Zhang L, Ojha A, Choe H, Farzan M. Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. PLoS Pathog 2021;17:e1009212. [PMID: 33465165 DOI: 10.1371/journal.ppat.1009212] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 35.0] [Reference Citation Analysis]
145 Tomazou M, Bourdakou MM, Minadakis G, Zachariou M, Oulas A, Karatzas E, Loizidou E, Kakouri A, Christodoulou C, Savva K, Zanti M, Onisiforou A, Afxenti S, Richter J, Christodoulou CG, Kyprianou T, Kolios G, Dietis N, Spyrou GM. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19. Brief Bioinform 2021:bbab114. [PMID: 34009288 DOI: 10.1093/bib/bbab114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Guruprasad L. Human coronavirus spike protein-host receptor recognition. Prog Biophys Mol Biol 2021;161:39-53. [PMID: 33137344 DOI: 10.1016/j.pbiomolbio.2020.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
147 Matarese A, Gambardella J, Sardu C, Santulli G. miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19. Biomedicines 2020;8:E462. [PMID: 33143053 DOI: 10.3390/biomedicines8110462] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
148 Santos AF, Póvoa P, Paixão P, Mendonça A, Taborda-Barata L. Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19. Front Chem 2021;9:685196. [PMID: 34568275 DOI: 10.3389/fchem.2021.685196] [Reference Citation Analysis]
149 Misra SS, Ahirwar AK, Sakarde A, Kaim K, Ahirwar P, Jahid M, Sorte SR, Lokhande SL, Kaur AP, Kumawat R. COVID-19 infection in pregnancy: a review of existing knowledge. Horm Mol Biol Clin Investig 2022. [PMID: 35172416 DOI: 10.1515/hmbci-2021-0081] [Reference Citation Analysis]
150 Dourado D, Freire DT, Pereira DT, Amaral-Machado L, N Alencar É, de Barros ALB, Egito EST. Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials? Biomed Pharmacother 2021;139:111578. [PMID: 33848774 DOI: 10.1016/j.biopha.2021.111578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
151 Dixon L, McNamara C, Gaur P, Mallon D, Coughlan C, Tona F, Jan W, Wilson M, Jones B. Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon? Stroke Vasc Neurol 2020;5:315-22. [PMID: 33208493 DOI: 10.1136/svn-2020-000652] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
152 Senger MR, Evangelista TCS, Dantas RF, Santana MVDS, Gonçalves LCS, de Souza Neto LR, Ferreira SB, Silva-Junior FP. COVID-19: molecular targets, drug repurposing and new avenues for drug discovery. Mem Inst Oswaldo Cruz 2020;115:e200254. [PMID: 33027420 DOI: 10.1590/0074-02760200254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
153 Rolfo A, Cosma S, Nuzzo AM, Salio C, Moretti L, Sassoè-pognetto M, Carosso AR, Borella F, Cutrin JC, Benedetto C. Increased Placental Anti-Oxidant Response in Asymptomatic and Symptomatic COVID-19 Third-Trimester Pregnancies. Biomedicines 2022;10:634. [DOI: 10.3390/biomedicines10030634] [Reference Citation Analysis]
154 Augustine DX, Keteepe-Arachi T, Malhotra A. Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation. Eur Cardiol 2021;16:e03. [PMID: 33708264 DOI: 10.15420/ecr.2020.36] [Reference Citation Analysis]
155 Wang QJ, Yao YZ, Song JS, Wang Q, Xu LY, Bao ZJ, Mao DW, Zhou JH, Zhang ZE, Wang Y, Li YW, Wang HP, Li L, Pan HY, Zhang GQ, Li SB. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study. BMC Infect Dis 2020;20:818. [PMID: 33167900 DOI: 10.1186/s12879-020-05549-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 [DOI: 10.1101/2020.06.09.142125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Vallée A, Lecarpentier Y, Vallée JN. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment. Front Immunol 2021;12:666693. [PMID: 33927728 DOI: 10.3389/fimmu.2021.666693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
158 Merdji H, Mayeur S, Schenck M, Oulehri W, Clere-Jehl R, Cunat S, Herbrecht JE, Janssen-Langenstein R, Nicolae A, Helms J, Meziani F, Chenard MP; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care, Sepsis Trial Group for Global Evaluation, Research in Sepsis). Histopathological features in fatal COVID-19 acute respiratory distress syndrome. Med Intensiva (Engl Ed) 2021;45:261-70. [PMID: 34059216 DOI: 10.1016/j.medine.2021.02.005] [Reference Citation Analysis]
159 Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci 2020;258:118185. [PMID: 32750438 DOI: 10.1016/j.lfs.2020.118185] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 23.5] [Reference Citation Analysis]
160 Vohora D, Jain S, Tripathi M, Potschka H. COVID-19 and seizures: Is there a link? Epilepsia 2020;61:1840-53. [PMID: 32944929 DOI: 10.1111/epi.16656] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
161 Guo J, Sheng K, Wu S, Chen H, Xu W. An Update on the Relationship of SARS-CoV-2 and Male Reproduction. Front Endocrinol (Lausanne) 2021;12:788321. [PMID: 34887838 DOI: 10.3389/fendo.2021.788321] [Reference Citation Analysis]
162 Afshar S, Bahmani A, Saidijam M. Molecular Docking and Fragment-Based QSAR Modeling for In Silico Screening of Approved Drugs and Candidate Compounds Against COVID-19. Avicenna J Med Biochem 2020;8:83-8. [DOI: 10.34172/ajmb.2020.12] [Reference Citation Analysis]
163 Adão R, Guzik TJ. Inside the heart of COVID-19. Cardiovasc Res 2020;116:e59-61. [PMID: 32266937 DOI: 10.1093/cvr/cvaa086] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
164 Fan S, Yan S, Liu X, Liu P, Huang L, Wang S. Human Coronavirus Infections and Pregnancy. Matern Fetal Med 2021;3:53-65. [PMID: 34192279 DOI: 10.1097/FM9.0000000000000071] [Reference Citation Analysis]
165 Hrenak J, Simko F. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome. Int J Mol Sci 2020;21:E8038. [PMID: 33126657 DOI: 10.3390/ijms21218038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
166 Parga-lozano C. Hibiscus Sabdariffa como candidato terapéutico para COVID-19. Duazary 2020;17:1-3. [DOI: 10.21676/2389783x.3597] [Reference Citation Analysis]
167 Sen S, Dey A, Bandhyopadhyay S, Uversky VN, Maulik U. Understanding structural malleability of the SARS-CoV-2 proteins and relation to the comorbidities. Brief Bioinform 2021:bbab232. [PMID: 34143202 DOI: 10.1093/bib/bbab232] [Reference Citation Analysis]
168 Barbosa LC, Gonçalves TL, de Araujo LP, Rosario LVO, Ferrer VP. Endothelial cells and SARS-CoV-2: An intimate relationship. Vascul Pharmacol 2021;137:106829. [PMID: 33422689 DOI: 10.1016/j.vph.2021.106829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
169 Körner RW, Majjouti M, Alcazar MAA, Mahabir E. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2. Viruses 2020;12:E880. [PMID: 32806708 DOI: 10.3390/v12080880] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
170 Burgoyne RA, Fisher AJ, Borthwick LA. The Role of Epithelial Damage in the Pulmonary Immune Response. Cells 2021;10:2763. [PMID: 34685744 DOI: 10.3390/cells10102763] [Reference Citation Analysis]
171 Grudlewska-Buda K, Wiktorczyk-Kapischke N, Wałecka-Zacharska E, Kwiecińska-Piróg J, Buszko K, Leis K, Juszczuk K, Gospodarek-Komkowska E, Skowron K. SARS-CoV-2-Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis. J Clin Med 2021;10:1962. [PMID: 34063654 DOI: 10.3390/jcm10091962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Yazdani M, Khezri J, Hadizadeh N, Amir Zakaria JZ, Naderi M, Mahmoodian S, Karkhanei AA, Razi F, Sanati MH, Hashemi E. Depinar, a drug that potentially inhibits the binding and entry of COVID-19 into host cells based on computer-aided studies. Res Pharm Sci 2021;16:315-25. [PMID: 34221065 DOI: 10.4103/1735-5362.314830] [Reference Citation Analysis]
173 Rehman SU, Tabish M. Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs. Clin Sci (Lond) 2020;134:1143-50. [PMID: 32442315 DOI: 10.1042/CS20200419] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
174 Shi F, Wen H, Liu R, Bai J, Wang F, Mubarik S, Liu X, Yu Y, Hong Q, Cao J, Yu C. The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China. Glob Health Res Policy 2021;6:18. [PMID: 34049599 DOI: 10.1186/s41256-021-00200-8] [Reference Citation Analysis]
175 Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M, Antó JM, Arcolaci A, Azkur AK, Azkur D, Beken B, Boccabella C, Bousquet J, Breiteneder H, Carvalho D, De Las Vecillas L, Diamant Z, Eguiluz-Gracia I, Eiwegger T, Eyerich S, Fokkens W, Gao YD, Hannachi F, Johnston SL, Jutel M, Karavelia A, Klimek L, Moya B, Nadeau KC, O'Hehir R, O'Mahony L, Pfaar O, Sanak M, Schwarze J, Sokolowska M, Torres MJ, van de Veen W, van Zelm MC, Wang Y, Zhang L, Jiménez-Saiz R, Akdis CA. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy 2020;75:2503-41. [PMID: 32535955 DOI: 10.1111/all.14449] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
176 Rastogi A, Tewari P. Covid 19 and its cardiovascular effects. Ann Card Anaesth 2020;23:401-8. [PMID: 33109794 DOI: 10.4103/aca.aca_237_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Osman EEA, Toogood PL, Neamati N. COVID-19: Living through Another Pandemic. ACS Infect Dis 2020;6:1548-52. [PMID: 32388976 DOI: 10.1021/acsinfecdis.0c00224] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
178 Hanna N, Hanna M, Sharma S. Is pregnancy an immunological contributor to severe or controlled COVID-19 disease? Am J Reprod Immunol 2020;84:e13317. [PMID: 32757366 DOI: 10.1111/aji.13317] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
179 Chiappalupi S, Salvadori L, Vukasinovic A, Donato R, Sorci G, Riuzzi F. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives. Life Sci 2021;272:119251. [PMID: 33636175 DOI: 10.1016/j.lfs.2021.119251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
180 Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T. Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug Dev Res 2021. [PMID: 34762760 DOI: 10.1002/ddr.21895] [Reference Citation Analysis]
181 Villa A, Brunialti E, Dellavedova J, Meda C, Rebecchi M, Conti M, Donnici L, De Francesco R, Reggiani A, Lionetti V, Ciana P. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic. Pharmacol Res 2021;175:105982. [PMID: 34798263 DOI: 10.1016/j.phrs.2021.105982] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
182 Verdecchia P, Cavallini C, Spanevello A, Angeli F. COVID-19: ACE2centric Infective Disease? Hypertension 2020;76:294-9. [PMID: 32476472 DOI: 10.1161/HYPERTENSIONAHA.120.15353] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 15.5] [Reference Citation Analysis]
183 See A, Toh ST. Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview. Head Neck 2020;42:1652-6. [PMID: 32357381 DOI: 10.1002/hed.26232] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
184 Yang Y, Ivanov DG, Kaltashov IA. The challenge of structural heterogeneity in the native mass spectrometry studies of the SARS-CoV-2 spike protein interactions with its host cell-surface receptor. bioRxiv 2021:2021. [PMID: 34189525 DOI: 10.1101/2021.06.20.449191] [Reference Citation Analysis]
185 Khare P, Sahu U, Pandey SC, Samant M. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection. Virus Res 2020;290:198169. [PMID: 32979476 DOI: 10.1016/j.virusres.2020.198169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
186 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Reference Citation Analysis]
187 Asandei A, Mereuta L, Schiopu I, Park Y, Luchian T. Teaching an old dog new tricks: A lipid membrane-based electric immunosensor for real-time probing of the spike S1 protein subunit from SARS-CoV-2. Proteomics 2021;:e2100047. [PMID: 34586750 DOI: 10.1002/pmic.202100047] [Reference Citation Analysis]
188 Irrera N, Russo M, Pallio G, Bitto A, Mannino F, Minutoli L, Altavilla D, Squadrito F. The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury. Int J Mol Sci 2020;21:E6204. [PMID: 32867310 DOI: 10.3390/ijms21176204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
189 Huang YF, Bai C, He F, Xie Y, Zhou H. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19). Pharmacol Res 2020;158:104939. [PMID: 32445956 DOI: 10.1016/j.phrs.2020.104939] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 34.5] [Reference Citation Analysis]
190 K Konstantinidou S, P Papanastasiou I. Repurposing current therapeutic regimens against SARS-CoV-2 (Review). Exp Ther Med 2020;20:1845-55. [PMID: 32782493 DOI: 10.3892/etm.2020.8905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
191 Hoseinzadeh E, Safoura Javan, Farzadkia M, Mohammadi F, Hossini H, Taghavi M. An updated min-review on environmental route of the SARS-CoV-2 transmission. Ecotoxicol Environ Saf 2020;202:111015. [PMID: 32800237 DOI: 10.1016/j.ecoenv.2020.111015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
192 Belbézier A, Arnaud M, Boccon-Gibod I, Pelletier F, McAvoy C, Gobert D, Fain O, Du-Thanh A, Launay D, Lupo J, Bouillet L. COVID-19 as a trigger of acute attacks in people with hereditary angioedema. Clin Exp Allergy 2021;51:947-50. [PMID: 33772888 DOI: 10.1111/cea.13870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
193 Bhandari B, Neupane S, Khanal R, Lnu K, Wert Y, Komanduri S. COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature. J Community Hosp Intern Med Perspect 2021;11:315-21. [PMID: 34191989 DOI: 10.1080/20009666.2021.1896429] [Reference Citation Analysis]
194 Shi C, Tingting W, Li JP, Sullivan MA, Wang C, Wang H, Deng B, Zhang Y. Comprehensive Landscape of Heparin Therapy for COVID-19. Carbohydr Polym 2021;254:117232. [PMID: 33357843 DOI: 10.1016/j.carbpol.2020.117232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
195 Arenas Jimenez MD, González-Parra E, Riera M, Rincón Bello A, López-Herradón A, Cao H, Hurtado S, Collado S, Ribera L, Barbosa F, Dapena F, Torregrosa V, Broseta JJ, Soto Montañez C, Navarro-González JF, Ramos R, Bover J, Nogués-Solan X, Crespo M, Dusso AS, Pascual J. Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics. Nutrients 2021;13:2559. [PMID: 34444716 DOI: 10.3390/nu13082559] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Iacob S, Iacob DG. SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus. Front Pharmacol 2020;11:1224. [PMID: 32982720 DOI: 10.3389/fphar.2020.01224] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
197 Hadizadeh F. Supplementation with vitamin D in the COVID-19 pandemic? Nutr Rev 2021;79:200-8. [PMID: 32679589 DOI: 10.1093/nutrit/nuaa081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
198 Zhan X, Dowell S, Shen Y, Lee DL. Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects? Heliyon 2020;6:e04900. [PMID: 32935064 DOI: 10.1016/j.heliyon.2020.e04900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
199 Franco-Moreno A, Muñoz-Rivas N, Mestre-Gómez B, Torres-Macho J. Pulmonary embolism and COVID-19: A paradigm change. Rev Clin Esp (Barc) 2020;220:459-61. [PMID: 32507399 DOI: 10.1016/j.rce.2020.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Shojaee A, Vahedian-Azimi A, Faizi F, Rahimi-Bashar F, Shahriary A, Galeh HEG, Nehrir B, Guest PC, Sahebkar A. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review. Adv Exp Med Biol. 2021;1321:53-68. [PMID: 33656713 DOI: 10.1007/978-3-030-59261-5_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
201 Poulakou G, Dimakakos E, Kollias A, Kyriakoulis KG, Rapti V, Trontzas I, Thanos C, Abdelrasoul M, Vantana T, Leontis K, Kakalou E, Argyraki K, Baraboutis I, Michelakis E, Giamarellos-Bourboulis E, Dimakou K, Tsoukalas G, Rapti A, Michelakis ED, Syrigos KN. Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo 2021;35:653-61. [PMID: 33402523 DOI: 10.21873/invivo.12305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
202 Cedro-Tanda A, Gómez-Romero L, Alcaraz N, de Anda-Jauregui G, Peñaloza F, Moreno B, Escobar-Arrazola MA, Ramirez-Vega OA, Munguia-Garza P, Garcia-Cardenas F, Cisneros-Villanueva M, Moreno-Camacho JL, Rodriguez-Gallegos J, Luna-Ruiz Esparza MA, Fernández Rojas MA, Mendoza-Vargas A, Reyes-Grajeda JP, Campos-Romero A, Angulo O, Ruiz R, Sheinbaum-Pardo C, Sifuentes-Osornio J, Kershenobich D, Hidalgo-Miranda A, Herrera LA. The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City. Viruses 2021;13:2182. [PMID: 34834987 DOI: 10.3390/v13112182] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Strafella C, Caputo V, Termine A, Barati S, Gambardella S, Borgiani P, Caltagirone C, Novelli G, Giardina E, Cascella R. Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications. Genes (Basel) 2020;11:E741. [PMID: 32635188 DOI: 10.3390/genes11070741] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
204 Bandara S, Ruwanpathirana A, Nagodawithana D, Alwis S. Hypertensive Crisis in Pregnancy with COVID19: Confirmed with rt-PCR for Nasopharyngeal Swab. Case Rep Obstet Gynecol 2020;2020:8868952. [PMID: 33312744 DOI: 10.1155/2020/8868952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Mansueto G, Niola M, Napoli C. Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases? Pathol Res Pract 2020;216:153086. [PMID: 32825954 DOI: 10.1016/j.prp.2020.153086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
206 Hanifi M, Chibane H, Houssin R, Cavallucci D. IPG as a new method to improve the agility of the initial analysis of the inventive design. FME Transactions 2021;49:549-62. [DOI: 10.5937/fme2103549h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
207 Dey A, Chozhavel Rajanathan TM, Chandra H, Pericherla HPR, Kumar S, Choonia HS, Bajpai M, Singh AK, Sinha A, Saini G, Dalal P, Vandriwala S, Raheem MA, Divate RD, Navlani NL, Sharma V, Parikh A, Prasath S, Sankar Rao M, Maithal K. Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models. Vaccine 2021;39:4108-16. [PMID: 34120764 DOI: 10.1016/j.vaccine.2021.05.098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
208 Alfaro M, Alfaro I, Angel C. Identification of potential inhibitors of SARS-CoV-2 papain-like protease from tropane alkaloids from Schizanthus porrigens: A molecular docking study. Chem Phys Lett 2020;761:138068. [PMID: 33052144 DOI: 10.1016/j.cplett.2020.138068] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
209 Gumashta J, Gumashta R. Role of the Backbenchers of the Renin-Angiotensin System ACE2 and AT2 Receptors in COVID-19: Lessons From SARS. Cureus 2020;12:e8411. [PMID: 32626626 DOI: 10.7759/cureus.8411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
210 Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, Singh A, Atif SM, Hariprasad G, Hasan GM, Hassan MI. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim Biophys Acta Mol Basis Dis 2020;1866:165878. [PMID: 32544429 DOI: 10.1016/j.bbadis.2020.165878] [Cited by in Crossref: 211] [Cited by in F6Publishing: 186] [Article Influence: 105.5] [Reference Citation Analysis]
211 Habas K, Nganwuchu C, Shahzad F, Gopalan R, Haque M, Rahman S, Majumder AA, Nasim T. Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti Infect Ther 2020;18:1201-11. [PMID: 32749914 DOI: 10.1080/14787210.2020.1797487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
212 Mercatelli D, Triboli L, Fornasari E, Ray F, Giorgi FM. Coronapp: A web application to annotate and monitor SARS-CoV-2 mutations. J Med Virol 2021;93:3238-45. [PMID: 33205830 DOI: 10.1002/jmv.26678] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
213 Papadopoulou A, Fragkou PC, Maratou E, Dimopoulou D, Kominakis A, Kokkinopoulou I, Kroupis C, Nikolaidou A, Antonakos G, Papaevangelou V, Armaganidis A, Tsantes A, Polyzogopoulou E, Tsiodras S, Antoniadou A, Moutsatsou P. Angiotensin-converting-enzyme insertion/deletion polymorphism, ACE activity, and COVID-19: A rather controversial hypothesis. A case-control study. J Med Virol 2021. [PMID: 34708878 DOI: 10.1002/jmv.27417] [Reference Citation Analysis]
214 Deng JL, Jiang YQ, Guo YK, Li HL. Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations? Chin Med J (Engl) 2020;133:2650-2. [PMID: 32804730 DOI: 10.1097/CM9.0000000000000996] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Braz HLB, Silveira JAM, Marinho AD, de Moraes MEA, Moraes Filho MO, Monteiro HSA, Jorge RJB. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Int J Antimicrob Agents 2020;56:106119. [PMID: 32738306 DOI: 10.1016/j.ijantimicag.2020.106119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
216 Isaac-Lam MF. Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex. In Silico Pharmacol 2021;9:55. [PMID: 34631362 DOI: 10.1007/s40203-021-00114-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Wozniak J, Floege J, Ostendorf T, Ludwig A. Key metalloproteinase-mediated pathways in the kidney. Nat Rev Nephrol 2021;17:513-27. [PMID: 33879883 DOI: 10.1038/s41581-021-00415-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
218 Paneroni M, Pasini E, Vitacca M, Scalvini S, Comini L, Pedrinolla A, Venturelli M. Altered Vascular Endothelium-Dependent Responsiveness in Frail Elderly Patients Recovering from COVID-19 Pneumonia: Preliminary Evidence. J Clin Med 2021;10:2558. [PMID: 34207876 DOI: 10.3390/jcm10122558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Li G, Chen Z, Lv Z, Li H, Chang D, Lu J. Diabetes Mellitus and COVID-19: Associations and Possible Mechanisms. Int J Endocrinol 2021;2021:7394378. [PMID: 33859687 DOI: 10.1155/2021/7394378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
220 Rando HM, MacLean AL, Lee AJ, Lordan R, Ray S, Bansal V, Skelly AN, Sell E, Dziak JJ, Shinholster L, D'Agostino McGowan L, Ben Guebila M, Wellhausen N, Knyazev S, Boca SM, Capone S, Qi Y, Park Y, Mai D, Sun Y, Boerckel JD, Brueffer C, Byrd JB, Kamil JP, Wang J, Velazquez R, Szeto GL, Barton JP, Goel RR, Mangul S, Lubiana T, Gitter A, Greene CS; COVID-19 Review Consortium Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang, Nils Wellhausen, . Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure. mSystems 2021;6:e0009521. [PMID: 34698547 DOI: 10.1128/mSystems.00095-21] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
221 Salahshoori I, Mobaraki-asl N, Seyfaee A, Mirzaei Nasirabad N, Dehghan Z, Faraji M, Ganjkhani M, Babapoor A, Shadmehr SZ, Hamrang A. Overview of COVID-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccines. Biologics 2021;1:2-40. [DOI: 10.3390/biologics1010002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
222 Xu F, Gao J, Munkhsaikhan U, Li N, Gu Q, Pierre JF, Starlard-Davenport A, Towbin JA, Cui Y, Purevjav E, Lu L. The Genetic Dissection of Ace2 Expression Variation in the Heart of Murine Genetic Reference Population. Front Cardiovasc Med 2020;7:582949. [PMID: 33330645 DOI: 10.3389/fcvm.2020.582949] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Mandal M, Chowdhury SK, Khan AA, Baildya N, Dutta T, Misra D, Ghosh NN. Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study. J Mol Struct 2021;1234:130152. [PMID: 33678903 DOI: 10.1016/j.molstruc.2021.130152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
224 Sahebnasagh A, Avan R, Saghafi F, Mojtahedzadeh M, Sadremomtaz A, Arasteh O, Tanzifi A, Faramarzi F, Negarandeh R, Safdari M, Khataminia M, Rezai Ghaleno H, Habtemariam S, Khoshi A. Pharmacological treatments of COVID-19. Pharmacol Rep 2020;72:1446-78. [PMID: 32816200 DOI: 10.1007/s43440-020-00152-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
225 Zheng Y, Jin, Lin J, Zhang Y, Tian J, Lian F, Tong X. Understanding COVID-19 in Wuhan From the Perspective of Cold-Dampness: Clinical Evidences and Mechanisms. Front Med (Lausanne) 2021;8:617659. [PMID: 33693014 DOI: 10.3389/fmed.2021.617659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
226 Krenn K, Tretter V, Kraft F, Ullrich R. The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome. Front Physiol 2022;12:806062. [DOI: 10.3389/fphys.2021.806062] [Reference Citation Analysis]
227 Valenzuela R, Rodriguez-Perez AI, Costa-Besada MA, Rivas-Santisteban R, Garrido-Gil P, Lopez-Lopez A, Navarro G, Lanciego JL, Franco R, Labandeira-Garcia JL. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria. Redox Biol 2021;46:102078. [PMID: 34333284 DOI: 10.1016/j.redox.2021.102078] [Reference Citation Analysis]
228 Li G, Zhou CL, Ba YM, Wang YM, Song B, Cheng XB, Dong QF, Wang LL, You SS. Nutritional risk and therapy for severe and critical COVID-19 patients: A multicenter retrospective observational study. Clin Nutr 2021;40:2154-61. [PMID: 33077274 DOI: 10.1016/j.clnu.2020.09.040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
229 Salbach C, Mueller-Hennessen M, Biener M, Stoyanov K, Preusch M, Kihm L, Merle U, Schnitzler P, Katus HA, Giannitsis E. Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction. Biomarkers 2021;26:401-9. [PMID: 33998352 DOI: 10.1080/1354750X.2021.1921031] [Reference Citation Analysis]
230 Remington JM, McKay KT, Ferrell JB, Schneebeli ST, Li J. Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein. Biophys J 2021;120:2848-58. [PMID: 34087207 DOI: 10.1016/j.bpj.2021.05.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
231 Dalan R, Bornstein SR, El-Armouche A, Rodionov RN, Markov A, Wielockx B, Beuschlein F, Boehm BO. The ACE-2 in COVID-19: Foe or Friend? Horm Metab Res 2020;52:257-63. [PMID: 32340044 DOI: 10.1055/a-1155-0501] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 33.0] [Reference Citation Analysis]
232 Sfera A, Osorio C, Jafri N, Diaz EL, Campo Maldonado JE. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis. Front Immunol 2020;11:1472. [PMID: 32655579 DOI: 10.3389/fimmu.2020.01472] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
233 Behl T, Kaur I, Aleya L, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target. Sci Total Environ 2021;808:152072. [PMID: 34863742 DOI: 10.1016/j.scitotenv.2021.152072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Monda VM, Porcellati F, Strollo F, Gentile S. ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? Diabetes Ther 2020;11:1909-14. [PMID: 32749644 DOI: 10.1007/s13300-020-00898-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
235 Razmi M, Hashemi F, Gheytanchi E, Dehghan Manshadi M, Ghods R, Madjd Z. Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review. Int Immunopharmacol 2020;88:106942. [PMID: 32896750 DOI: 10.1016/j.intimp.2020.106942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
236 Chenna A, Konala VM, Bose S, Roy S, Madhira BR, Gayam V, Naramala S, Adapa S. Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade. Case Rep Nephrol 2020;2020:8811931. [PMID: 32685221 DOI: 10.1155/2020/8811931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Hosseini NF, Dalirfardouei R, Aliramaei MR, Najafi R. Stem cells or their exosomes: which is preferred in COVID-19 treatment? Biotechnol Lett. [DOI: 10.1007/s10529-021-03209-8] [Reference Citation Analysis]
238 Zhang Z, Zhang G, Guo M, Tao W, Liu X, Wei H, Jin T, Zhang Y, Zhu S. The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy. Pathogens 2021;10:881. [PMID: 34358031 DOI: 10.3390/pathogens10070881] [Reference Citation Analysis]
239 Stasi A, Castellano G, Ranieri E, Infante B, Stallone G, Gesualdo L, Netti GS. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure. J Clin Med 2020;9:E4057. [PMID: 33334050 DOI: 10.3390/jcm9124057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
240 Ferreira AO, Polonini HC, Dijkers ECF. Postulated Adjuvant Therapeutic Strategies for COVID-19. J Pers Med 2020;10:E80. [PMID: 32764275 DOI: 10.3390/jpm10030080] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
241 Tian C, Li N, Bai Y, Xiao H, Li S, Ge QG, Shen N, Ma QB. Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension. World J Clin Cases 2021; 9(1): 47-60 [PMID: 33511171 DOI: 10.12998/wjcc.v9.i1.47] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
242 Deravi N, Yaghoobpoor S, Fathi M, Vakili K, Ahsan E, Mokhtari M, Vaezjalali M. 2019 Novel Coronavirus Infection in Children and Infants: Where We Are and What We Know? Arch Clin Infect Dis 2020;15. [DOI: 10.5812/archcid.103785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Samad A, Jafar T, Rafi JH. Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses. Genomics 2020;112:4912-23. [PMID: 32916258 DOI: 10.1016/j.ygeno.2020.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
244 Ryu G, Shin HW. SARS-CoV-2 Infection of Airway Epithelial Cells. Immune Netw 2021;21:e3. [PMID: 33728096 DOI: 10.4110/in.2021.21.e3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
245 Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV 3rd, Kwon DH, Singh T, Tilton JC, Tsai EJ, Tucker NR, Barnard J, Loscalzo J. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ Res 2021;128:1214-36. [PMID: 33856918 DOI: 10.1161/CIRCRESAHA.121.317997] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
246 Gyebi GA, Ogunyemi OM, Ibrahim IM, Ogunro OB, Adegunloye AP, Afolabi SO. SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids. J Genet Eng Biotechnol 2021;19:113. [PMID: 34351542 DOI: 10.1186/s43141-021-00209-z] [Reference Citation Analysis]
247 Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504-7. [PMID: 32317203 DOI: 10.1016/j.ajem.2020.04.048] [Cited by in Crossref: 275] [Cited by in F6Publishing: 221] [Article Influence: 137.5] [Reference Citation Analysis]
248 Ziyaeifard M, Ziyaeifard P. Cardiac anesthesia and COVID-19 outbreak: What should we know? J Res Med Sci 2020;25:89. [PMID: 33273934 DOI: 10.4103/jrms.JRMS_336_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Cennamo G, Reibaldi M, Montorio D, D'Andrea L, Fallico M, Triassi M. Optical Coherence Tomography Angiography Features in Post-COVID-19 Pneumonia Patients: A Pilot Study. Am J Ophthalmol 2021;227:182-90. [PMID: 33781767 DOI: 10.1016/j.ajo.2021.03.015] [Reference Citation Analysis]
250 Vijayakumar BG, Ramesh D, Joji A, Jayachandra Prakasan J, Kannan T. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur J Pharmacol 2020;886:173448. [PMID: 32768503 DOI: 10.1016/j.ejphar.2020.173448] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 15.5] [Reference Citation Analysis]
251 McGonagle D, Plein S, O'Donnell JS, Sharif K, Bridgewood C. Increased cardiovascular mortality in African Americans with COVID-19. Lancet Respir Med 2020;8:649-51. [PMID: 32473125 DOI: 10.1016/S2213-2600(20)30244-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
252 Klhůfek J. The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero? Acta Clinica Belgica. [DOI: 10.1080/17843286.2020.1786324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
253 Magamela MR, Dzinamarira T, Hlongwa M. COVID-19 consequences on mental health: An African perspective. S Afr J Psychiatr 2021;27:1611. [PMID: 33604078 DOI: 10.4102/sajpsychiatry.v27i0.1611] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
254 Deane K, Sarfraz A, Sarfraz Z, Valentine D, Idowu AR, Sanchez V. Unilateral Optic Neuritis Associated with SARS-CoV-2 Infection: A Rare Complication. Am J Case Rep 2021;22:e931665. [PMID: 34120138 DOI: 10.12659/AJCR.931665] [Reference Citation Analysis]
255 Aggarwal S, Acharjee A, Mukherjee A, Baker MS, Srivastava S. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis. J Proteome Res 2021;20:1107-32. [PMID: 33426872 DOI: 10.1021/acs.jproteome.0c00771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
256 P V S, Rai A, Wadhwa C. Postpartum Atypical Posterior Reversible Encephalopathy Syndrome in a COVID-19 Patient - An Obstetric Emergency. J Stroke Cerebrovasc Dis 2020;29:105357. [PMID: 33039765 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
257 Liu Y, Wu S, Qin M, Jiang W, Liu X. Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data. J Am Heart Assoc 2020;9:e016812. [PMID: 32673529 DOI: 10.1161/JAHA.120.016812] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
258 Álvez F. SARS-CoV2 coronavirus: so far polite with children. Debatable immunological and non-immunological evidence. Allergol Immunopathol (Madr) 2020;48:500-6. [PMID: 32771236 DOI: 10.1016/j.aller.2020.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Gannedi V, Villuri BK, Reddy SN, Ku CC, Wong CH, Hung SC. Practical Remdesivir Synthesis through One-Pot Organocatalyzed Asymmetric (S)-P-Phosphoramidation. J Org Chem 2021;86:4977-85. [PMID: 33634692 DOI: 10.1021/acs.joc.0c02888] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
260 Safari F, Afarid M, Rastegari B, Borhani-Haghighi A, Barekati-Mowahed M, Behzad-Behbahani A. CRISPR systems: Novel approaches for detection and combating COVID-19. Virus Res 2021;294:198282. [PMID: 33428981 DOI: 10.1016/j.virusres.2020.198282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
261 Majidi S, Fifi JT, Ladner TR, Lara-Reyna J, Yaeger KA, Yim B, Dangayach N, Oxley TJ, Shigematsu T, Kummer BR, Stein LK, Weinberger J, Fara MG, De Leacy R, Dhamoon MS, Tuhrim S, Mocco J. Emergent Large Vessel Occlusion Stroke During New York City's COVID-19 Outbreak: Clinical Characteristics and Paraclinical Findings. Stroke 2020;51:2656-63. [PMID: 32755349 DOI: 10.1161/STROKEAHA.120.030397] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 21.5] [Reference Citation Analysis]
262 Wani AR, Yadav K, Khursheed A, Rather MA. An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses. Microb Pathog 2021;152:104620. [PMID: 33212200 DOI: 10.1016/j.micpath.2020.104620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
263 Zhong W, Zhang X, Zeng Y, Lin D, Wu J. Recent applications and strategies in nanotechnology for lung diseases. Nano Res 2021;:1-23. [PMID: 33456721 DOI: 10.1007/s12274-020-3180-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
264 Ebihara T, Masuda A, Takahashi D, Hino M, Mon H, Kakino K, Fujii T, Fujita R, Ueda T, Lee JM, Kusakabe T. Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System. Mol Biotechnol 2021. [PMID: 34304364 DOI: 10.1007/s12033-021-00373-0] [Reference Citation Analysis]
265 Espino-Y-Sosa S, Martinez-Portilla RJ, Torres-Torres J, Solis-Paredes JM, Estrada-Gutierrez G, Hernandez-Pacheco JA, Espejel-Nuñez A, Mateu-Rogell P, Juarez-Reyes A, Lopez-Ceh FE, Villafan-Bernal JR, Rojas-Zepeda L, Guzman-Guzman IP, Poon LC. Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19. Viruses 2021;13:1906. [PMID: 34696336 DOI: 10.3390/v13101906] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Vadasz Z, Brenner B, Toubi E. Immune-Mediated Coagulopathy in COVID-19 Infection. Semin Thromb Hemost 2020;46:838-40. [PMID: 32877959 DOI: 10.1055/s-0040-1714272] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
267 Zumla A, Wang FS, Ippolito G, Petrosillo N, Agrati C, Azhar EI, Chang C, El-Kafrawy SA, Osman M, Zitvogel L, Galle PR, Locatelli F, Gorman E, Cordon-Cardo C, O'Kane C, McAuley D, Maeurer M. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis. 2020;96:431-439. [PMID: 32425638 DOI: 10.1016/j.ijid.2020.05.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
268 Mir N, D'Amico A, Dasher J, Tolwani A, Valentine V. Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness. Blood Rev 2021;45:100731. [PMID: 32829961 DOI: 10.1016/j.blre.2020.100731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Petrović T, Lauc G, Trbojević-Akmačić I. The Importance of Glycosylation in COVID-19 Infection. Adv Exp Med Biol 2021;1325:239-64. [PMID: 34495539 DOI: 10.1007/978-3-030-70115-4_12] [Reference Citation Analysis]
270 Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series. Brain Behav Immun 2020;88:940-4. [PMID: 32525049 DOI: 10.1016/j.bbi.2020.06.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 27.5] [Reference Citation Analysis]
271 Tseng YH, Yang RC, Lu TS. Two hits to the renin-angiotensin system may play a key role in severe COVID-19. Kaohsiung J Med Sci. 2020;36:389-392. [PMID: 32492292 DOI: 10.1002/kjm2.12237] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
272 Signorini C, Pignatti P, Coccini T. How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn. Life (Basel) 2021;11:182. [PMID: 33669011 DOI: 10.3390/life11030182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
273 Trahtemberg U, Slutsky AS, Villar J. What have we learned ventilating COVID-19 patients? Intensive Care Med 2020;46:2458-60. [PMID: 33044572 DOI: 10.1007/s00134-020-06275-0] [Reference Citation Analysis]
274 Goli M. Review of novel human β-coronavirus (2019-nCoV or SARS-CoV-2) from the food industry perspective-Appropriate approaches to food production technology. Food Sci Nutr 2020. [PMID: 33042532 DOI: 10.1002/fsn3.1892] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
275 Tzanno-Martins C. Covid-19 pandemic: from carnival masks to surgical masks. J Bras Nefrol 2020;42:361-5. [PMID: 32865541 DOI: 10.1590/2175-8239-JBN-2020-0078] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
276 Xiu S, Dick A, Ju H, Mirzaie S, Abdi F, Cocklin S, Zhan P, Liu X. Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. J Med Chem 2020;63:12256-74. [PMID: 32539378 DOI: 10.1021/acs.jmedchem.0c00502] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 29.5] [Reference Citation Analysis]
277 Sekulic M, Harper H, Nezami BG, Shen DL, Sekulic SP, Koeth AT, Harding CV, Gilmore H, Sadri N. Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases. Am J Clin Pathol 2020;154:190-200. [PMID: 32451533 DOI: 10.1093/ajcp/aqaa091] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 20.5] [Reference Citation Analysis]
278 Ceccarelli G, d'Ettorre G, Innocenti GP, Mastroianni CM, Ciccozzi M, d'Ettorre G. Is previous influenza-like illness a potential Trojan horse for COVID-19? Crit Care 2020;24:503. [PMID: 32799917 DOI: 10.1186/s13054-020-03226-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
279 Kerro A. Encephalopathy with progression to posterior reversible encephalopathy pattern in a patient with COVID-19: clinical, imaging findings and follow-up. BMJ Case Rep 2021;14:e241240. [PMID: 33622758 DOI: 10.1136/bcr-2020-241240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Luo J, Zhu X, Jian J, Chen X, Yin K. Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment. Acta Biochim Biophys Sin (Shanghai) 2021;53:273-82. [PMID: 33428706 DOI: 10.1093/abbs/gmaa176] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Junaid K, Ejaz H, Abdalla AE, Abosalif KOA, Ullah MI, Yasmeen H, Younas S, Hamam SSM, Rehman A. Effective Immune Functions of Micronutrients against SARS-CoV-2. Nutrients 2020;12:E2992. [PMID: 33003648 DOI: 10.3390/nu12102992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
282 Kavianpour M, Saleh M, Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther 2020;11:404. [PMID: 32948252 DOI: 10.1186/s13287-020-01849-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
283 Aliabadi F, Ajami M, Pazoki–toroudi H. Why does COVID‐19 pathology have several clinical forms? BioEssays 2020;42:2000198. [DOI: 10.1002/bies.202000198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
284 Ranard LS, Fried JA, Abdalla M, Anstey DE, Givens RC, Kumaraiah D, Kodali SK, Takeda K, Karmpaliotis D, Rabbani LE, Sayer G, Kirtane AJ, Leon MB, Schwartz A, Uriel N, Masoumi A. Approach to Acute Cardiovascular Complications in COVID-19 Infection. Circ Heart Fail 2020;13:e007220. [PMID: 32500721 DOI: 10.1161/CIRCHEARTFAILURE.120.007220] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
285 Liu C, Mu C, Zhang Q, Yang X, Yan H, Jiao H. Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review. Med Sci Monit 2021;27:e930168. [PMID: 34193809 DOI: 10.12659/MSM.930168] [Reference Citation Analysis]
286 Dan S, Pant M, Upadhyay SK. The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic. Curr Pharmacol Rep 2020;:1-10. [PMID: 32953401 DOI: 10.1007/s40495-020-00239-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
287 Safadi MAP. The intriguing features of COVID-19 in children and its impact on the pandemic. J Pediatr (Rio J) 2020;96:265-8. [PMID: 32305211 DOI: 10.1016/j.jped.2020.04.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
288 Bagheri-Hosseinabadi Z, Pirsadeghi A, Rahnama A, Bahrehmand F, Abbasifard M. Is there any relationship between serum zinc levels and angiotensin-converting enzyme 2 gene expression in patients with coronavirus disease 2019? Meta Gene 2022;31:100991. [PMID: 34778004 DOI: 10.1016/j.mgene.2021.100991] [Reference Citation Analysis]
289 Minakshi R, Jan AT, Rahman S, Kim J. A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host. Front Cell Infect Microbiol 2020;10:575404. [PMID: 33262955 DOI: 10.3389/fcimb.2020.575404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
290 Nagu P, Parashar A, Behl T, Mehta V. CNS implications of COVID-19: a comprehensive review. Rev Neurosci 2021;32:219-34. [PMID: 33550782 DOI: 10.1515/revneuro-2020-0070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
291 Vasanthakumar N. Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients. Bioessays 2020;42:e2000094. [PMID: 32815593 DOI: 10.1002/bies.202000094] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
292 Datta PK, Liu F, Fischer T, Rappaport J, Qin X. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics 2020;10:7448-64. [PMID: 32642005 DOI: 10.7150/thno.48076] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 30.0] [Reference Citation Analysis]
293 Porzionato A, Emmi A, Barbon S, Boscolo-Berto R, Stecco C, Stocco E, Macchi V, De Caro R. Sympathetic activation: a potential link between comorbidities and COVID-19. FEBS J 2020;287:3681-8. [PMID: 32779891 DOI: 10.1111/febs.15481] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
294 Ye S, Zhang G, Jiang J. AI-based spectroscopic monitoring of real-time interactions between SARS-CoV-2 and human ACE2. Proc Natl Acad Sci U S A 2021;118:e2025879118. [PMID: 34185681 DOI: 10.1073/pnas.2025879118] [Reference Citation Analysis]
295 Maab H, Mustafa F, Shabbir SJ. Cardiovascular impact of COVID-19: an array of presentations. Acta Biomed 2021;92:e2021021. [PMID: 33988162 DOI: 10.23750/abm.v92i2.10299] [Reference Citation Analysis]
296 Omidi N, Forouzannia SK, Poorhosseini H, Tafti SHA, Salehbeigi S, Lotfi-Tokaldany M. Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about? J Card Surg 2020;35:2500-5. [PMID: 33043651 DOI: 10.1111/jocs.14707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
297 Acuña-Castroviejo D, Escames G, Figueira JC, de la Oliva P, Borobia AM, Acuña-Fernández C. Clinical trial to test the efficacy of melatonin in COVID-19. J Pineal Res 2020;69:e12683. [PMID: 32770854 DOI: 10.1111/jpi.12683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
298 Heimfarth L, Serafini MR, Martins-Filho PR, Quintans JSS, Quintans-Júnior LJ. Drug repurposing and cytokine management in response to COVID-19: A review. Int Immunopharmacol 2020;88:106947. [PMID: 32919216 DOI: 10.1016/j.intimp.2020.106947] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
299 Huang F, Ma W, Zheng H, Ye Y, Chen H, Su N, Li X, Li X, Wang Y, Jin J, Yu Z, Li Y, Wang J. Early risk factors for extrapulmonary organ injury in adult COVID-19 patients. Ann Transl Med 2021;9:701. [PMID: 33987399 DOI: 10.21037/atm-21-1561] [Reference Citation Analysis]
300 Karpiński TM, Ożarowski M, Seremak-Mrozikiewicz A, Wolski H, Wlodkowic D. The 2020 race towards SARS-CoV-2 specific vaccines. Theranostics 2021;11:1690-702. [PMID: 33408775 DOI: 10.7150/thno.53691] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
301 Popovic DS, Papanas N, Pantea Stoian A, Rizvi AA, Janez A, Rizzo M. Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review. Diabetes Ther 2021;12:3037-54. [PMID: 34699021 DOI: 10.1007/s13300-021-01170-3] [Reference Citation Analysis]
302 Sagris D, Papanikolaou A, Kvernland A, Korompoki E, Frontera JA, Troxel AB, Gavriatopoulou M, Milionis H, Lip GYH, Michel P, Yaghi S, Ntaios G. COVID-19 and ischemic stroke. Eur J Neurol 2021. [PMID: 34224187 DOI: 10.1111/ene.15008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
303 Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Katulanda P, Grossman AB. The Impact of SARS-Cov-2 Virus Infection on the Endocrine System. J Endocr Soc. 2020;4:bvaa082. [PMID: 32728654 DOI: 10.1210/jendso/bvaa082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
304 Akiyama T, Hirata T, Fujimoto T, Hatakeyama S, Yamazaki R, Nomura T. The Natural-Mineral-Based Novel Nanomaterial IFMC Increases Intravascular Nitric Oxide without Its Intake: Implications for COVID-19 and beyond. Nanomaterials (Basel) 2020;10:E1699. [PMID: 32872395 DOI: 10.3390/nano10091699] [Reference Citation Analysis]
305 Sanchez-Guzman D, Boland S, Brookes O, Mc Cord C, Lai Kuen R, Sirri V, Baeza Squiban A, Devineau S. Long-term evolution of the epithelial cell secretome in preclinical 3D models of the human bronchial epithelium. Sci Rep 2021;11:6621. [PMID: 33758289 DOI: 10.1038/s41598-021-86037-0] [Reference Citation Analysis]
306 Chan DX, Lin XF, George JM, Liu CW. Clinical Challenges and Considerations in Management of Chronic Pain Patients During a COVID-19 Pandemic. Ann Acad Med Singap 2020;49:669-73. [DOI: 10.47102/annals-acadmedsg.2020130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
307 Williams A, Branscome H, Khatkar P, Mensah GA, Al Sharif S, Pinto DO, DeMarino C, Kashanchi F. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system. J Neurovirol 2021;27:667-90. [PMID: 34581996 DOI: 10.1007/s13365-021-00998-6] [Reference Citation Analysis]
308 Fernández-Martínez NF, Ortiz-González-Serna R, Serrano-Ortiz Á, Rivera-Izquierdo M, Ruiz-Montero R, Pérez-Contreras M, Guerrero-Fernández de Alba I, Romero-Duarte Á, Salcedo-Leal I. Sex Differences and Predictors of In-Hospital Mortality among Patients with COVID-19: Results from the ANCOHVID Multicentre Study. Int J Environ Res Public Health 2021;18:9018. [PMID: 34501608 DOI: 10.3390/ijerph18179018] [Reference Citation Analysis]
309 Savina K, Sreekumar R, Soonu VK, Variyar EJ. Various vaccine platforms in the field of COVID-19. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00215-1] [Reference Citation Analysis]
310 Freeman TL, Swartz TH. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol 2020;11:1518. [PMID: 32655582 DOI: 10.3389/fimmu.2020.01518] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 49.5] [Reference Citation Analysis]
311 Addeo A, Friedlaender A. Cancer and COVID-19: Unmasking their ties. Cancer Treat Rev 2020;88:102041. [PMID: 32516704 DOI: 10.1016/j.ctrv.2020.102041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
312 Ghasemi M, Umeton RP, Keyhanian K, Mohit B, Rahimian N, Eshaghhosseiny N, Davoudi V. SARS-CoV-2 and Acute Cerebrovascular Events: An Overview. J Clin Med 2021;10:3349. [PMID: 34362133 DOI: 10.3390/jcm10153349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
313 Asl SH, Nikfarjam S, Majidi Zolbanin N, Nassiri R, Jafari R. Immunopharmacological perspective on zinc in SARS-CoV-2 infection. Int Immunopharmacol 2021;96:107630. [PMID: 33882442 DOI: 10.1016/j.intimp.2021.107630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
314 Mostafa T. Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection? Sex Med Rev 2021;9:15-22. [PMID: 33077403 DOI: 10.1016/j.sxmr.2020.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
315 Rex DAB, Deepak K, Vaid N, Dagamajalu S, Kandasamy RK, Flo TH, Keshava Prasad TS. A modular map of Bradykinin-mediated inflammatory signaling network. J Cell Commun Signal 2021. [PMID: 34714516 DOI: 10.1007/s12079-021-00652-0] [Reference Citation Analysis]
316 Farnós O, Venereo-Sánchez A, Xu X, Chan C, Dash S, Chaabane H, Sauvageau J, Brahimi F, Saragovi U, Leclerc D, Kamen AA. Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation. Vaccines (Basel) 2020;8:E654. [PMID: 33158147 DOI: 10.3390/vaccines8040654] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
317 Zuo Z, Wu T, Pan L, Zuo C, Hu Y, Luo X, Jiang L, Xia Z, Xiao X, Liu J, Ye M, Deng M. Modalities and Mechanisms of Treatment for Coronavirus Disease 2019. Front Pharmacol 2020;11:583914. [PMID: 33643033 DOI: 10.3389/fphar.2020.583914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
318 Toori KU, Chaudhry A, Qureshi MA. Time to negative PCR in various disease categories of COVID-19 infection in Pakistani population. Pak J Med Sci 2022;38:243-7. [PMID: 35035433 DOI: 10.12669/pjms.38.1.4476] [Reference Citation Analysis]
319 Tariq A, Mateen RM, Afzal MS, Saleem M. Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19. Int J Infect Dis 2020;98:166-75. [PMID: 32579907 DOI: 10.1016/j.ijid.2020.06.063] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
320 Wilson NM, Norton A, Young FP, Collins DW. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review. Anaesthesia 2020;75:1086-95. [PMID: 32311771 DOI: 10.1111/anae.15093] [Cited by in Crossref: 155] [Cited by in F6Publishing: 134] [Article Influence: 77.5] [Reference Citation Analysis]
321 McLachlan CS. The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms. Clin Hypertens. 2020;26:14. [PMID: 32685191 DOI: 10.1186/s40885-020-00147-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
322 Haghpanah A, Masjedi F, Alborzi S, Hosseinpour A, Dehghani A, Malekmakan L, Roozbeh J. Potential mechanisms of SARS-CoV-2 action on male gonadal function and fertility: Current status and future prospects. Andrologia 2021;53:e13883. [PMID: 33108833 DOI: 10.1111/and.13883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
323 Song W, Li J, Zou N, Guan W, Pan J, Xu W. Clinical features of pediatric patients with coronavirus disease (COVID-19). J Clin Virol 2020;127:104377. [PMID: 32361323 DOI: 10.1016/j.jcv.2020.104377] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 21.5] [Reference Citation Analysis]
324 Peters EMJ, Schedlowski M, Watzl C, Gimsa U. To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2. Neurobiol Stress 2021;14:100296. [PMID: 33527083 DOI: 10.1016/j.ynstr.2021.100296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
325 Di Nardo M, van Leeuwen G, Loreti A, Barbieri MA, Guner Y, Locatelli F, Ranieri VM. A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children. Pediatr Res 2021;89:1101-8. [PMID: 32679582 DOI: 10.1038/s41390-020-1065-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
326 Moitinho MS, Belasco AGDS, Barbosa DA, Fonseca CDD. Acute Kidney Injury by SARS-CoV-2 virus in patients with COVID-19: an integrative review. Rev Bras Enferm 2020;73 Suppl 2:e20200354. [PMID: 32667578 DOI: 10.1590/0034-7167-2020-0354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
327 Ghasemy E, Miri Jahromi A, Khedri M, Zandi P, Maleki R, Tayebi L. In-silico study on viability of MXenes in suppressing the coronavirus infection and distribution. J Biomol Struct Dyn 2021;:1-7. [PMID: 34328374 DOI: 10.1080/07391102.2021.1957711] [Reference Citation Analysis]
328 Ramasamy S, Subbian S. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. Clin Microbiol Rev 2021;34:e00299-20. [PMID: 33980688 DOI: 10.1128/CMR.00299-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
329 Antonio ADS, Wiedemann LSM, Veiga-junior VF. Natural products' role against COVID-19. RSC Adv 2020;10:23379-93. [DOI: 10.1039/d0ra03774e] [Cited by in Crossref: 61] [Article Influence: 30.5] [Reference Citation Analysis]
330 Nascimento CRD, Leão SC, Barbosa RHA, Tenório PP. Cardiovascular damage due to COVID-19: what do we need to know? Rev Assoc Med Bras (1992) 2021;67Suppl 1:121-6. [PMID: 34406302 DOI: 10.1590/1806-9282.67.Suppl1.20200706] [Reference Citation Analysis]
331 Cousin VL, Giraud R, Bendjelid K. Pathophysiology of COVID-19: Everywhere You Look You Will See ACE2! Front Med (Lausanne) 2021;8:694029. [PMID: 34513868 DOI: 10.3389/fmed.2021.694029] [Reference Citation Analysis]
332 Vinciguerra M, Romiti S, Fattouch K, De Bellis A, Greco E. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm. J Clin Med. 2020;9. [PMID: 32635302 DOI: 10.3390/jcm9072095] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
333 Li W, Rios S, Nagraj S, Hajra A, Saralidze T, Varrias D, Mathai SV, Novakovic M, Hupart KH, Miles JA, Katamreddy A, Palaiodimos L, Faillace RT. Statin use in hospitalized patients with COVID-19: A comprehensive analysis of the New York City Public Hospital System. Am J Med 2022:S0002-9343(22)00169-3. [PMID: 35296403 DOI: 10.1016/j.amjmed.2022.02.018] [Reference Citation Analysis]
334 Chen S, Li J, Liu Z, Chen D, Zhou L, Hu D, Li M, Long W, Huang Y, Huang J, Wang S, Li Q, Zeng W, Guo L, Wu X. Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients. Front Pharmacol 2021;12:587816. [PMID: 33828483 DOI: 10.3389/fphar.2021.587816] [Reference Citation Analysis]
335 Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, Shafaati M, Abdoli A. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol 2021;101:108232. [PMID: 34673335 DOI: 10.1016/j.intimp.2021.108232] [Reference Citation Analysis]
336 Mbugua SN, Njenga LW, Odhiambo RA, Wandiga SO, Onani MO, Ignjatovic N. COVID-19 and Cancer Therapy: Interrelationships and Management of Cancer Cases in the Era of COVID-19. Journal of Chemistry 2021;2021:1-10. [DOI: 10.1155/2021/9923518] [Reference Citation Analysis]
337 Divyaveer S, Jha V. COVID-19 and care for patients with chronic kidney disease: Challenges and lessons. FASEB Bioadv 2021. [PMID: 34230909 DOI: 10.1096/fba.2021-00002] [Reference Citation Analysis]
338 Mohamadi F, Fazeli A. A Review on Applications of CFD Modeling in COVID-19 Pandemic. Arch Computat Methods Eng. [DOI: 10.1007/s11831-021-09706-3] [Reference Citation Analysis]
339 Rauf A, Rashid U, Khalil AA, Khan SA, Anwar S, Alafnan A, Alamri A, Rengasamy KR. Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae. S Afr J Bot 2021. [PMID: 34226782 DOI: 10.1016/j.sajb.2021.06.033] [Reference Citation Analysis]
340 Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L, Wang Y. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int J Infect Dis 2020;99:47-56. [PMID: 32721533 DOI: 10.1016/j.ijid.2020.07.029] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 41.5] [Reference Citation Analysis]
341 Sivasankarapillai VS, Pillai AM, Rahdar A, Sobha AP, Das SS, Mitropoulos AC, Mokarrar MH, Kyzas GZ. On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges. Nanomaterials (Basel) 2020;10:E852. [PMID: 32354113 DOI: 10.3390/nano10050852] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 27.0] [Reference Citation Analysis]
342 Feng Y, Marchal T, Sperry T, Yi H. Influence of wind and relative humidity on the social distancing effectiveness to prevent COVID-19 airborne transmission: A numerical study. J Aerosol Sci 2020;147:105585. [PMID: 32427227 DOI: 10.1016/j.jaerosci.2020.105585] [Cited by in Crossref: 110] [Cited by in F6Publishing: 66] [Article Influence: 55.0] [Reference Citation Analysis]
343 Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, Díez-Villanueva P, Ayesta A, Sanchis Forés J, Vidán-Austiz MT, Formiga F, Ariza-Solé A, Martínez-Sellés M; Los autores firmantes pertenecen a las siguientes entidades científicas. [Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology]. Rev Esp Cardiol 2020;73:569-76. [PMID: 32292226 DOI: 10.1016/j.recesp.2020.03.027] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 20.5] [Reference Citation Analysis]
344 Tsuchiya H, Mizogami M. Interaction of drugs with lipid raft membrane domains as a possible target. Drug Target Insights 2020;14:34-47. [PMID: 33510571 DOI: 10.33393/dti.2020.2185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
345 Lano G, Braconnier A, Bataille S, Cavaille G, Moussi-Frances J, Gondouin B, Bindi P, Nakhla M, Mansour J, Halin P, Levy B, Canivet E, Gaha K, Kazes I, Noel N, Wynckel A, Debrumetz A, Jourde-Chiche N, Moal V, Vial R, Scarfoglière V, Bobot M, Gully M, Legris T, Pelletier M, Sallee M, Burtey S, Brunet P, Robert T, Rieu P. Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort. Clin Kidney J 2020;13:878-88. [PMID: 33354330 DOI: 10.1093/ckj/sfaa199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
346 Hikisz P, Bernasinska-Slomczewska J. Beneficial Properties of Bromelain. Nutrients 2021;13:4313. [PMID: 34959865 DOI: 10.3390/nu13124313] [Reference Citation Analysis]
347 Pang J, Liu M, Ling W, Jin T. Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment. Obes Med 2021;22:100312. [PMID: 33426364 DOI: 10.1016/j.obmed.2020.100312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
348 Angeli F, Zappa M, Reboldi G, Trapasso M, Cavallini C, Spanevello A, Verdecchia P. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later. Eur J Intern Med 2021;93:28-34. [PMID: 34588140 DOI: 10.1016/j.ejim.2021.09.007] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
349 Sieńko J, Kotowski M, Bogacz A, Lechowicz K, Drożdżal S, Rosik J, Sietnicki M, Sieńko M, Kotfis K. COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients. Clin Interv Aging 2020;15:1231-40. [PMID: 32764907 DOI: 10.2147/CIA.S261516] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
350 Shrivastava R, Vijay M, Maneby N, Shrivastava R. Clinical Efficacy of an Osmotic, Antiviral and Anti-Inflammatory Polymeric Nasal Film to Treat Covid-19 Early-Phase Respiratory Symptoms. OAJCT 2021;Volume 13:11-20. [DOI: 10.2147/oajct.s307144] [Reference Citation Analysis]
351 Elrashdy F, Redwan EM, Uversky VN. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics? Biomolecules 2020;10:E1312. [PMID: 32933047 DOI: 10.3390/biom10091312] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
352 Li CC, Wang RF. Challenges and opportunities brought by COVID-19: Understanding and prevention of COVID-19. Shijie Huaren Xiaohua Zazhi 2020; 28(8): 275-279 [DOI: 10.11569/wcjd.v28.i8.275] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
353 Barati F, Pouresmaieli M, Ekrami E, Asghari S, Ziarani FR, Mamoudifard M. Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review. Biol Proced Online 2020;22:15. [PMID: 32754003 DOI: 10.1186/s12575-020-00129-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
354 Sharma D, Sharma J, Singh A. Exploring the Mystery of Angiotensin-Converting Enzyme II (ACE2) in the Battle against SARS-CoV-2. J Renin Angiotensin Aldosterone Syst 2021;2021:9939929. [PMID: 34285711 DOI: 10.1155/2021/9939929] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
355 [DOI: 10.1101/2020.06.11.146878] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
356 Hassler L, Wysocki J, Gelarden I, Tomatsidou A, Gula H, Nicoleascu V, Randall G, Henkin J, Yeldandi A, Batlle D. A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 33758841 DOI: 10.1101/2021.03.12.435191] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
357 Czick M, Shapter C, Shapter R. COVID's Razor: RAS Imbalance, the Common Denominator Across Disparate, Unexpected Aspects of COVID-19. Diabetes Metab Syndr Obes 2020;13:3169-92. [PMID: 32982349 DOI: 10.2147/DMSO.S265518] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
358 Ferreira-Duarte M, Estevinho MM, Duarte-Araújo M, Magro F, Morato M. Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1787-95. [PMID: 33064147 DOI: 10.1093/ibd/izaa249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
359 Alexandre J, Cracowski JL, Richard V, Bouhanick B; French Society of Pharmacology and Therapeutics (SFPT). Drugs acting on renin angiotensin system and use in ill patients with COVID-19. Therapie 2020;75:319-25. [PMID: 32553503 DOI: 10.1016/j.therap.2020.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
360 Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets. Oxid Med Cell Longev 2021;2021:8671713. [PMID: 34457119 DOI: 10.1155/2021/8671713] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
361 Polito MV, Silverio A, Bellino M, Iuliano G, Di Maio M, Alfano C, Iannece P, Esposito N, Galasso G. Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? Cardiol Ther 2021. [PMID: 34191268 DOI: 10.1007/s40119-021-00232-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
362 Ambra R, Canali R, Pastore G, Natella F. Covid-19 and diet: an evaluation of information available on internet in Italy. Acta Biomed 2021;92:e2021077. [PMID: 33682806 DOI: 10.23750/abm.v92i1.11033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
363 Yang J, Zhang P, Cheng WX, Lu Y, Gang W, Ren G. Exposing Structural Variations in SARS-CoV-2 Evolution. Res Sq 2021:rs. [PMID: 34545355 DOI: 10.21203/rs.3.rs-800496/v1] [Reference Citation Analysis]
364 Noorbakhsh A, Askandar RH, Alhagh MS, Farshadfar C, Seyedi SH, Ahmadizad M, Rahimi A, Ardalan N, Koushki EH. Prevention of SARS-CoV-2 Proliferation with a Novel and Potent Main Protease Inhibitor by Docking, ADMET, MM-PBSA, and Molecular Dynamics Simulation. J Comput Biophys Chem 2021;20:305-22. [DOI: 10.1142/s2737416521500149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
366 Bouayad A. Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far? Rev Med Virol 2021. [PMID: 33793006 DOI: 10.1002/rmv.2236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Di Nora A, Pizzo F, Costanza G, Ruggieri M, Falsaperla R. Human herpes 6 encephalitis in co-infection with Covid-19. Acta Neurol Belg 2022. [PMID: 35499703 DOI: 10.1007/s13760-022-01961-w] [Reference Citation Analysis]
368 Basu A, Pamreddy A, Singh P, Sharma K. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models. J Mol Biol 2021;:167213. [PMID: 34437890 DOI: 10.1016/j.jmb.2021.167213] [Reference Citation Analysis]
369 Yang Y, Du Y, Kaltashov IA. The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor. Anal Chem 2020;92:10930-4. [PMID: 32678978 DOI: 10.1021/acs.analchem.0c02449] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
370 Zhou Y, Ge Y, Yang X, Cai Q, Ding Y, Hu L, Lu G. Prevalence and Outcomes of Pancreatic Enzymes Elevation in Patients With COVID-19: A Meta-Analysis and Systematic Review. Front Public Health 2022;10:865855. [DOI: 10.3389/fpubh.2022.865855] [Reference Citation Analysis]
371 Touyz R, Li H, Delles C. ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19. Clinical Science 2020;134:747-50. [DOI: 10.1042/cs20200363] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
372 Knížatová N, Massányi M, Roychoudhury S, Guha P, Greifová H, Tokárová K, Jambor T, Massányi P, Lukáč N. Is there impact of the SARS-CoV-2 pandemic on steroidogenesis and fertility? Physiol Res 2021;70:S161-75. [PMID: 34913350 DOI: 10.33549/physiolres.934756] [Reference Citation Analysis]
373 Musavi H, Abazari O, Barartabar Z, Kalaki-Jouybari F, Hemmati-Dinarvand M, Esmaeili P, Mahjoub S. The benefits of Vitamin D in the COVID-19 pandemic: biochemical and immunological mechanisms. Arch Physiol Biochem 2020;:1-9. [PMID: 33030073 DOI: 10.1080/13813455.2020.1826530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
374 Santoro F, Núñez-Gil IJ, Viana-Llamas MC, Maroun Eid C, Romero R, Fernández Rozas I, Aparisi A, Becerra-Muñoz VM, García Aguado M, Huang J, Maltese L, Cerrato E, Alfonso-Rodriguez E, Castro Mejía AF, Marin F, Raposeiras Roubin S, Pepe M, Moreno Munguia VH, Feltes G, Navas JV, Cortese B, Buzón L, Liebetrau C, Ramos-Martinez R, Fernandez-Ortiz A, Estrada V, Brunetti ND. Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]). Crit Care Med 2021;49:e624-33. [PMID: 33861553 DOI: 10.1097/CCM.0000000000005010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
375 Vellas C, Delobel P, de Souto Barreto P, Izopet J. COVID-19, Virology and Geroscience: A Perspective. J Nutr Health Aging 2020;24:685-91. [PMID: 32744561 DOI: 10.1007/s12603-020-1416-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
376 Sharma S, Mishra A, Ashraf Z. COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection. TH Open 2022;6:e70-9. [PMID: 35280973 DOI: 10.1055/s-0042-1744185] [Reference Citation Analysis]
377 Andrews PLR, Cai W, Rudd JA, Sanger GJ. COVID-19, nausea, and vomiting. J Gastroenterol Hepatol. 2021;36:646-656. [PMID: 32955126 DOI: 10.1111/jgh.15261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
378 Chornenkyy Y, Mejia-Bautista M, Brucal M, Blanke T, Dittmann D, Yeldandi A, Boike JR, Lomasney JW, Nayar R, Jennings LJ, Pezhouh MK. Liver Pathology and SARS-CoV-2 Detection in Formalin-Fixed Tissue of Patients With COVID-19. Am J Clin Pathol 2021;155:802-14. [PMID: 33914058 DOI: 10.1093/ajcp/aqab009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
379 Shukla BK, Tyagi H, Bhandari H, Garg S. Nanotechnology-Based Approach to Combat Pandemic COVID 19: A Review. Macromol Symp 2021;397:2000336. [PMID: 34511843 DOI: 10.1002/masy.202000336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
380 McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571-587. [PMID: 32586214 DOI: 10.1161/circresaha.120.317447] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 71.5] [Reference Citation Analysis]
381 [DOI: 10.1101/2020.04.12.20062380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
382 Lokhande AS, Devarajan PV. A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. Eur J Pharmacol 2021;891:173748. [PMID: 33227285 DOI: 10.1016/j.ejphar.2020.173748] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
383 Yerukala Sathipati S, Shukla SK, Ho SY. Tracking the amino acid changes of spike proteins across diverse host species of severe acute respiratory syndrome coronavirus 2. iScience 2022;25:103560. [PMID: 34877480 DOI: 10.1016/j.isci.2021.103560] [Reference Citation Analysis]
384 Garreta E, Nauryzgaliyeva Z, Montserrat N. Human induced pluripotent stem cell-derived kidney organoids toward clinical implementations. Current Opinion in Biomedical Engineering 2021;20:100346. [DOI: 10.1016/j.cobme.2021.100346] [Reference Citation Analysis]
385 Di Tano G, De Maria R, Loffi M, Moschini L, Galeazzi G, Danzi GB. Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia. Rev Esp Cardiol (Engl Ed) 2020;73:964-6. [PMID: 32792314 DOI: 10.1016/j.rec.2020.07.001] [Reference Citation Analysis]
386 Tavazzi G, Corradi F, Mojoli F, Forfori F, Via G. Contextualizing cardiac dysfunction in critically ill patients with COVID-19. Minerva Anestesiol 2020;86:1340-5. [PMID: 33174406 DOI: 10.23736/S0375-9393.20.14859-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
387 Medina-Enríquez MM, Lopez-León S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci 2020;10:148. [PMID: 33380340 DOI: 10.1186/s13578-020-00519-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
388 Arnold RH. COVID-19 - Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack? Heart Lung Circ 2020;29:964-72. [PMID: 32564908 DOI: 10.1016/j.hlc.2020.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
389 Abdel-Basset M, Hawash H, Elhoseny M, Chakrabortty RK, Ryan M. DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing. IEEE Access 2020;8:170433-51. [PMID: 34786289 DOI: 10.1109/ACCESS.2020.3024238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
390 Gao L, Jiang D, Wen XS, Cheng XC, Sun M, He B, You LN, Lei P, Tan XW, Qin S, Cai GQ, Zhang DY. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res. 2020;21:83. [PMID: 32293449 DOI: 10.1186/s12931-020-01352-w] [Cited by in Crossref: 112] [Cited by in F6Publishing: 108] [Article Influence: 56.0] [Reference Citation Analysis]
391 Palit P, Chattopadhyay D, Thomas S, Kundu A, Kim HS, Rezaei N. Phytopharmaceuticals mediated Furin and TMPRSS2 receptor blocking: can it be a potential therapeutic option for Covid-19? Phytomedicine 2021;85:153396. [PMID: 33380375 DOI: 10.1016/j.phymed.2020.153396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
392 Fierz W, Walz B. Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS. Front Immunol 2020;11:1120. [PMID: 32582200 DOI: 10.3389/fimmu.2020.01120] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
393 [DOI: 10.1101/2020.05.03.075473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
394 De Francia S, Ferretti A, Chiara F, Allegra S, Mancardi D, Allice TG, Milia MG, Gregori G, Burdino E, Avanzini C, Ghisetti V, Durio A. The Influence of Sex, Gender, and Age on COVID-19 Data in the Piedmont Region (Northwest Italy): The Virus Prefers Men. Life 2022;12:643. [DOI: 10.3390/life12050643] [Reference Citation Analysis]
395 Singh P, Tripathi MK, Yasir M, Khare R, Tripathi MK, Shrivastava R. Potential Inhibitors for SARS-CoV-2 and Functional Food Components as Nutritional Supplement for COVID-19: A Review. Plant Foods Hum Nutr 2020;75:458-66. [PMID: 33037564 DOI: 10.1007/s11130-020-00861-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
396 Jamal M, Shah M, Almarzooqi SH, Aber H, Khawaja S, El Abed R, Alkhatib Z, Samaranayake LP. Overview of transnational recommendations for COVID-19 transmission control in dental care settings. Oral Dis 2021;27 Suppl 3:655-64. [PMID: 32428372 DOI: 10.1111/odi.13431] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
397 Sharma P, Shanavas A. Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis. J Biomol Struct Dyn 2021;39:5819-30. [PMID: 32691697 DOI: 10.1080/07391102.2020.1794970] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
398 Vasanthakumar N. Can beta-adrenergic blockers be used in the treatment of COVID-19? Med Hypotheses 2020;142:109809. [PMID: 32388480 DOI: 10.1016/j.mehy.2020.109809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
399 Sahu S, Patil CR, Kumar S, Apparsundaram S, Goyal RK. Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 complications and its dietary modulation. Mol Cell Biochem 2021. [PMID: 34655418 DOI: 10.1007/s11010-021-04275-2] [Reference Citation Analysis]
400 Li H, Zhou Y, Zhang M, Wang H, Zhao Q, Liu J. Updated approaches against SARS-CoV-2. Antimicrob Agents Chemother. 2020;64. [PMID: 32205349 DOI: 10.1128/aac.00483-20] [Cited by in Crossref: 119] [Cited by in F6Publishing: 89] [Article Influence: 59.5] [Reference Citation Analysis]
401 Cai L, Guo X, Cao Y, Ying P, Hong L, Zhang Y, Yi G, Fu M. Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review). Int J Mol Med 2021;47:43. [PMID: 33576441 DOI: 10.3892/ijmm.2021.4876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
402 Robinson-Agramonte MA, Gonçalves CA, Noris-García E, Préndes Rivero N, Brigida AL, Schultz S, Siniscalco D, García García RJ. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatr 2021; 11(7): 347-354 [PMID: 34327127 DOI: 10.5498/wjp.v11.i7.347] [Reference Citation Analysis]
403 Eshrati B, Baradaran HR, Erfanpoor S, Mohazzab A, Moradi Y. Investigating the factors affecting the survival rate in patients with COVID-19: A retrospective cohort study. Med J Islam Repub Iran 2020;34:88. [PMID: 33306063 DOI: 10.34171/mjiri.34.88] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
404 Dima M, Enatescu I, Craina M, Petre I, Iacob ER, Iacob D. First neonates with severe acute respiratory syndrome coronavirus 2 infection in Romania: Three case reports. Medicine (Baltimore) 2020;99:e21284. [PMID: 32871986 DOI: 10.1097/MD.0000000000021284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
405 Câmara DAD, Porcacchia AS, Lizier NF, De-sá-júnior PL. A COVID-19 Overview and Potential Applications of Cell Therapy. Biologics 2021;1:177-88. [DOI: 10.3390/biologics1020011] [Reference Citation Analysis]
406 Samidurai A, Das A. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies. Int J Mol Sci. 2020;21. [PMID: 32947927 DOI: 10.3390/ijms21186790] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
407 Dhillon P, Breuer M, Hirst N. COVID-19 breakthroughs: separating fact from fiction. FEBS J 2020;287:3612-32. [PMID: 32500928 DOI: 10.1111/febs.15442] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
408 Sindelar M, Stancliffe E, Schwaiger-Haber M, Anbukumar DS, Albrecht RA, Liu WC, Travis KA, García-Sastre A, Shriver LP, Patti GJ. Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity. medRxiv 2021:2021. [PMID: 33564793 DOI: 10.1101/2021.02.05.21251173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
409 De A, Dash M, Tiwari A, Sinha A. Malaria, COVID-19 and angiotensin-converting enzyme 2: what does the available population data say? Open Biol 2021;11:210213. [PMID: 34637655 DOI: 10.1098/rsob.210213] [Reference Citation Analysis]
410 Mohanty S, Paul S, Ahmad Y. Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s). Virusdisease 2021;:1-10. [PMID: 34109260 DOI: 10.1007/s13337-021-00696-1] [Reference Citation Analysis]
411 Khan S, Rasool ST, Ahmed SI. Role of Cardiac Biomarkers in COVID-19: What Recent Investigations Tell Us? Curr Probl Cardiol 2021;:100842. [PMID: 33994028 DOI: 10.1016/j.cpcardiol.2021.100842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
412 Targher G, Mantovani A, Wang XB, Yan HD, Sun QF, Pan KH, Byrne CD, Zheng KI, Chen YP, Eslam M, George J, Zheng MH. Patients with diabetes are at higher risk for severe illness from COVID-19. Diabetes Metab 2020;46:335-7. [PMID: 32416321 DOI: 10.1016/j.diabet.2020.05.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 30.0] [Reference Citation Analysis]
413 Kumric M, Ticinovic Kurir T, Martinovic D, Zivkovic PM, Bozic J. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence. World J Gastroenterol 2021; 27(25): 3748-3761 [PMID: 34321841 DOI: 10.3748/wjg.v27.i25.3748] [Reference Citation Analysis]
414 Simon Junior H, Sakano TMS, Rodrigues RM, Eisencraft AP, Carvalho VEL, Schvartsman C, Reis AGADC. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view. J Pediatr (Rio J). 2021;97:140-159. [PMID: 32946801 DOI: 10.1016/j.jped.2020.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
415 Hijikata A, Shionyu-Mitsuyama C, Nakae S, Shionyu M, Ota M, Kanaya S, Shirai T. Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs. FEBS Lett 2020;594:1960-73. [PMID: 32379896 DOI: 10.1002/1873-3468.13806] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
416 [DOI: 10.1101/2020.06.12.20129478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
417 Ahmed Z, Zeeshan S, Foran DJ, Kleinman LC, Wondisford FE, Dong X. Integrative clinical, genomics and metabolomics data analysis for mainstream precision medicine to investigate COVID-19. BMJ Innov 2020;7:6-10. [DOI: 10.1136/bmjinnov-2020-000444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
418 Davoodi L, Jafarpour H, Taghavi M, Razavi A. COVID-19 Presented With Deep Vein Thrombosis: An Unusual Presenting. J Investig Med High Impact Case Rep 2020;8:2324709620931239. [PMID: 32493073 DOI: 10.1177/2324709620931239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
419 Papadopoulos V, Li L, Samplaski M. Why does COVID-19 kill more elderly men than women? Is there a role for testosterone? Andrology 2021;9:65-72. [PMID: 32681716 DOI: 10.1111/andr.12868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
420 Taha BA, Al-Jubouri Q, Al Mashhadany Y, Zan MSDB, Bakar AAA, Fadhel MM, Arsad N. Photonics enabled intelligence system to identify SARS-CoV 2 mutations. Appl Microbiol Biotechnol 2022. [PMID: 35484414 DOI: 10.1007/s00253-022-11930-1] [Reference Citation Analysis]
421 Ljungman P, Mikulska M, de la Camara R, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Dolstra H, Lankester AC, Mohty M, Montoto S, Murray J, Peffault de Latour R, Snowden JA, Yakoub-Agha I, Verhoeven B, Kröger N, Styczynski J; European Society for Blood and Marrow Transplantation. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplant 2020;55:2071-6. [PMID: 32404975 DOI: 10.1038/s41409-020-0919-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 32.5] [Reference Citation Analysis]
422 Fallon L, Belfon KAA, Raguette L, Wang Y, Stepanenko D, Cuomo A, Guerra J, Budhan S, Varghese S, Corbo CP, Rizzo RC, Simmerling C. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket. J Am Chem Soc 2021;143:11349-60. [PMID: 34270232 DOI: 10.1021/jacs.1c00556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
423 Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, Chen Y, Han Y. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132-1141. [PMID: 32354800 DOI: 10.1136/heartjnl-2020-317056] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 60.5] [Reference Citation Analysis]
424 Landecho MF, Yuste JR, Gándara E, Sunsundegui P, Quiroga J, Alcaide AB, García-Layana A. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med 2021;289:116-20. [PMID: 32729633 DOI: 10.1111/joim.13156] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
425 Sarkar J, Das S, Aich S, Bhattacharyya P, Acharya K. Antiviral potential of nanoparticles for the treatment of Coronavirus infections. Journal of Trace Elements in Medicine and Biology 2022. [DOI: 10.1016/j.jtemb.2022.126977] [Reference Citation Analysis]
426 Ren Y, Yin Z, Dai J, Yang Z, Ye B, Ma Y, Zhang T, Shi Y. Evidence-Based Complementary and Alternative Medicine Exploring Active Components and Mechanism of Jinhua Qinggan Granules in Treatment of COVID-19 Based on Virus-Host Interaction. Natural Product Communications 2020;15:1934578X2094721. [DOI: 10.1177/1934578x20947213] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
427 Lo MW, Kemper C, Woodruff TM. COVID-19: Complement, Coagulation, and Collateral Damage. J Immunol 2020;205:1488-95. [PMID: 32699160 DOI: 10.4049/jimmunol.2000644] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
428 Bolay H, Gül A, Baykan B. COVID-19 is a Real Headache! Headache 2020;60:1415-21. [PMID: 32412101 DOI: 10.1111/head.13856] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 30.5] [Reference Citation Analysis]
429 Garg M, Christensen B, Lubel JS. Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy? Gastroenterology 2020;159:1623-1624.e3. [PMID: 32353370 DOI: 10.1053/j.gastro.2020.04.051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
430 Silva JKRD, Figueiredo PLB, Byler KG, Setzer WN. Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation. Int J Mol Sci 2020;21:E3426. [PMID: 32408699 DOI: 10.3390/ijms21103426] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 18.0] [Reference Citation Analysis]
431 Pillay TS. Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein. J Clin Pathol 2020;73:366-9. [PMID: 32376714 DOI: 10.1136/jclinpath-2020-206658] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 30.5] [Reference Citation Analysis]
432 Castro P, Palomo M, Moreno-Castaño AB, Fernández S, Torramadé-Moix S, Pascual G, Martinez-Sanchez J, Richardson E, Téllez A, Nicolas JM, Carreras E, Richardson PG, Badimon JJ, Escolar G, Diaz-Ricart M. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Cardiovasc Drugs Ther 2021. [PMID: 34097193 DOI: 10.1007/s10557-021-07207-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
433 Pillai P, Joseph JP, Fadzillah NHM, Mahmod M. COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems. J Stroke Cerebrovasc Dis 2021;30:105427. [PMID: 33137615 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
434 Rezasoltani S, Hatami B, Yadegar A, Asadzadeh Aghdaei H, Zali MR. How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19? Front Med (Lausanne) 2020;7:398. [PMID: 32754608 DOI: 10.3389/fmed.2020.00398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
435 Rath S, Perikala V, Jena AB, Dandapat J. Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs. Biomed Pharmacother 2021;143:112095. [PMID: 34479017 DOI: 10.1016/j.biopha.2021.112095] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
436 Bogan-Brown K, Nkrumah-Elie Y, Ishtiaq Y, Redpath P, Shao A. Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19. J Diet Suppl 2021;:1-29. [PMID: 33594938 DOI: 10.1080/19390211.2021.1881686] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
437 Maccio U, Zinkernagel AS, Shambat SM, Zeng X, Cathomas G, Ruschitzka F, Schuepbach RA, Moch H, Varga Z. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine 2021;63:103182. [PMID: 33422990 DOI: 10.1016/j.ebiom.2020.103182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
438 Zhong M, Lin B, Pathak JL, Gao H, Young AJ, Wang X, Liu C, Wu K, Liu M, Chen JM, Huang J, Lee LH, Qi CL, Ge L, Wang L. ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal-Oral Routes. Front Med (Lausanne) 2020;7:580796. [PMID: 33363183 DOI: 10.3389/fmed.2020.580796] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
439 Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19. Cancer Cell Int 2021;21:431. [PMID: 34399734 DOI: 10.1186/s12935-021-02129-x] [Reference Citation Analysis]
440 Marhaeny HD, Widyawaruyanti A, Widiandani T, Fuad Hafid A, Wahyuni TS. Phyllanthin and hypophyllanthin, the isolated compounds of Phyllanthus niruri inhibit protein receptor of corona virus (COVID-19) through in silico approach. J Basic Clin Physiol Pharmacol 2021;32:809-15. [PMID: 34214339 DOI: 10.1515/jbcpp-2020-0473] [Reference Citation Analysis]
441 Shanmugarajan D, P. P, Kumar BRP, Suresh B. Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets. RSC Adv 2020;10:31385-99. [DOI: 10.1039/d0ra03167d] [Cited by in Crossref: 10] [Article Influence: 5.0] [Reference Citation Analysis]
442 Bristow MR, Zisman LS, Altman NL, Gilbert EM, Lowes BD, Minobe WA, Slavov D, Schwisow JA, Rodriguez EM, Carroll IA, Keuer TA, Buttrick PM, Kao DP. Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium. JACC Basic Transl Sci 2020;5:871-83. [PMID: 32838074 DOI: 10.1016/j.jacbts.2020.06.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
443 Bhalerao A, Raut S, Noorani B, Mancuso S, Cucullo L. Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy. Cells 2021;10:2878. [PMID: 34831101 DOI: 10.3390/cells10112878] [Reference Citation Analysis]
444 Ryan PM, Caplice N. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response. Open Heart 2020;7:e001302. [PMID: 32532804 DOI: 10.1136/openhrt-2020-001302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
445 Mahajan A, Hirsch JA. Novel Coronavirus: What Neuroradiologists as Citizens of the World Need to Know. AJNR Am J Neuroradiol 2020;41:552-4. [PMID: 32198164 DOI: 10.3174/ajnr.A6526] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
446 Aşıkgarip N, Temel E, Hızmalı L, Örnek K, Sezgin FM. Retinal Vessel Diameter Changes in COVID-19 Infected Patients. Ocul Immunol Inflamm 2021;:1-7. [PMID: 33497297 DOI: 10.1080/09273948.2020.1853783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
447 Luan YY, Liu Y, Liu XY, Yu BJ, Chen RL, Peng M, Ren D, Li HL, Huang L, Li JX, Feng YW, Wu M. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study. Thromb Res. 2020;195:62-68. [PMID: 32659462 DOI: 10.1016/j.thromres.2020.07.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
448 Neurath MF. COVID-19 and immunomodulation in IBD. Gut 2020;69:1335-42. [PMID: 32303609 DOI: 10.1136/gutjnl-2020-321269] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 54.0] [Reference Citation Analysis]
449 Prasanth DSNBK, Murahari M, Chandramohan V, Guntupalli C, Atmakuri LR. Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2. J Biomol Struct Dyn 2021;:1-15. [PMID: 34396938 DOI: 10.1080/07391102.2021.1965027] [Reference Citation Analysis]
450 [DOI: 10.1101/2020.04.10.20060335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
451 Saiz ML, DeDiego ML, López-García D, Corte-Iglesias V, Baragaño Raneros A, Astola I, Asensi V, López-Larrea C, Suarez-Alvarez B. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity. Clin Epigenetics 2021;13:187. [PMID: 34635175 DOI: 10.1186/s13148-021-01168-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
452 Rex DAB, Dagamajalu S, Kandasamy RK, Raju R, Prasad TSK. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19. J Cell Commun Signal 2021. [PMID: 34181169 DOI: 10.1007/s12079-021-00632-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
453 Mehata AK, Viswanadh MK, Priya V, Vikas, Muthu MS. Harnessing immunological targets for COVID-19 immunotherapy. Future Virol 2021. [PMID: 34447458 DOI: 10.2217/fvl-2021-0048] [Reference Citation Analysis]
454 Brizneda MV, Bansal A, Jain V, Kapadia S, Svensson LG, Menon V, Cremer P, Reed G, Rampersad P, Grimm R, Griffin BP, Xu B. Coronavirus disease and the cardiovascular system: a narrative review of the mechanisms of injury and management implications. Cardiovasc Diagn Ther 2021;11:939-53. [PMID: 34295715 DOI: 10.21037/cdt-20-779] [Reference Citation Analysis]
455 Getachew B, Tizabi Y. Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity. J Med Virol 2021;93:5285-94. [PMID: 33990955 DOI: 10.1002/jmv.27075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
456 Shukla N, Prasad A, Kanga U, Suravajhala R, Nigam VK, Kishor PBK, Polavarapu R, Chaubey G, Singh KK, Suravajhala P. SARS-CoV-2 transgressing LncRNAs uncovers the known unknowns. Physiol Genomics 2021;53:433-40. [PMID: 34492207 DOI: 10.1152/physiolgenomics.00075.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
457 Mescoli A, Maffei G, Pillo G, Bortone G, Marchesi S, Morandi E, Ranzi A, Rotondo F, Serra S, Vaccari M, Zauli Sajani S, Mascolo MG, Jacobs MN, Colacci A. The Secretive Liaison of Particulate Matter and SARS-CoV-2. A Hypothesis and Theory Investigation. Front Genet 2020;11:579964. [PMID: 33240326 DOI: 10.3389/fgene.2020.579964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
458 Lechowicz K, Drożdżal S, Machaj F, Rosik J, Szostak B, Zegan-Barańska M, Biernawska J, Dabrowski W, Rotter I, Kotfis K. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. J Clin Med 2020;9:E1917. [PMID: 32575380 DOI: 10.3390/jcm9061917] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
459 Rusu I, Turlacu M, Micheu MM. Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications. World J Clin Cases 2022; 10(3): 762-776 [DOI: 10.12998/wjcc.v10.i3.762] [Reference Citation Analysis]
460 Pouya F, Imani Saber Z, Kerachian MA. Molecular Aspects of Co-morbidities in COVID-19 Infection. Arch Bone Jt Surg 2020;8:226-30. [PMID: 32607393 DOI: 10.22038/abjs.2020.47828.2361] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
461 Dragon-Durey MA, Chen X, Kirilovsky A, Ben Hamouda N, El Sissy C, Russick J, Charpentier E, Binois Y, Marliot F, Meylan M, Granier C, Pere H, Saldmann A, Rance B, Jannot AS, Baron S, Chebbi M, Fayol A, Josseaume N, Rives-Lange C, Tharaux PL, Cholley B, Diehl JL, Arlet JB, Azizi M, Karras A, Czernichow S, Smadja DM, Hulot JS, Cremer I, Tartour E, Mousseaux E, Pagès F. Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity. PLoS One 2021;16:e0252026. [PMID: 34038475 DOI: 10.1371/journal.pone.0252026] [Reference Citation Analysis]
462 Alshrari AS, Hudu SA, Imran M, Asdaq SMB, Ali AM, Rabbani SI. Innovations and development of Covid-19 vaccines: A patent review. J Infect Public Health 2021:S1876-0341(21)00342-7. [PMID: 34742639 DOI: 10.1016/j.jiph.2021.10.021] [Reference Citation Analysis]
463 Sun AM, Hoffman T, Luu BQ, Ashammakhi N, Li S. Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review. Biodes Manuf 2021;:1-19. [PMID: 34178414 DOI: 10.1007/s42242-021-00136-5] [Reference Citation Analysis]
464 Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol 2020;16:636-44. [PMID: 32839585 DOI: 10.1038/s41582-020-0398-3] [Cited by in Crossref: 112] [Cited by in F6Publishing: 122] [Article Influence: 56.0] [Reference Citation Analysis]
465 Sessa R, Anastasi E, Brandolino G, Brunelli R, Di Pietro M, Filardo S, Masciullo L, Terrin G, Viscardi MF, Porpora MG. What is the Hidden Biological Mechanism Underlying the Possible SARS-CoV-2 Vertical Transmission? A Mini Review. Front Physiol 2022;13:875806. [DOI: 10.3389/fphys.2022.875806] [Reference Citation Analysis]
466 Tabibzadeh A, Esghaei M, Soltani S, Yousefi P, Taherizadeh M, Safarnezhad Tameshkel F, Golahdooz M, Panahi M, Ajdarkosh H, Zamani F, Karbalaie Niya MH. Evolutionary study of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emerging coronavirus: Phylogenetic analysis and literature review. Vet Med Sci 2021;7:559-71. [PMID: 33210477 DOI: 10.1002/vms3.394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
467 Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J, Weber C, Bochaton-Piallat ML, Bäck M. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020;116:2177-84. [PMID: 32750108 DOI: 10.1093/cvr/cvaa230] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 44.5] [Reference Citation Analysis]
468 Tristán-Flores FE, Casique-Aguirre D, Pliego-Arreaga R, Cervantes-Montelongo JA, García-Gutierrez P, Acosta-García G, Silva-Martínez GA. Identification of potential inhibitors of SARS-CoV-2 S protein-ACE2 interaction by in silico drug repurposing. F1000Res 2021;10:Chem Inf Sci-358. [PMID: 34900223 DOI: 10.12688/f1000research.52168.2] [Reference Citation Analysis]
469 Kuriakose J, Montezano AC, Touyz RM. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci (Lond) 2021;135:387-407. [PMID: 33511992 DOI: 10.1042/CS20200480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
470 Dahal A, Sonju JJ, Kousoulas KG, Jois SD. Peptides and peptidomimetics as therapeutic agents for Covid-19. Pept Sci (Hoboken) 2021;:e24245. [PMID: 34901700 DOI: 10.1002/pep2.24245] [Reference Citation Analysis]
471 Ishaqat A, Herrmann A. Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics. J Am Chem Soc 2021;143:20529-45. [PMID: 34841867 DOI: 10.1021/jacs.1c08484] [Reference Citation Analysis]
472 Toor R, Zamora FJ, Fatteh N, Drexler N, Lozada J. Use of Low-Molecular-Weight Heparin and Peak anti-Xa Monitoring In Severe SARS-CoV-2 Disease: A Brief Report. Hosp Pharm 2021;56:640-5. [PMID: 34732915 DOI: 10.1177/0018578720954154] [Reference Citation Analysis]
473 Saheera S, Potnuri AG, Krishnamurthy P. Nano-Vesicle (Mis)Communication in Senescence-Related Pathologies. Cells 2020;9:E1974. [PMID: 32859053 DOI: 10.3390/cells9091974] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
474 Tsuchiya H. Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review. Dent J (Basel) 2021;9:32. [PMID: 33799583 DOI: 10.3390/dj9030032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
475 Zheng X, Yang H, Li X, Li H, Xu L, Yu Q, Dong Y, Zhao Y, Wang J, Hou W, Zhang X, Li Y, Hu F, Gao H, Lv J, Yang L. Prevalence of Kidney Injury and Associations with Critical Illness and Death in Patients with COVID-19. Clin J Am Soc Nephrol 2020;15:1549-56. [PMID: 32943396 DOI: 10.2215/CJN.04780420] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
476 Li Z, Wang Z, Dinh PC, Zhu D, Popowski KD, Lutz H, Hu S, Lewis MG, Cook A, Andersen H, Greenhouse J, Pessaint L, Lobo LJ, Cheng K. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19. Nat Nanotechnol 2021;16:942-51. [PMID: 34140674 DOI: 10.1038/s41565-021-00923-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
477 Crosby JC, Heimann MA, Burleson SL, Anzalone BC, Swanson JF, Wallace DW, Greene CJ. COVID-19: A review of therapeutics under investigation. J Am Coll Emerg Physicians Open 2020. [PMID: 32838367 DOI: 10.1002/emp2.12081] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
478 Debela D, Ababulgu E, Desu G, Abebe S, Adugna T. Distal Deep Vein Thrombosis in a Patient Cured of Severe COVID-19 Pneumonia at Jimma, Oromia, Ethiopia 2021: A Rare Case Report. Int Med Case Rep J 2021;14:519-22. [PMID: 34393520 DOI: 10.2147/IMCRJ.S322301] [Reference Citation Analysis]
479 Ashrafzadeh-Kian S, Campbell MR, Jara Aguirre JC, Walsh J, Kumanovics A, Jenkinson G, Rinaldo P, Snyder MR, Algeciras-Schimnich A. Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients. Cytokine 2022;150:155790. [PMID: 34991059 DOI: 10.1016/j.cyto.2021.155790] [Reference Citation Analysis]
480 Goyal N, Chung M, Bernheim A, Keir G, Mei X, Huang M, Li S, Kanne JP. Computed Tomography Features of Coronavirus Disease 2019 (COVID-19): A Review for Radiologists. J Thorac Imaging 2020;35:211-8. [PMID: 32427651 DOI: 10.1097/RTI.0000000000000527] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
481 Garg M, Royce SG, Lubel JS. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors. Aliment Pharmacol Ther 2020;52:569-70. [PMID: 32374032 DOI: 10.1111/apt.15814] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
482 Scheim D. Ivermectin for COVID-19 Treatment: Clinical Response at Quasi-Threshold Doses Via Hypothesized Alleviation of CD147-Mediated Vascular Occlusion. SSRN Journal. [DOI: 10.2139/ssrn.3636557] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
483 Moharana M, Das A, Sahu SN, Pattanayak SK, Khan F. Evaluation of binding performance of bioactive compounds against main protease and mutant model spike receptor binding domain of SARS-CoV-2: Docking, ADMET properties and molecular dynamics simulation study. Journal of the Indian Chemical Society 2022;99:100417. [DOI: 10.1016/j.jics.2022.100417] [Reference Citation Analysis]
484 Bielka W, Przezak A, Pawlik A. Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection. Int J Mol Sci 2021;22:7605. [PMID: 34299225 DOI: 10.3390/ijms22147605] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
485 Tamanna S, Clifton VL, Rae K, van Helden DF, Lumbers ER, Pringle KG. Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age. Front Physiol 2020;11:590787. [PMID: 33101066 DOI: 10.3389/fphys.2020.590787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
486 Dey A, Sen S, Maulik U. Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade. Brief Bioinform. 2020;. [PMID: 32968798 DOI: 10.1093/bib/bbaa214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
487 Asrani P, Hasan GM, Sohal SS, Hassan MI. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century. OMICS 2020;24:634-44. [PMID: 32940573 DOI: 10.1089/omi.2020.0131] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
488 Hernández A, Viñals M, Pablos A, Vilás F, Papadakos PJ, Wijeysundera DN, Bergese SD, Vives M. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study. Int Immunopharmacol 2021;90:107261. [PMID: 33310665 DOI: 10.1016/j.intimp.2020.107261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
489 Saleemi MA, Ahmad B, Benchoula K, Vohra MS, Mea HJ, Chong PP, Palanisamy NK, Wong EH. Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics. Infect Genet Evol 2020;85:104583. [PMID: 33035643 DOI: 10.1016/j.meegid.2020.104583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
490 Dolskiy AA, Gudymo AS, Taranov OS, Grishchenko IV, Shitik EM, Prokopov DY, Soldatov VO, Sobolevskaya EV, Bodnev SA, Danilchenko NV, Moiseeva AA, Torzhkova PY, Bulanovich YA, Onhonova GS, Ivleva EK, Kubekina MV, Belykh AE, Tregubchak TV, Ryzhikov AB, Gavrilova EV, Maksyutov RA, Deykin AV, Yudkin DV. The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2. Front Mol Biosci 2022;8:821506. [DOI: 10.3389/fmolb.2021.821506] [Reference Citation Analysis]
491 Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, Salazar-Mather TP, Dumenco L, Savaria MC, Aung SN, Flanigan T, Michelow IC. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021;31:1-10. [PMID: 32845042 DOI: 10.1002/rmv.2146] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 20.0] [Reference Citation Analysis]
492 Sugiyama MG, Cui H, Redka DS, Karimzadeh M, Rujas E, Maan H, Hayat S, Cheung K, Misra R, McPhee JB, Viirre RD, Haller A, Botelho RJ, Karshafian R, Sabatinos SA, Fairn GD, Madani Tonekaboni SA, Windemuth A, Julien JP, Shahani V, MacKinnon SS, Wang B, Antonescu CN. Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease. Sci Rep 2021;11:23315. [PMID: 34857794 DOI: 10.1038/s41598-021-02432-7] [Reference Citation Analysis]
493 Papazafiropoulou AK, Antonopoulos S. The COVID-19 pandemic and diabetes mellitus. Arch Med Sci Atheroscler Dis 2020;5:e200-5. [PMID: 32832721 DOI: 10.5114/amsad.2020.97435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
494 Jakobsson J, Cotgreave I, Furberg M, Arnberg N, Svensson M. Potential Physiological and Cellular Mechanisms of Exercise That Decrease the Risk of Severe Complications and Mortality Following SARS-CoV-2 Infection. Sports (Basel) 2021;9:121. [PMID: 34564326 DOI: 10.3390/sports9090121] [Reference Citation Analysis]
495 Ardestani Zadeh A, Arab D. COVID-19 and male reproductive system: pathogenic features and possible mechanisms. J Mol Histol 2021. [PMID: 34232425 DOI: 10.1007/s10735-021-10003-3] [Reference Citation Analysis]
496 Ghareeb DA, Saleh SR, Nofal MS, Kaddah MMY, Hassan SF, Seif IK, El-Zahaby SA, Khedr SM, Kenawy MY, Masoud AA, Soudi SA, Sobhy AA, Sery JG, El-Wahab MGA, Elmoneam AAA, Al-Mahallawi AM, El-Demellawy MA. Potential therapeutic and pharmacological strategies for SARS-CoV2. J Pharm Investig 2021;:1-16. [PMID: 33688448 DOI: 10.1007/s40005-021-00520-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
497 Ding P, Song B, Liu X, Fang X, Cai H, Zhang D, Zheng X. Elevated Pancreatic Enzymes in ICU Patients With COVID-19 in Wuhan, China: A Retrospective Study. Front Med (Lausanne) 2021;8:663646. [PMID: 34485322 DOI: 10.3389/fmed.2021.663646] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
498 Bibiana S O F, Vargas-Pinilla P, Amorim CEG, Sortica VA, Bortolini MC. ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2. Genet Mol Biol 2020;43:e20200104. [PMID: 32520981 DOI: 10.1590/1678-4685-gmb-2020-0104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
499 Shi D, Wu W, Wang Q, Xu K, Xie J, Wu J, Lv L, Sheng J, Guo J, Wang K, Fang D, Li Y, Li L. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study. J Infect Dis 2020;222:910-8. [PMID: 32614392 DOI: 10.1093/infdis/jiaa388] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
500 Momtazi-Borojeni AA, Banach M, Reiner Ž, Pirro M, Bianconi V, Al-Rasadi K, Sahebkar A. Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19. Angiology 2021;72:122-30. [PMID: 32864982 DOI: 10.1177/0003319720952284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
501 Cippà PE, Cugnata F, Ferrari P, Brombin C, Ruinelli L, Bianchi G, Beria N, Schulz L, Bernasconi E, Merlani P, Ceschi A, Di Serio C. A data-driven approach to identify risk profiles and protective drugs in COVID-19. Proc Natl Acad Sci U S A 2021;118:e2016877118. [PMID: 33303654 DOI: 10.1073/pnas.2016877118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
502 Xia X, Wang Y, Zheng J. COVID-19 and Alzheimer's disease: how one crisis worsens the other. Transl Neurodegener 2021;10:15. [PMID: 33941272 DOI: 10.1186/s40035-021-00237-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
503 Farnoosh G, Ghanei M, Khorramdelazad H, Alishiri G, Jalali Farahani A, Shahriary A, Hosseini Zijoud SR. Are Iranian Sulfur Mustard Gas-Exposed Survivors More Vulnerable to SARS-CoV-2? Some Similarity in Their Pathogenesis. Disaster Med Public Health Prep 2020;14:826-32. [PMID: 32418550 DOI: 10.1017/dmp.2020.156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
504 Kulkarni S, Jenner BL, Wilkinson I. COVID-19 and hypertension. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320927851. [PMID: 32431227 DOI: 10.1177/1470320320927851] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
505 Tompa DR, Immanuel A, Srikanth S, Kadhirvel S. Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. Int J Biol Macromol 2021;172:524-41. [PMID: 33454328 DOI: 10.1016/j.ijbiomac.2021.01.076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
506 Michaud V, Deodhar M, Arwood M, Al Rihani SB, Dow P, Turgeon J. ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System. J Clin Med 2020;9:E2096. [PMID: 32635289 DOI: 10.3390/jcm9072096] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
507 Rafiq D, Batool A, Bazaz MA. Three months of COVID-19: A systematic review and meta-analysis. Rev Med Virol 2020;30:e2113. [PMID: 32420674 DOI: 10.1002/rmv.2113] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
508 Valencia I, Peiró C, Lorenzo Ó, Sánchez-Ferrer CF, Eckel J, Romacho T. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Front Pharmacol 2020;11:1161. [PMID: 32848769 DOI: 10.3389/fphar.2020.01161] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
509 Illi B, Vasapollo B, Valensise H, Totta P. SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia. Reprod Med 2021;2:95-106. [DOI: 10.3390/reprodmed2020010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Chavda VP, Kapadia C, Soni S, Prajapati R, Chauhan SC, Yallapu MM, Apostolopoulos V. A global picture: therapeutic perspectives for COVID-19. Immunotherapy. [DOI: 10.2217/imt-2021-0168] [Reference Citation Analysis]
511 Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B, He H, Wang Z, Ye D, Zhao M, Luo Z, Liu M, Zhang P, Gu J, Liu M, Li D, Liu J, Wan J. Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients. Hypertension 2020;76:732-41. [PMID: 32654555 DOI: 10.1161/HYPERTENSIONAHA.120.15289] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 12.5] [Reference Citation Analysis]
512 Elhamzaoui H, Rebahi H, Hachimi A. Coronavirus disease 2019 (COVID-19) pathogenesis: a concise narrative review. Pan Afr Med J 2021;39:8. [PMID: 34178236 DOI: 10.11604/pamj.2021.39.8.23546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
513 Zahradník J, Marciano S, Shemesh M, Zoler E, Harari D, Chiaravalli J, Meyer B, Rudich Y, Li C, Marton I, Dym O, Elad N, Lewis MG, Andersen H, Gagne M, Seder RA, Douek DC, Schreiber G. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol 2021;6:1188-98. [PMID: 34400835 DOI: 10.1038/s41564-021-00954-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 15.0] [Reference Citation Analysis]
514 John Wort S, Arachchillage DJ, McCabe C, Price LC. Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective. Respir Med Res 2020;78:100781. [PMID: 32889497 DOI: 10.1016/j.resmer.2020.100781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
515 Mitsuyama K, Tsuruta K, Takedatsu H, Yoshioka S, Morita M, Niwa M, Matsumoto S. Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19. J Clin Med. 2020;9:3630. [PMID: 33187280 DOI: 10.3390/jcm9113630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
516 Mule S, Singh A, Greish K, Sahebkar A, Kesharwani P, Shukla R. Drug repurposing strategies and key challenges for COVID-19 management. J Drug Target 2021;:1-17. [PMID: 34854327 DOI: 10.1080/1061186X.2021.2013852] [Reference Citation Analysis]
517 Zwart SR, Smith SM. Vitamin D and COVID-19: Lessons from Spaceflight Analogs. J Nutr 2020;150:2624-7. [PMID: 32710111 DOI: 10.1093/jn/nxaa233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
518 Wang Y, Wang P, Qin J. Human Organoids and Organs-on-Chips for Addressing COVID-19 Challenges. Adv Sci (Weinh) 2022;:e2105187. [PMID: 35107217 DOI: 10.1002/advs.202105187] [Reference Citation Analysis]
519 Saratale GD, Shin H, Shinde SK, Kim D, Saratale RG, Kadam AA, Kumar M, Bahkali AH, Syed A, Ghodake GS. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. JPM 2022;12:349. [DOI: 10.3390/jpm12030349] [Reference Citation Analysis]
520 Kothandan R, Rajan CASG, Arjun J, Raj RRM, Syed S. Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection. Beni Suef Univ J Basic Appl Sci 2021;10:9. [PMID: 33527080 DOI: 10.1186/s43088-021-00095-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
521 Ahmed Z, Renart EG, Zeeshan S. Investigating underlying human immunity genes, implicated diseases and their relationship to COVID-19. Per Med 2022. [PMID: 35261286 DOI: 10.2217/pme-2021-0132] [Reference Citation Analysis]
522 Shao S, Yang Q, Pan R, Yu X, Chen Y. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes. Front Endocrinol (Lausanne) 2021;12:731974. [PMID: 34690930 DOI: 10.3389/fendo.2021.731974] [Reference Citation Analysis]
523 Anastasiou IA, Eleftheriadou I, Tentolouris A, Tsilingiris D, Tentolouris N. In Vitro Data of Current Therapies for SARS-CoV-2. Curr Med Chem 2020;27:4542-8. [PMID: 32400323 DOI: 10.2174/0929867327666200513075430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
524 Antushevich H. Interplays between inflammasomes and viruses, bacteria (pathogenic and probiotic), yeasts and parasites. Immunol Lett 2020;228:1-14. [PMID: 32971149 DOI: 10.1016/j.imlet.2020.09.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
525 Esposito L, Cancro FP, Silverio A, Di Maio M, Iannece P, Damato A, Alfano C, De Luca G, Vecchione C, Galasso G. COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives. Oxid Med Cell Longev 2021;2021:4936571. [PMID: 34484561 DOI: 10.1155/2021/4936571] [Reference Citation Analysis]
526 Worku E, Gill D, Brodie D, Lorusso R, Combes A, Shekar K. Provision of ECPR during COVID-19: evidence, equity, and ethical dilemmas. Crit Care 2020;24:462. [PMID: 32718340 DOI: 10.1186/s13054-020-03172-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
527 Ruiz-Rodríguez JC, Chiscano-Camon L, Ruiz D, Sacanell J, Argudo E, Nuvials FX, Ferrer R. Cardiac tamponade as a cause of cardiac arrest in severe COVID-19 pneumonia. Resuscitation 2020;155:1-2. [PMID: 32702395 DOI: 10.1016/j.resuscitation.2020.07.008] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
528 Wang SF, Chen KH, Wang SY, Yarmishyn AA, Lai WY, Lin YY, Wang ML, Chou SJ, Yang YP, Chang YL. The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2. J Chin Med Assoc 2020;83:712-8. [PMID: 32433345 DOI: 10.1097/JCMA.0000000000000353] [Reference Citation Analysis]
529 Scala S, Pacelli R. Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs. Front Immunol 2020;11:1201. [PMID: 32574268 DOI: 10.3389/fimmu.2020.01201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
530 George JA, Khoza S. SARS-CoV-2 Infection and the Kidneys: An Evolving Picture. Adv Exp Med Biol 2021;1327:107-18. [PMID: 34279832 DOI: 10.1007/978-3-030-71697-4_8] [Reference Citation Analysis]
531 Saksena N, Bonam SR, Miranda-Saksena M. Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic. Front Genet 2021;12:581726. [PMID: 33828579 DOI: 10.3389/fgene.2021.581726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
532 Wu CY, Lin YS, Yang YH, Shu LH, Cheng YC, Liu HT. GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies. Biomed Pharmacother 2020;132:110816. [PMID: 33049583 DOI: 10.1016/j.biopha.2020.110816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
533 Permana H, Huang I, Purwiga A, Kusumawardhani NY, Sihite TA, Martanto E, Wisaksana R, Soetedjo NNM. In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis. Pharmacol Rep. 2021;73:769-780. [PMID: 33608850 DOI: 10.1007/s43440-021-00233-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
534 Bumiller-Bini V, de Freitas Oliveira-Toré C, Carvalho TM, Kretzschmar GC, Gonçalves LB, Alencar NM, Gasparetto Filho MA, Beltrame MH, Winter Boldt AB. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genet Mol Biol 2021;44:e20200199. [PMID: 33729332 DOI: 10.1590/1678-4685-GMB-2020-0199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
535 Giryes S, Bragazzi NL, Bridgewood C, De Marco G, McGonagle D. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. Semin Immunopathol 2022. [PMID: 35412072 DOI: 10.1007/s00281-022-00928-6] [Reference Citation Analysis]
536 Paniri A, Hosseini MM, Akhavan-Niaki H. First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations. J Biomol Struct Dyn 2021;39:3576-93. [PMID: 32410502 DOI: 10.1080/07391102.2020.1767690] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
537 Mantovani A, Byrne CD, Zheng MH, Targher G. Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2020;30:1236-1248. [PMID: 32571616 DOI: 10.1016/j.numecd.2020.05.014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 41.0] [Reference Citation Analysis]
538 Aksoy H, Karadag AS, Wollina U. Angiotensin II receptors: Impact for COVID-19 severity. Dermatol Ther 2020;33:e13989. [PMID: 32645228 DOI: 10.1111/dth.13989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
539 Imran M, Iqbal S, Hussain A, Uddin J, Shahzad M, Khaliq T, Razzaq Ahmed A, Mushtaq L, Kashif M, Mahmood K. In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease. Arab J Chem 2022;15:103473. [PMID: 34909065 DOI: 10.1016/j.arabjc.2021.103473] [Reference Citation Analysis]
540 Miesbach W, Makris M. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clin Appl Thromb Hemost. 2020;26:1076029620938149. [PMID: 32677459 DOI: 10.1177/1076029620938149] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 45.0] [Reference Citation Analysis]
541 Ortega MA, Fraile-Martínez O, García-Montero C, García-Gallego S, Sánchez-Trujillo L, Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N, Bujan J, Álvarez-Mon M, Asúnsolo Á, De la Torre B. An integrative look at SARS‑CoV‑2 (Review). Int J Mol Med 2021;47:415-34. [PMID: 33416095 DOI: 10.3892/ijmm.2020.4828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
542 Sriram K, Insel PA. A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance. Br J Pharmacol 2020;177:4825-44. [PMID: 32333398 DOI: 10.1111/bph.15082] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 39.0] [Reference Citation Analysis]
543 Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms. Journal of Cardiac Failure 2020;26:470-5. [DOI: 10.1016/j.cardfail.2020.04.009] [Cited by in Crossref: 131] [Cited by in F6Publishing: 118] [Article Influence: 65.5] [Reference Citation Analysis]
544 Safadi MAP. The intriguing features of COVID‐19 in children and its impact on the pandemic. Jornal de Pediatria (Versão em Português) 2020;96:265-8. [DOI: 10.1016/j.jpedp.2020.04.001] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
545 Dambha-Miller H, Albasri A, Hodgson S, Wilcox C, Islam N, Khan S, Little P, Griffin S. Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol. BJGP Open 2020;4:bjgpopen20X101115. [PMID: 32665234 DOI: 10.3399/bjgpopen20X101115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
546 Bolay H, Karadas Ö, Oztürk B, Sonkaya R, Tasdelen B, Bulut TDS, Gülbahar Ö, Özge A, Baykan B. HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. J Headache Pain 2021;22:94. [PMID: 34384355 DOI: 10.1186/s10194-021-01306-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
547 Singh SP, Pritam M, Pandey B, Yadav TP. Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive review. J Med Virol 2021;93:275-99. [PMID: 32617987 DOI: 10.1002/jmv.26254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
548 Yanes Cardozo LL, Rezq S, Pruett JE, Romero DG. Androgens, the kidney, and COVID-19: an opportunity for translational research. Am J Physiol Renal Physiol 2021;320:F243-8. [PMID: 33464168 DOI: 10.1152/ajprenal.00601.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
549 Franco-moreno A, Muñoz-rivas N, Mestre-gómez B, Torres-macho J. Pulmonary embolism and COVID-19: A paradigm change. Revista Clínica Española (English Edition) 2020;220:459-61. [DOI: 10.1016/j.rceng.2020.05.007] [Reference Citation Analysis]
550 Paulsson-Habegger L, Snabaitis AK, Wren SP. Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection. Bioorg Med Chem 2021;48:116389. [PMID: 34543844 DOI: 10.1016/j.bmc.2021.116389] [Reference Citation Analysis]
551 Hyseni I, Molesti E, Benincasa L, Piu P, Casa E, Temperton NJ, Manenti A, Montomoli E. Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays. Viruses 2020;12:E1011. [PMID: 32927639 DOI: 10.3390/v12091011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
552 Ullah MA, Araf Y, Sarkar B, Moin AT, Reshad RAI, Rahman MH. Pathogenesis, Diagnosis and Possible Therapeutic Options for COVID-19. J Clin Exp Invest 2020;11:em00755. [DOI: 10.29333/jcei/8564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
553 Tan Y, Zhang W, Zhu Z, Qiao N, Ling Y, Guo M, Yin T, Fang H, Xu X, Lu G, Zhang P, Yang S, Fu Z, Liang D, Xie Y, Zhang R, Jiang L, Yu S, Lu J, Jiang F, Chen J, Xiao C, Wang S, Chen S, Bian XW, Lu H, Liu F, Chen S. Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19. Cell Discov 2021;7:42. [PMID: 34103487 DOI: 10.1038/s41421-021-00274-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
554 Loras C, Sanz JC. Información preliminar de las características virológicas del nuevo coronavirus SARS-CoV-2. REMASP 2020;4:1-10. [DOI: 10.36300/remasp.2020.061] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
555 Huang HC, Lai YJ, Liao CC, Yang WF, Huang KB, Lee IJ, Chou WC, Wang SH, Wang LH, Hsu JM, Sun CP, Kuo CT, Wang J, Hsiao TC, Yang PJ, Lee TA, Huang W, Li FA, Shen CY, Lin YL, Tao MH, Li CW. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. EBioMedicine 2021;74:103712. [PMID: 34839261 DOI: 10.1016/j.ebiom.2021.103712] [Reference Citation Analysis]
556 Li Volti G, Caruso M, Polosa R. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships? J Clin Med 2020;9:E1321. [PMID: 32370269 DOI: 10.3390/jcm9051321] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
557 Fadaka AO, Sibuyi NRS, Adewale OB, Bakare OO, Akanbi MO, Klein A, Madiehe AM, Meyer M. Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2. J Int Med Res 2020;48:300060520949077. [PMID: 32842818 DOI: 10.1177/0300060520949077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
558 Vuille-Dit-Bille RN, Liechty KW, Verrey F, Guglielmetti LC. SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age. Amino Acids 2020;52:1063-5. [PMID: 32627059 DOI: 10.1007/s00726-020-02870-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
559 Al-Zyoud W, Haddad H. Mutational sensitivity of D614G in spike protein of SARS-CoV-2 in Jordan. Biochem Biophys Rep 2021;25:100896. [PMID: 33506114 DOI: 10.1016/j.bbrep.2020.100896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
560 Vidali S, Morosetti D, Cossu E, Luisi MLE, Pancani S, Semeraro V, Consales G. D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review. ERJ Open Res 2020;6:00260-2020. [PMID: 32685436 DOI: 10.1183/23120541.00260-2020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 17.0] [Reference Citation Analysis]
561 Parohan M, Yaghoubi S, Seraji A. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies. Eur Heart J Acute Cardiovasc Care 2020;9:665-77. [PMID: 32567326 DOI: 10.1177/2048872620937165] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
562 Rajpoot S, Ohishi T, Kumar A, Pan Q, Banerjee S, Zhang KYJ, Baig MS. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor. Drugs R D 2021;21:273-83. [PMID: 34324175 DOI: 10.1007/s40268-021-00357-0] [Reference Citation Analysis]
563 Khourssaji M, Chapelle V, Evenepoel A, Belkhir L, Yombi JC, van Dievoet MA, Saussoy P, Coche E, Fillée C, Constantinescu SN, Rodriguez-Villalobos H, Defour JP, Gruson D. A biological profile for diagnosis and outcome of COVID-19 patients. Clin Chem Lab Med 2020;58:2141-50. [PMID: 33064667 DOI: 10.1515/cclm-2020-0626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
564 Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, Díez-Villanueva P, Ayesta A, Sanchis Forés J, Vidán-Austiz MT, Formiga F, Ariza-Solé A, Martínez-Sellés M; Scientific societies of the authors. The contributing authors are members of the following scientific bodies. Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology. Rev Esp Cardiol (Engl Ed) 2020;73:569-76. [PMID: 32446793 DOI: 10.1016/j.rec.2020.05.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
565 Muralidar S, Gopal G, Visaga Ambi S. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. J Med Virol 2021;93:5260-76. [PMID: 33851732 DOI: 10.1002/jmv.27019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
566 Rybakova MG, Karev VE, Kuznetsova IA. [Anatomical pathology of novel coronavirus (COVID-19) infection. First impressions]. Arkh Patol 2020;82:5-15. [PMID: 33054027 DOI: 10.17116/patol2020820515] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
567 Chen KG, Park K, Spence JR. Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids. Nat Cell Biol 2021;23:822-33. [PMID: 34341531 DOI: 10.1038/s41556-021-00721-x] [Reference Citation Analysis]
568 Amiral J, Vissac AM, Seghatchian J. Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients? Transfus Apher Sci 2020;59:102804. [PMID: 32387238 DOI: 10.1016/j.transci.2020.102804] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
569 Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MÁ, Urquiza J, Ramírez D, Alonso C, Campillo NE, Martinez A. COVID-19: Drug Targets and Potential Treatments. J Med Chem 2020;63:12359-86. [PMID: 32511912 DOI: 10.1021/acs.jmedchem.0c00606] [Cited by in Crossref: 119] [Cited by in F6Publishing: 97] [Article Influence: 59.5] [Reference Citation Analysis]
570 Faheem, Kumar BK, Sekhar KVGC, Kunjiappan S, Jamalis J, Balaña-Fouce R, Tekwani BL, Sankaranarayanan M. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19. Bioorg Chem 2020;104:104269. [PMID: 32947136 DOI: 10.1016/j.bioorg.2020.104269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
571 Ozieranski K, Tyminska A, Jonik S, Marcolongo R, Baritussio A, Grabowski M, Filipiak KJ, Opolski G, Caforio ALP. Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction? J Card Fail 2021;27:92-6. [PMID: 33166657 DOI: 10.1016/j.cardfail.2020.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
572 Kocak OF, Ozgeris FB, Parlak E, Kadıoglu Y, Yuce N, Yaman ME, Bakan E. Evaluation of Serum Trace Element Levels and Biochemical Parameters of COVID-19 Patients According to Disease Severity. Biol Trace Elem Res 2021. [PMID: 34608570 DOI: 10.1007/s12011-021-02946-1] [Reference Citation Analysis]
573 Gadi N, Wu SC, Spihlman AP, Moulton VR. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses. Front Immunol 2020;11:2147. [PMID: 32983176 DOI: 10.3389/fimmu.2020.02147] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
574 Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A, Poulas K. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep 2020;7:658-63. [PMID: 32355638 DOI: 10.1016/j.toxrep.2020.04.012] [Cited by in Crossref: 98] [Cited by in F6Publishing: 108] [Article Influence: 49.0] [Reference Citation Analysis]
575 Smart L, Fawkes N, Goggin P, Pennick G, Rainsford KD, Charlesworth B, Shah N. A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality. Inflammopharmacology 2020;28:1141-52. [PMID: 32797326 DOI: 10.1007/s10787-020-00745-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
576 [DOI: 10.1101/2020.07.22.216150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
577 Quiles JL, Rivas-García L, Varela-López A, Llopis J, Battino M, Sánchez-González C. Do nutrients and other bioactive molecules from foods have anything to say in the treatment against COVID-19? Environ Res 2020;191:110053. [PMID: 32835682 DOI: 10.1016/j.envres.2020.110053] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
578 Sheikhzadeh Hesari F, Hosseinzadeh SS, Asl Monadi Sardroud MA. Review of COVID-19 and male genital tract. Andrologia 2021;53:e13914. [PMID: 33236375 DOI: 10.1111/and.13914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
579 Holmes EA, O'Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, Ballard C, Christensen H, Cohen Silver R, Everall I, Ford T, John A, Kabir T, King K, Madan I, Michie S, Przybylski AK, Shafran R, Sweeney A, Worthman CM, Yardley L, Cowan K, Cope C, Hotopf M, Bullmore E. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547-560. [PMID: 32304649 DOI: 10.1016/s2215-0366(20)30168-1] [Cited by in Crossref: 1657] [Cited by in F6Publishing: 1049] [Article Influence: 828.5] [Reference Citation Analysis]
580 Khan FI, Kang T, Ali H, Lai D. Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations. Front Pharmacol 2021;12:710778. [PMID: 34305617 DOI: 10.3389/fphar.2021.710778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
581 Stefano ML, Kream RM, Stefano GB. A Novel Vaccine Employing Non-Replicating Rabies Virus Expressing Chimeric SARS-CoV-2 Spike Protein Domains: Functional Inhibition of Viral/Nicotinic Acetylcholine Receptor Complexes. Med Sci Monit 2020;26:e926016. [PMID: 32463026 DOI: 10.12659/MSM.926016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
582 Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
583 Shukla AK, Banerjee M. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. High Blood Press Cardiovasc Prev 2021;28:129-39. [PMID: 33635533 DOI: 10.1007/s40292-021-00439-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
584 Metcalfe SM. COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF). Medicine in Drug Discovery 2020;6:100043. [DOI: 10.1016/j.medidd.2020.100043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
585 Sharma S. COVID-19: A Concern for Cardiovascular Disease Patients. Cardiovasc Toxicol 2020;20:443-7. [PMID: 32729064 DOI: 10.1007/s12012-020-09596-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
586 Borges E Jr, Setti AS, Iaconelli A Jr, Braga DPAF. Current status of the COVID-19 and male reproduction: A review of the literature. Andrology 2021;9:1066-75. [PMID: 33998143 DOI: 10.1111/andr.13037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
587 Gandhi Y, Mishra SK, Rawat H, Grewal J, Kumar R, Shakya SK, Jain VK, Babu G, Singh A, Singh R, Acharya R, Kumar V. Phytomedicines Explored under In vitro and In silico Studies against Coronavirus: An Opportunity to Develop Traditional Medicines. South African Journal of Botany 2022. [DOI: 10.1016/j.sajb.2022.04.053] [Reference Citation Analysis]
588 Beys-da-Silva WO, da Rosa RL, Santi L, Tureta EF, Terraciano PB, Guimarães JA, Passos EP, Berger M. The risk of COVID-19 for pregnant women: Evidences of molecular alterations associated with preeclampsia in SARS-CoV-2 infection. Biochim Biophys Acta Mol Basis Dis 2021;1867:165999. [PMID: 33137411 DOI: 10.1016/j.bbadis.2020.165999] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
589 Assaf AM, Haddadin RN, Akour AA. COVID-19: Between Past and Present. Viral Immunol 2021;34:145-57. [PMID: 33017280 DOI: 10.1089/vim.2020.0102] [Reference Citation Analysis]
590 Haidar MA, Jourdi H, Haj Hassan Z, Ashekyan O, Fardoun M, Wehbe Z, Maaliki D, Wehbe M, Mondello S, Abdelhady S, Shahjouei S, Bizri M, Mechref Y, Gold MS, Dbaibo G, Zaraket H, Eid AH, Kobeissy F. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms. Neuroscientist 2021;:1073858420984106. [PMID: 33393420 DOI: 10.1177/1073858420984106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
591 Kim J, Mukherjee A, Nelson D, Jozic A, Sahay G. Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32743574 DOI: 10.1101/2020.07.24.205583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
592 Li Y, Jerkic M, Slutsky AS, Zhang H. Molecular mechanisms of sex bias differences in COVID-19 mortality. Crit Care 2020;24:405. [PMID: 32646459 DOI: 10.1186/s13054-020-03118-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
593 Crisan-Dabija R, Pavel CA, Popa IV, Tarus A, Burlacu A. "A Chain Only as Strong as Its Weakest Link": An Up-to-Date Literature Review on the Bidirectional Interaction of Pulmonary Fibrosis and COVID-19. J Proteome Res 2020;19:4327-38. [PMID: 32883081 DOI: 10.1021/acs.jproteome.0c00387] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
594 Ajmera V, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Sriram K, Insel PA, Collier S, Richards L, Loomba R. RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. Contemp Clin Trials 2021;103:106330. [PMID: 33631357 DOI: 10.1016/j.cct.2021.106330] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
595 Miesbach W. Pathological Role of Angiotensin II in Severe COVID-19. TH Open 2020;4:e138-44. [PMID: 32607467 DOI: 10.1055/s-0040-1713678] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
596 Hesam-Shariati N, Fatehi P, Fathi F, Abouzaripour M, Hesam Shariati MB. A case report of greater saphenous vein thrombosis in a patient with coronavirus (COVID-19) infection. Trop Dis Travel Med Vaccines 2021;7:6. [PMID: 33658082 DOI: 10.1186/s40794-021-00131-9] [Reference Citation Analysis]
597 Das AK, Kalra S, B K, Sharma K, John M, Nair T, Shaikh S, Khandelwal D, Priya G, Dutta D, Gangadhar P, Dhingra A, Tiwaskar M, Shukla R, Das S, Baruah MP, Gangopadhyay KK, Ramakrishnan S, Deshmukh V, Dasgupta A, Kumar G, Pandey N, Joshi A, Surana VK, Punyani H, Shah P, Rattan A, Chandrasekaran S, Asirwatham A. Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion. Diabetes Metab Syndr 2021;15:55-62. [PMID: 33310177 DOI: 10.1016/j.dsx.2020.11.014] [Reference Citation Analysis]
598 Din AU, Mazhar M, Waseem M, Ahmad W, Bibi A, Hassan A, Ali N, Gang W, Qian G, Ullah R, Shah T, Ullah M, Khan I, Nisar MF, Wu J. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother. 2021;133:110947. [PMID: 33197765 DOI: 10.1016/j.biopha.2020.110947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
599 Dalan R, Ang LW, Tan WYT, Fong SW, Tay WC, Chan YH, Renia L, Ng LFP, Lye DC, Chew DEK, Young BE. The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study. Eur Heart J Cardiovasc Pharmacother 2021;7:e48-51. [PMID: 32766831 DOI: 10.1093/ehjcvp/pvaa098] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 20.0] [Reference Citation Analysis]
600 Porzionato A, Emmi A, Stocco E, Barbon S, Boscolo-Berto R, Macchi V, De Caro R. The potential role of the carotid body in COVID-19. Am J Physiol Lung Cell Mol Physiol 2020;319:L620-6. [PMID: 32755325 DOI: 10.1152/ajplung.00309.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
601 Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J, Cai J, Yang R, Han J, Huang Y, He S. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study. Hypertension 2020;76:51-8. [DOI: 10.1161/hypertensionaha.120.15143] [Cited by in Crossref: 145] [Cited by in F6Publishing: 82] [Article Influence: 72.5] [Reference Citation Analysis]
602 Zaman S, MacIsaac AI, Jennings GL, Schlaich MP, Inglis SC, Arnold R, Kumar S, Thomas L, Wahi S, Lo S, Naismith C, Duffy SJ, Nicholls SJ, Newcomb A, Almeida AA, Wong S, Lund M, Chew DP, Kritharides L, Chow CK, Bhindi R. Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement. Med J Aust 2020;213:182-7. [PMID: 32734645 DOI: 10.5694/mja2.50714] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 15.5] [Reference Citation Analysis]
603 Gabutti G, d'Anchera E, Sandri F, Savio M, Stefanati A. Coronavirus: Update Related to the Current Outbreak of COVID-19. Infect Dis Ther 2020;:1-13. [PMID: 32292686 DOI: 10.1007/s40121-020-00295-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 24.5] [Reference Citation Analysis]
604 Avila J, Long B, Holladay D, Gottlieb M. Thrombotic complications of COVID-19. Am J Emerg Med 2021;39:213-8. [PMID: 33036855 DOI: 10.1016/j.ajem.2020.09.065] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
605 Cai X, Prominski A, Lin Y, Ankenbruck N, Rosenberg J, Chen M, Shi J, Chang EB, Penaloza-MacMaster P, Tian B, Huang J. A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2. bioRxiv 2020:2020. [PMID: 33269351 DOI: 10.1101/2020.11.30.404624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
606 Qaisrani MN, Belousov R, Rehman JU, Goliaei EM, Girotto I, Franklin-Mergarejo R, Güell O, Hassanali A, Roldán É. Phospholipids dock SARS-CoV-2 spike protein via hydrophobic interactions: a minimal in-silico study of lecithin nasal spray therapy. Eur Phys J E Soft Matter 2021;44:132. [PMID: 34718875 DOI: 10.1140/epje/s10189-021-00137-3] [Reference Citation Analysis]
607 Micallef J, Soeiro T, Jonville-Béra AP; French Society of Pharmacology, Therapeutics (SFPT). Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection. Therapie 2020;75:355-62. [PMID: 32418728 DOI: 10.1016/j.therap.2020.05.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
608 Sriram K, Insel PA. Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. Physiol Rev 2021;101:545-67. [PMID: 33124941 DOI: 10.1152/physrev.00035.2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
609 Wang X, Guan Y. COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays. Med Res Rev 2021;41:5-28. [PMID: 32864815 DOI: 10.1002/med.21728] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
610 Millet JK, Jaimes JA, Whittaker GR. Molecular diversity of coronavirus host cell entry receptors. FEMS Microbiol Rev 2021;45:fuaa057. [PMID: 33118022 DOI: 10.1093/femsre/fuaa057] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
611 Borczuk AC, Salvatore SP, Seshan SV, Patel SS, Bussel JB, Mostyka M, Elsoukkary S, He B, Del Vecchio C, Fortarezza F, Pezzuto F, Navalesi P, Crisanti A, Fowkes ME, Bryce CH, Calabrese F, Beasley MB. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol 2020;33:2156-68. [PMID: 32879413 DOI: 10.1038/s41379-020-00661-1] [Cited by in Crossref: 127] [Cited by in F6Publishing: 128] [Article Influence: 63.5] [Reference Citation Analysis]
612 Sharma HN, Latimore COD, Matthews QL. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19. Pathogens 2021;10:1218. [PMID: 34578250 DOI: 10.3390/pathogens10091218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
613 Mostafa T. Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection? Sex Med Rev 2021;9:15-22. [PMID: 33077403 DOI: 10.1016/j.sxmr.2020.08.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
614 Pan XW, Xu D, Zhang H, Zhou W, Wang LH, Cui XG. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. 2020;46:1114-1116. [PMID: 32236644 DOI: 10.1007/s00134-020-06026-1] [Cited by in Crossref: 196] [Cited by in F6Publishing: 213] [Article Influence: 98.0] [Reference Citation Analysis]
615 Majdic G. Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus? Front Cell Infect Microbiol 2020;10:327. [PMID: 32582576 DOI: 10.3389/fcimb.2020.00327] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
616 Ferrara F, Vitiello A. Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance. Cardiovasc Toxicol 2021;21:498-503. [PMID: 33835386 DOI: 10.1007/s12012-021-09649-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
617 Peiró C, Moncada S. Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection? Circulation 2020;141:1665-6. [PMID: 32242749 DOI: 10.1161/CIRCULATIONAHA.120.047297] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 19.0] [Reference Citation Analysis]
618 Chen H, Tong Z, Ma Z, Luo L, Tang Y, Teng Y, Yu H, Meng H, Peng C, Zhang Q, Zhu T, Zhao H, Chu G, Li H, Lu H, Qi X. Gastrointestinal Bleeding, but Not Other Gastrointestinal Symptoms, Is Associated With Worse Outcomes in COVID-19 Patients. Front Med (Lausanne) 2021;8:759152. [PMID: 34722595 DOI: 10.3389/fmed.2021.759152] [Reference Citation Analysis]
619 Raha AA, Chakraborty S, Henderson J, Mukaetova-Ladinska E, Zaman S, Trowsdale J, Raha-Chowdhury R. Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology. Biosci Rep 2020;40:BSR20203092. [PMID: 33205807 DOI: 10.1042/BSR20203092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
620 Ming Y, Qiang L. Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications. SN Compr Clin Med 2020;:1-6. [PMID: 32838164 DOI: 10.1007/s42399-020-00400-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
621 Khattab ESAEH, Ragab A, Abol-Ftouh MA, Elhenawy AA. Therapeutic strategies for Covid-19 based on molecular docking and dynamic studies to the ACE-2 receptors, Furin, and viral spike proteins. J Biomol Struct Dyn 2021;:1-19. [PMID: 34647855 DOI: 10.1080/07391102.2021.1989036] [Reference Citation Analysis]
622 Ye Q, Lu D, Shang S, Fu J, Gong F, Shu Q, Mao J. Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment. ESC Heart Fail 2020. [PMID: 32935928 DOI: 10.1002/ehf2.12960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
623 Paek JH, Kim Y, Park WY, Jin K, Hyun M, Lee JY, Kim HA, Kwon YS, Park JS, Han S. Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality. PLoS One 2020;15:e0243528. [PMID: 33296419 DOI: 10.1371/journal.pone.0243528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
624 Eftekhar SP, Kazemi S, Moghadamnia AA. A brief review of the latest pharmacological treatments of COVID-19. Caspian J Intern Med 2020;11:460-5. [PMID: 33425262 DOI: 10.22088/cjim.11.0.460] [Reference Citation Analysis]
625 Zhang QH, Huang HZ, Qiu M, Wu ZF, Xin ZC, Cai XF, Shang Q, Lin JZ, Zhang DK, Han L. Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19. Front Pharmacol 2021;12:719758. [PMID: 34899289 DOI: 10.3389/fphar.2021.719758] [Reference Citation Analysis]
626 Mahmud-Al-Rafat A, Muzammal Haque Asim M, Taylor-Robinson AW, Majumder A, Muktadir A, Muktadir H, Karim M, Khan I, Mainul Ahasan M, Morsaline Billah M. A combinational approach to restore cytokine balance and to inhibit virus growth may promote patient recovery in severe COVID-19 cases. Cytokine 2020;136:155228. [PMID: 32822911 DOI: 10.1016/j.cyto.2020.155228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
627 Bellinvia S, Edwards CJ, Schisano M, Banfi P, Fallico M, Murabito P. The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm? Inflamm Res 2020;69:757-63. [PMID: 32468151 DOI: 10.1007/s00011-020-01366-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
628 Umeta Chali B, Melaku T, Berhanu N, Mengistu B, Milkessa G, Mamo G, Alemu S, Mulugeta T. Traditional Medicine Practice in the Context of COVID-19 Pandemic: Community Claim in Jimma Zone, Oromia, Ethiopia. Infect Drug Resist 2021;14:3773-83. [PMID: 34557002 DOI: 10.2147/IDR.S331434] [Reference Citation Analysis]
629 Raghavan S, Leo MD. Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells. Front Pharmacol 2022;13:872736. [DOI: 10.3389/fphar.2022.872736] [Reference Citation Analysis]
630 Allen JD, Watanabe Y, Chawla H, Newby ML, Crispin M. Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition. J Mol Biol 2021;433:166762. [PMID: 33340519 DOI: 10.1016/j.jmb.2020.166762] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
631 Matschinske J, Salgado-Albarrán M, Sadegh S, Bongiovanni D, Baumbach J, Blumenthal DB. Individuating Possibly Repurposable Drugs and Drug Targets for COVID-19 Treatment Through Hypothesis-Driven Systems Medicine Using CoVex. Assay Drug Dev Technol 2020;18:348-55. [PMID: 33164550 DOI: 10.1089/adt.2020.1010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
632 Chhabra HS, Bagaraia V, Keny S, Kalidindi KKV, Mallepally A, Dhillon MS, Malhotra R, Rajasekharan S. COVID-19: Current Knowledge and Best Practices for Orthopaedic Surgeons. Indian J Orthop. 2020: 1-15. [PMID: 32425237 DOI: 10.1007/s43465-020-00135-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
633 Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh SS, Chello M, Bouzguenda A, Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines 2022;10:702. [DOI: 10.3390/biomedicines10030702] [Reference Citation Analysis]
634 Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, Andrade FTA, González TB, Arévalo ANG, Almeida JP, Bacal F, Oliveira GMM, Lacerda MVG, Barberato SH, Chagas ACP, Rochitte CE, Ramires JAF, Kalil Filho R, Hajjar LA. The Heart and COVID-19: What Cardiologists Need to Know. Arq Bras Cardiol 2020;114:805-16. [PMID: 32401847 DOI: 10.36660/abc.20200279] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
635 Franzini M, Valdenassi L, Ricevuti G, Chirumbolo S, Depfenhart M, Bertossi D, Tirelli U. Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int Immunopharmacol 2020;88:106879. [PMID: 32795898 DOI: 10.1016/j.intimp.2020.106879] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
636 Perchiazzi G, Pellegrini M, Chiodaroli E, Urits I, Kaye AD, Viswanath O, Varrassi G, Puntillo F. The use of positive end expiratory pressure in patients affected by COVID-19: Time to reconsider the relation between morphology and physiology. Best Pract Res Clin Anaesthesiol 2020;34:561-7. [PMID: 33004167 DOI: 10.1016/j.bpa.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
637 Singla R, Mishra A, Joshi R, Jha S, Sharma AR, Upadhyay S, Sarma P, Prakash A, Medhi B. Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence. Vet Res Commun 2020;44:119-30. [PMID: 32926266 DOI: 10.1007/s11259-020-09781-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
638 de Simone G, Mancusi C. Speculation is not evidence: antihypertensive therapy and COVID-19. Eur Heart J Cardiovasc Pharmacother 2020;6:133-4. [PMID: 32236478 DOI: 10.1093/ehjcvp/pvaa021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
639 Saadatpour F, Mohammadipanah F. Physicochemical susceptibility of SARS-CoV-2 to disinfection and physical approach of prophylaxis. Health Sci Rep 2020;3:e213. [PMID: 33305015 DOI: 10.1002/hsr2.213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
640 Dutta T, Baildya N, Khan AA, Ghosh NN. Inhibitory effect of anti-HIV compounds extracted from Indian medicinal plants to retard the replication and transcription process of SARS-CoV-2: an insight from molecular docking and MD-simulation studies. Netw Model Anal Health Inform Bioinform 2021;10:32. [PMID: 33948424 DOI: 10.1007/s13721-021-00309-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
641 Piagnerelli M, Vanderelst J, Rousseau A, Monteyne D, Perez-morga D, Biston P, Zouaoui Boudjeltia K. Red Blood Cell Shape and Deformability in Patients With COVID-19 Acute Respiratory Distress Syndrome. Front Physiol 2022;13:849910. [DOI: 10.3389/fphys.2022.849910] [Reference Citation Analysis]
642 Tripathi N, Goel B, Bhardwaj N, Sahu B, Kumar H, Jain SK. Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors. J Biomol Struct Dyn 2020;:1-13. [PMID: 33213294 DOI: 10.1080/07391102.2020.1848630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
643 Wang Y, Li F, Zhang Y, Zhou Y, Tan Y, Chen Y, Zhu F. Databases for the targeted COVID-19 therapeutics. Br J Pharmacol 2020;177:4999-5001. [PMID: 32845521 DOI: 10.1111/bph.15234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
644 Uddin MB, Sajib EH, Hoque SF, Bappy MNI, Elahi F, Ghosh A, Muhit S, Hassan MM, Hasan M, Chelliah R, Park SJ, Mony TJ, Oh DH, Ahmed SSU. Genomic diversity and molecular dynamics interaction on mutational variances among RB domains of SARS-CoV-2 interplay drug inactivation. Infect Genet Evol 2021;:105128. [PMID: 34752930 DOI: 10.1016/j.meegid.2021.105128] [Reference Citation Analysis]
645 Tascioglu D, Akkaya E, Genc S. The understanding of the immunopathology in COVID-19 infection. Scand J Clin Lab Invest 2021;81:255-63. [PMID: 34032527 DOI: 10.1080/00365513.2021.1892817] [Reference Citation Analysis]
646 Manjunath SN, Sakar M, Katapadi M, Geetha Balakrishna R. Recent case studies on the use of ozone to combat coronavirus: Problems and perspectives. Environ Technol Innov 2021;21:101313. [PMID: 33344687 DOI: 10.1016/j.eti.2020.101313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
647 Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, Röhl A, Freiwald A, Szyrwiel L, Ludwig D, Correia-Melo C, Aulakh SK, Helbig ET, Stubbemann P, Lippert LJ, Grüning NM, Blyuss O, Vernardis S, White M, Messner CB, Joannidis M, Sonnweber T, Klein SJ, Pizzini A, Wohlfarter Y, Sahanic S, Hilbe R, Schaefer B, Wagner S, Mittermaier M, Machleidt F, Garcia C, Ruwwe-Glösenkamp C, Lingscheid T, Bosquillon de Jarcy L, Stegemann MS, Pfeiffer M, Jürgens L, Denker S, Zickler D, Enghard P, Zelezniak A, Campbell A, Hayward C, Porteous DJ, Marioni RE, Uhrig A, Müller-Redetzky H, Zoller H, Löffler-Ragg J, Keller MA, Tancevski I, Timms JF, Zaikin A, Hippenstiel S, Ramharter M, Witzenrath M, Suttorp N, Lilley K, Mülleder M, Sander LE, Ralser M, Kurth F; PA-COVID-19 Study group. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst 2021;12:780-794.e7. [PMID: 34139154 DOI: 10.1016/j.cels.2021.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
648 Horne JR, Vohl MC. Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity. Am J Physiol Endocrinol Metab 2020;318:E830-3. [PMID: 32310688 DOI: 10.1152/ajpendo.00150.2020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
649 Wild PS, Dimmeler S, Eschenhagen T. An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations. J Mol Cell Cardiol 2020;141:108-9. [PMID: 32268149 DOI: 10.1016/j.yjmcc.2020.03.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
650 Linnemann B, Bauersachs R, Grebe M, Klamroth R, Müller O, Schellong S, Lichtenberg M. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA). Vasa 2020;49:259-63. [PMID: 32501145 DOI: 10.1024/0301-1526/a000885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
651 Ali L, Naeem M, Canibano B, John A, Iqrar A. Bilateral Acute Optic Perineuritis Associated With COVID-19 in a Patient With Seronegative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody. Cureus 2021;13:e18234. [PMID: 34712522 DOI: 10.7759/cureus.18234] [Reference Citation Analysis]
652 Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med 2020;38:1715-21. [PMID: 32731141 DOI: 10.1016/j.ajem.2020.06.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
653 Ostermann M, Lumlertgul N, Forni LG, Hoste E. What every Intensivist should know about COVID-19 associated acute kidney injury. J Crit Care. 2020;60:91-95. [PMID: 32777758 DOI: 10.1016/j.jcrc.2020.07.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
654 Kang K, Kim HH, Choi Y. Tiotropium is Predicted to be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis. Viruses 2020;12:E776. [PMID: 32698440 DOI: 10.3390/v12070776] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
655 Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 2020;20:363-74. [PMID: 32346093 DOI: 10.1038/s41577-020-0311-8] [Cited by in Crossref: 1506] [Cited by in F6Publishing: 1403] [Article Influence: 753.0] [Reference Citation Analysis]
656 Wang Z, He Y, Huang J, Yang X. Integrative web-based analysis of omics data for study of drugs against SARS-CoV-2. Sci Rep 2021;11:10763. [PMID: 34031435 DOI: 10.1038/s41598-021-89578-6] [Reference Citation Analysis]
657 Abdel‐moneim A. COVID ‐19 complications on the digestive system and liver: A current clinical and pathophysiological approach. Adv in Digestive Med. [DOI: 10.1002/aid2.13260] [Reference Citation Analysis]
658 Sebuhyan M, Mirailles R, Crichi B, Frere C, Bonnin P, Bergeron-Lafaurie A, Denis B, Liegeon G, Peyrony O, Farge D; Saint-Louis CORE (COVID-19 RESEARCH) group. How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units. J Med Vasc 2020;45:334-43. [PMID: 33248536 DOI: 10.1016/j.jdmv.2020.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
659 Han T, Kang J, Li G, Ge J, Gu J. Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study. Ann Transl Med. 2020;8:1077. [PMID: 33145296 DOI: 10.21037/atm-20-4281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
660 Rossi GP, Sanga V, Barton M. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Elife 2020;9:e57278. [PMID: 32250244 DOI: 10.7554/eLife.57278] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 31.5] [Reference Citation Analysis]
661 Lu L, Liu X, Jin R, Guan R, Lin R, Qu Z. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19. Biomed Res Int 2020;2020:7520746. [PMID: 33204713 DOI: 10.1155/2020/7520746] [Reference Citation Analysis]
662 Veselý J. (Treatment with ACE inhibitors and AT1-blockers during the COVID-19 pandemic). Cor Vasa 2020;62:27-32. [DOI: 10.33678/cor.2020.047] [Reference Citation Analysis]
663 Raj V, Park JG, Cho KH, Choi P, Kim T, Ham J, Lee J. Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches. Int J Biol Macromol 2021;168:474-85. [PMID: 33290767 DOI: 10.1016/j.ijbiomac.2020.12.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
664 Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of Coronavirus Disease 2019. Crit Care Med 2020;48:1358-64. [PMID: 32467443 DOI: 10.1097/CCM.0000000000004458] [Cited by in Crossref: 151] [Cited by in F6Publishing: 105] [Article Influence: 75.5] [Reference Citation Analysis]
665 Luo L, Qiu Q, Huang F, Liu K, Lan Y, Li X, Huang Y, Cui L, Luo H. Drug repurposing against coronavirus disease 2019 (COVID-19): A review. J Pharm Anal 2021. [PMID: 34513115 DOI: 10.1016/j.jpha.2021.09.001] [Reference Citation Analysis]
666 Uddin M, Mustafa F, Rizvi TA, Loney T, Suwaidi HA, Al-Marzouqi AHH, Eldin AK, Alsabeeha N, Adrian TE, Stefanini C, Nowotny N, Alsheikh-Ali A, Senok AC. SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Viruses 2020;12:E526. [PMID: 32397688 DOI: 10.3390/v12050526] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 38.5] [Reference Citation Analysis]
667 Sampson V, Kamona N, Sampson A. Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? Br Dent J 2020;228:971-5. [PMID: 32591714 DOI: 10.1038/s41415-020-1747-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
668 Kamat S, Kumari M. Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity. Front Pharmacol 2021;12:576093. [PMID: 33912030 DOI: 10.3389/fphar.2021.576093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
669 Curran CS, Rivera DR, Kopp JB. COVID-19 Usurps Host Regulatory Networks. Front Pharmacol 2020;11:1278. [PMID: 32922297 DOI: 10.3389/fphar.2020.01278] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
670 Ragia G, Manolopoulos VG. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies. Eur J Clin Pharmacol 2020;76:1623-30. [PMID: 32696234 DOI: 10.1007/s00228-020-02963-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
671 Maneira C, Bermejo PM, Pereira GAG, de Mello FDSB. Exploring G protein-coupled receptors and yeast surface display strategies for viral detection in baker's yeast: SARS-CoV-2 as a case study. FEMS Yeast Res 2021;21:foab004. [PMID: 33469649 DOI: 10.1093/femsyr/foab004] [Reference Citation Analysis]
672 Hammoud SH, Wehbe Z, Abdelhady S, Kobeissy F, Eid AH, El-Yazbi AF. Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity. Mol Pharmacol. 2021;99:17-28. [PMID: 33082267 DOI: 10.1124/molpharm.120.000119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
673 Pranata R, Henrina J, Raffaello WM, Lawrensia S, Huang I. Diabetes and COVID-19: The past, the present, and the future. Metabolism 2021;121:154814. [PMID: 34119537 DOI: 10.1016/j.metabol.2021.154814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
674 Rauf A, Abu-Izneid T, Olatunde A, Ahmed Khalil A, Alhumaydhi FA, Tufail T, Shariati MA, Rebezov M, Almarhoon ZM, Mabkhot YN, Alsayari A, Rengasamy KRR. COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional Therapies. Int J Environ Res Public Health 2020;17:E8155. [PMID: 33158234 DOI: 10.3390/ijerph17218155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
675 Adrish M, Chilimuri S, Sun H, Mantri N, Yugay A, Zahid M. The Association of Renin-Angiotensin-Aldosterone System Inhibitors With Outcomes Among a Predominantly Ethnic Minority Patient Population Hospitalized With COVID-19: The Bronx Experience. Cureus 2020;12:e10217. [PMID: 32905551 DOI: 10.7759/cureus.10217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
676 Tolah AMK, Sohrab SS, Tolah KMK, Hassan AM, El-Kafrawy SA, Azhar EI. Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay. Diagnostics (Basel) 2021;11:994. [PMID: 34070824 DOI: 10.3390/diagnostics11060994] [Reference Citation Analysis]
677 Rabbani G, Ahn SN, Kwon H, Ahmad K, Choi I. Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein. Biochem Biophys Rep 2021;28:101170. [PMID: 34778573 DOI: 10.1016/j.bbrep.2021.101170] [Reference Citation Analysis]
678 Qi X, Northridge ME, Hu M, Wu B. Oral Health Conditions and COVID-19: A Systematic Review and Meta-analysis of the Current Evidence. Aging and Health Research 2022. [DOI: 10.1016/j.ahr.2022.100064] [Reference Citation Analysis]
679 Santoro F, Nuñez-Gil IJ, Vitale E, Viana-Llamas MC, Reche-Martinez B, Romero-Pareja R, Feltez Guzman G, Fernandez Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, Garcia-Aguado M, Huang J, Ortega-Armas ME, Garcia Prieto JF, Corral Rubio EM, Ugo F, Bianco M, Mulet A, Raposeiras-Roubin S, Jativa Mendez JL, Espejo Paeres C, Albarrán AR, Marín F, Guerra F, Akin I, Cortese B, Ramakrishna H, Macaya C, Fernandez-Ortiz A, Brunetti ND. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry. Heart 2021:heartjnl-2021-319552. [PMID: 34611045 DOI: 10.1136/heartjnl-2021-319552] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
680 Szegedi I, Orbán-Kálmándi R, Csiba L, Bagoly Z. Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature. J Clin Med 2020;9:E3137. [PMID: 32998398 DOI: 10.3390/jcm9103137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
681 Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 2020;41:1141-9. [PMID: 32747721 DOI: 10.1038/s41401-020-0485-4] [Cited by in Crossref: 352] [Cited by in F6Publishing: 324] [Article Influence: 176.0] [Reference Citation Analysis]
682 Mohammadpour S, Torshizi Esfahani A, Halaji M, Lak M, Ranjbar R. An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19. J Cell Physiol 2021;236:49-54. [PMID: 32542735 DOI: 10.1002/jcp.29868] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
683 Cormican DS, Winter D, McHugh S, Sonny A, Crowley J, Yu R, Barrack F, Núñez-Gil IJ, Ramakrishna H. Severe Acute Respiratory Syndrome Coronavirus-2 Cardiovascular Complications: Implications for Cardiothoracic Anesthesiology. J Cardiothorac Vasc Anesth 2021;35:932-43. [PMID: 32601001 DOI: 10.1053/j.jvca.2020.05.035] [Reference Citation Analysis]
684 Hu Y, Liu L, Lu X. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19? Front Endocrinol (Lausanne) 2021;12:725967. [PMID: 34745001 DOI: 10.3389/fendo.2021.725967] [Reference Citation Analysis]
685 Bekbossynova M, Ainur T. Hypertension as a manifestation of COVID-19 pneumonia. Clin Case Rep 2021;9:e04720. [PMID: 34484759 DOI: 10.1002/ccr3.4720] [Reference Citation Analysis]
686 Abdin SM, Elgendy SM, Alyammahi SK, Alhamad DW, Omar HA. Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sci 2020;257:118054. [PMID: 32663575 DOI: 10.1016/j.lfs.2020.118054] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
687 Ingraham NE, Barakat AG, Reilkoff R, Bezdicek T, Schacker T, Chipman JG, Tignanelli CJ, Puskarich MA. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J 2020;56:2000912. [PMID: 32341103 DOI: 10.1183/13993003.00912-2020] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 34.5] [Reference Citation Analysis]
688 Sweid A, Hammoud B, Weinberg JH, Oneissi M, Raz E, Shapiro M, DePrince M, Tjoumakaris S, Gooch MR, Herial NA, Zarzour H, Romo V, Rosenwasser RH, Jabbour P. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients. Neurosurgery 2020;87:E400-6. [PMID: 32496534 DOI: 10.1093/neuros/nyaa254] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
689 Barison A, Aimo A, Castiglione V, Arzilli C, Lupón J, Codina P, Santiago-Vacas E, Cediel G, Emdin M, Bayes-Genis A. Cardiovascular disease and COVID-19: les liaisons dangereuses. Eur J Prev Cardiol 2020;27:1017-25. [PMID: 32391719 DOI: 10.1177/2047487320924501] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
690 Majumdar S, Verma R, Saha A, Bhattacharyya P, Maji P, Surjit M, Kundu M, Basu J, Saha S. Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India. Front Genet 2021;12:637362. [PMID: 33664772 DOI: 10.3389/fgene.2021.637362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
691 Batarseh E, Kersten BP, Pinelo AC, Nadler JN, Schwartz SA. Angioedema in African American Patients Hospitalized for COVID-19. Am J Respir Crit Care Med 2020;202:1581-4. [PMID: 33052705 DOI: 10.1164/rccm.202006-2223LE] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
692 Merdji H, Mayeur S, Schenck M, Oulehri W, Clere-Jehl R, Cunat S, Herbrecht JE, Janssen-Langenstein R, Nicolae A, Helms J, Meziani F, Chenard MP; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care, Sepsis Trial Group for Global Evaluation, Research in Sepsis). Histopathological features in fatal COVID-19 acute respiratory distress syndrome. Med Intensiva (Engl Ed) 2021;45:261-70. [PMID: 34054173 DOI: 10.1016/j.medin.2021.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
693 Dean AQ, Bozza WP, Twomey JD, Luo S, Nalli A, Zhang B. The fight against COVID-19: Striking a balance in the renin-angiotensin system. Drug Discov Today 2021:S1359-6446(21)00192-6. [PMID: 33865979 DOI: 10.1016/j.drudis.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
694 Bahadoram S, Keikhaei B, Bahadoram M, Mahmoudian-Sani MR, Hassanzadeh S, Saeedi-Boroujeni A, Alikhani K. [Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials]. Vopr Virusol 2022;67:126-32. [PMID: 35521985 DOI: 10.36233/0507-4088-106] [Reference Citation Analysis]
695 Li P, Wu W, Zhang T, Wang Z, Li J, Zhu M, Liang Y, You W, Li K, Ding R, Huang B, Wu L, Duan W, Han Y, Li X, Tang X, Wang X, Shen H, Wang Q, Yan H, Xia X, Ji Y, Chen H. Implications of cardiac markers in risk-stratification and management for COVID-19 patients. Crit Care 2021;25:158. [PMID: 33902676 DOI: 10.1186/s13054-021-03555-z] [Reference Citation Analysis]
696 Logunov DY, Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Shcheblyakov DV, Dzharullaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Esmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Egorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. Lancet 2020;396:887-97. [PMID: 32896291 DOI: 10.1016/S0140-6736(20)31866-3] [Cited by in Crossref: 325] [Cited by in F6Publishing: 225] [Article Influence: 162.5] [Reference Citation Analysis]
697 Pfeifer ND, Lo A, Bourdet DL, Colley K, Singh D. Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19. Clin Transl Sci 2021. [PMID: 34318597 DOI: 10.1111/cts.13123] [Reference Citation Analysis]
698 Joyce KE, Weaver SR, Lucas SJE. Geographic components of SARS-CoV-2 expansion: a hypothesis. J Appl Physiol (1985) 2020;129:257-62. [PMID: 32702272 DOI: 10.1152/japplphysiol.00362.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
699 Alnefaie A, Albogami S. Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective. Saudi Pharm J 2020;28:1333-52. [PMID: 32905015 DOI: 10.1016/j.jsps.2020.08.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
700 Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB, Oudit GY. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020;126:1456-1474. [PMID: 32264791 DOI: 10.1161/circresaha.120.317015] [Cited by in Crossref: 691] [Cited by in F6Publishing: 485] [Article Influence: 345.5] [Reference Citation Analysis]
701 Gao J, Zeng L, Yao L, Wang Z, Yang X, Shi J, Hu L, Liu Q, Chen C, Xia T, Qu G, Zhang XE, Jiang G. Inherited and acquired corona of coronavirus in the host: Inspiration from the biomolecular corona of nanoparticles. Nano Today 2021;39:101161. [PMID: 33897804 DOI: 10.1016/j.nantod.2021.101161] [Reference Citation Analysis]
702 Baratchian M, McManus JM, Berk M, Nakamura F, Mukhopadhyay S, Xu W, Erzurum S, Drazba J, Peterson J, Klein EA, Gaston B, Sharifi N. Sex, androgens and regulation of pulmonary AR, TMPRSS2 and ACE2. bioRxiv 2020:2020. [PMID: 33083800 DOI: 10.1101/2020.04.21.051201] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
703 Franco BDGDM, Landgraf M, Pinto UM. Alimentos, Sars-CoV-2 e Covid-19: contato possível, transmissão improvável. Estud av 2020;34:189-202. [DOI: 10.1590/s0103-4014.2020.34100.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
704 Lutz C, Maher L, Lee C, Kang W. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice. Hum Genomics 2020;14:20. [PMID: 32498696 DOI: 10.1186/s40246-020-00272-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 17.0] [Reference Citation Analysis]
705 Maas MN, Hintzen JCJ, Löffler PMG, Mecinović J. Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides. Chem Commun (Camb) 2021;57:3283-6. [PMID: 33651072 DOI: 10.1039/d0cc08387a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
706 Yan YY, Zhou WM, Wang YQ, Guo QR, Zhao FX, Zhu ZY, Xing YX, Zhang HY, Aljofan M, Jarrahi AM, Makabel B, Zhang JY. The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge. Front Mol Biosci 2021;8:699929. [PMID: 34368228 DOI: 10.3389/fmolb.2021.699929] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
707 Calabrese M, Garofano M, Palumbo R, Di Pietro P, Izzo C, Damato A, Venturini E, Iesu S, Virtuoso N, Strianese A, Ciccarelli M, Galasso G, Vecchione C. Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications: State of Art. Life (Basel) 2021;11:259. [PMID: 33801080 DOI: 10.3390/life11030259] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
708 Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections? Front Physiol 2020;11:571416. [PMID: 33510644 DOI: 10.3389/fphys.2020.571416] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 40.0] [Reference Citation Analysis]
709 Saad HM, GamalEl Din SF, Elbokl OM, Adel A. Predictive factors of erectile dysfunction in Egyptian individuals after contracting COVID-19: A prospective case-control study. Andrologia 2021;:e14308. [PMID: 34773422 DOI: 10.1111/and.14308] [Reference Citation Analysis]
710 Ray B, Schütz M, Mukherjee S, Jana S, Ray S, Marschall M. Exploiting the Amazing Diversity of Natural Source-Derived Polysaccharides: Modern Procedures of Isolation, Engineering, and Optimization of Antiviral Activities. Polymers (Basel) 2020;13:E136. [PMID: 33396933 DOI: 10.3390/polym13010136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
711 Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK, Gupta G, Bhardwaj S, Kumar N, Jeyaraman M, Jain R, Muthu S, Kar R, Kumar D, Goswami VK, Ruokolainen J, Kesari KK, Singh SK, Dua K. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci 2021;71:2192-209. [PMID: 33464535 DOI: 10.1007/s12031-020-01767-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
712 Stahlmann R, Lode H. Medication for COVID-19-an Overview of Approaches Currently Under Study. Dtsch Arztebl Int 2020;117:213-9. [PMID: 32343658 DOI: 10.3238/arztebl.2020.0213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
713 Zimmerman MI, Porter JR, Ward MD, Singh S, Vithani N, Meller A, Mallimadugula UL, Kuhn CE, Borowsky JH, Wiewiora RP, Hurley MFD, Harbison AM, Fogarty CA, Coffland JE, Fadda E, Voelz VA, Chodera JD, Bowman GR. SARS-CoV-2 Simulations Go Exascale to Capture Spike Opening and Reveal Cryptic Pockets Across the Proteome. bioRxiv 2020:2020. [PMID: 32637963 DOI: 10.1101/2020.06.27.175430] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
714 Augoustides JGT. The Renin-Angiotensin-Aldosterone System in Coronavirus Infection-Current Considerations During the Pandemic. J Cardiothorac Vasc Anesth. 2020;34:1717-1719. [PMID: 32360010 DOI: 10.1053/j.jvca.2020.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
715 Zhang D, Li L, Chen Y, Ma J, Yang Y, Aodeng S, Cui Q, Wen K, Xiao M, Xie J, Xu Y, Li Y. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19. Mol Med 2021;27:151. [PMID: 34861818 DOI: 10.1186/s10020-021-00412-1] [Reference Citation Analysis]
716 Xie Y, Meng Z, Gao J, Liu C, Wang J, Guo R, Zhao J, Lopez B, Christopher T, Lee D, Ma X, Wang Y. C1q Complement/Tumor Necrosis Factor-Associated Proteins in Cardiovascular Disease and COVID-19. Proteomes 2021;9:12. [PMID: 33804408 DOI: 10.3390/proteomes9010012] [Reference Citation Analysis]
717 Lee SA, Park R, Yang JH, Min IK, Park JT, Han SH, Kang SW, Yoo TH. Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis. Sci Rep 2021;11:13588. [PMID: 34193877 DOI: 10.1038/s41598-021-92323-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
718 Kumar P, Kumar M, Bedi O, Gupta M, Kumar S, Jaiswal G, Rahi V, Yedke NG, Bijalwan A, Sharma S, Jamwal S. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology 2021;29:1001-16. [PMID: 34110533 DOI: 10.1007/s10787-021-00826-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
719 Nappi F, Iervolino A, Avtaar Singh SS. Thromboembolic Complications of SARS-CoV-2 and Metabolic Derangements: Suggestions from Clinical Practice Evidence to Causative Agents. Metabolites 2021;11:341. [PMID: 34070672 DOI: 10.3390/metabo11060341] [Reference Citation Analysis]
720 Bolay H, Özge A, Uludüz D, Baykan B. Are Migraine Patients at Increased Risk for Symptomatic Coronavirus Disease 2019 Due to Shared Comorbidities? Headache 2020;60:2508-21. [PMID: 33124044 DOI: 10.1111/head.13998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
721 E G Müller W, Schröder HC, Neufurth M, Wang X. An unexpected biomaterial against SARS-CoV-2: Bio-polyphosphate blocks binding of the viral spike to the cell receptor. Mater Today (Kidlington) 2021. [PMID: 34366696 DOI: 10.1016/j.mattod.2021.07.029] [Reference Citation Analysis]
722 Rodriguez-Llanes JM, Castro Delgado R, Pedersen MG, Meneghini M, Arcos González P. Surging critical care capacity for COVID-19: Key now and in the future. Prog Disaster Sci 2020;8:100136. [PMID: 34173451 DOI: 10.1016/j.pdisas.2020.100136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
723 Zhang N, Wang C, Zhu F, Mao H, Bai P, Chen LL, Zeng T, Peng MM, Qiu KL, Wang Y, Yu M, Xu S, Zhao J, Li N, Zhou M. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China. Front Endocrinol (Lausanne) 2020;11:571037. [PMID: 33071977 DOI: 10.3389/fendo.2020.571037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
724 Lamure S, Duléry R, Di Blasi R, Chauchet A, Laureana C, Deau-fischer B, Drenou B, Soussain C, Rossi C, Noël N, Choquet S, Bologna S, Joly B, Kohn M, Malak S, Fouquet G, Daguindau E, Bernard S, Thiéblemont C, Cartron G, Lacombe K, Besson C. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study. EClinicalMedicine 2020;27:100549. [DOI: 10.1016/j.eclinm.2020.100549] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
725 Mukherjee T, Behl T, Sharma S, Sehgal A, Singh S, Sharma N, Mathew B, Kaur J, Kaur R, Das M, Aleya L, Bungau S. Anticipated pharmacological role of Aviptadil on COVID-19. Environ Sci Pollut Res Int 2021. [PMID: 34846667 DOI: 10.1007/s11356-021-17824-5] [Reference Citation Analysis]
726 Suganya S, Divya S, Parani M. Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development. Rev Med Virol 2021;31:e2174. [PMID: 32965078 DOI: 10.1002/rmv.2174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
727 Jamalipour Soufi G, Iravani S. Potential inhibitors of SARS-CoV-2: recent advances. J Drug Target 2021;29:349-64. [PMID: 33210953 DOI: 10.1080/1061186X.2020.1853736] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
728 Sindelar M, Stancliffe E, Schwaiger-Haber M, Anbukumar DS, Adkins-Travis K, Goss CW, O'Halloran JA, Mudd PA, Liu WC, Albrecht RA, García-Sastre A, Shriver LP, Patti GJ. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med 2021;2:100369. [PMID: 34308390 DOI: 10.1016/j.xcrm.2021.100369] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
729 Schepler H, Wang X, Neufurth M, Wang S, Schröder HC, Müller WEG. The therapeutic potential of inorganic polyphosphate: A versatile physiological polymer to control coronavirus disease (COVID-19). Theranostics 2021;11:6193-213. [PMID: 33995653 DOI: 10.7150/thno.59535] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
730 Frattini S, Maccagni G, Italia L, Metra M, Danzi GB. Coronavirus disease 2019 and cardiovascular implications. J Cardiovasc Med (Hagerstown) 2020;21:725-32. [PMID: 32858623 DOI: 10.2459/JCM.0000000000001068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
731 Booeshaghi AS, Pachter L. Normalization of single-cell RNA-seq counts by log(x + 1)* or log(1 + x). Bioinformatics 2021:btab085. [PMID: 33676365 DOI: 10.1093/bioinformatics/btab085] [Reference Citation Analysis]
732 [DOI: 10.1101/2020.03.31.20038935] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
733 Ghaemi F, Amiri A, Bajuri MY, Yuhana NY, Ferrara M. Role of different types of nanomaterials against diagnosis, prevention and therapy of COVID-19. Sustain Cities Soc 2021;72:103046. [PMID: 34055576 DOI: 10.1016/j.scs.2021.103046] [Reference Citation Analysis]
734 Fedorov V, Kholina E, Khruschev S, Kovalenko I, Rubin A, Strakhovskaya M. What Binds Cationic Photosensitizers Better: Brownian Dynamics Reveals Key Interaction Sites on Spike Proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2. Viruses 2021;13:1615. [PMID: 34452480 DOI: 10.3390/v13081615] [Reference Citation Analysis]
735 Tulay P, Ergoren MC, Dundar M. COVID-19 vaccines: Where do we stand? The EuroBiotech Journal 2021;5:4-7. [DOI: 10.2478/ebtj-2021-0002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
736 Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 2020;15:1375-87. [PMID: 32653981 DOI: 10.1007/s11739-020-02432-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
737 Pence BD. Severe COVID-19 and aging: are monocytes the key? Geroscience 2020;42:1051-61. [PMID: 32556942 DOI: 10.1007/s11357-020-00213-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 26.5] [Reference Citation Analysis]
738 Raj V, Lee JH, Shim JJ, Lee J. Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS-CoV-2 using computational and in vitro approaches. J Mol Liq 2022;:118775. [PMID: 35194277 DOI: 10.1016/j.molliq.2022.118775] [Reference Citation Analysis]
739 Lee KS, Talenfeld AD, Browne WF, Holzwanger DJ, Harnain C, Kesselman A, Pua BB. Role of interventional radiology in the treatment of COVID-19 patients: Early experience from an epicenter. Clin Imaging 2021;71:143-6. [PMID: 33259979 DOI: 10.1016/j.clinimag.2020.10.048] [Reference Citation Analysis]
740 Iraji F, Galehdari H, Siadat AH, Bokaei Jazi S. Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection: A case report. Clin Case Rep 2021;9:830-4. [PMID: 33598253 DOI: 10.1002/ccr3.3596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
741 Chary MA, Barbuto AF, Izadmehr S, Hayes BD, Burns MM. COVID-19: Therapeutics and Their Toxicities. J Med Toxicol 2020;16:284-94. [PMID: 32356252 DOI: 10.1007/s13181-020-00777-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 18.5] [Reference Citation Analysis]
742 Tousoulis D. Diabetes mellitus: Lessons from the COVID-19 pandemic. Hellenic J Cardiol 2020;61:1-2. [PMID: 32425483 DOI: 10.1016/j.hjc.2020.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
743 Hassanpour M, Rezaie J, Nouri M, Panahi Y. The role of extracellular vesicles in COVID-19 virus infection. Infect Genet Evol 2020;85:104422. [PMID: 32544615 DOI: 10.1016/j.meegid.2020.104422] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 29.5] [Reference Citation Analysis]
744 Alexandrova R, Beykov P, Vassilev D, Jukić M, Podlipnik Č. The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19. Biotechnology & Biotechnological Equipment 2021;35:74-102. [DOI: 10.1080/13102818.2020.1847683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
745 Gioia M, Ciaccio C, Calligari P, De Simone G, Sbardella D, Tundo G, Fasciglione GF, Di Masi A, Di Pierro D, Bocedi A, Ascenzi P, Coletta M. Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches. Biochem Pharmacol 2020;182:114225. [PMID: 32956643 DOI: 10.1016/j.bcp.2020.114225] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
746 Mosleh H, Moradi F, Mehdizadeh M, Ajdary M, Moeinzadeh A, Shabani R. Health concerns regarding the effect of the COVID-19 pandemic on male fertility. Clin Exp Reprod Med 2021. [PMID: 34352169 DOI: 10.5653/cerm.2021.04378] [Reference Citation Analysis]
747 Fukao Y, Nagasawa H, Nihei Y, Hiki M, Naito T, Kihara M, Gohda T, Ueda S, Suzuki Y. COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine. Clin Exp Nephrol 2021. [PMID: 34245398 DOI: 10.1007/s10157-021-02101-z] [Reference Citation Analysis]
748 Hasan A, Paray BA, Hussain A, Qadir FA, Attar F, Aziz FM, Sharifi M, Derakhshankhah H, Rasti B, Mehrabi M, Shahpasand K, Saboury AA, Falahati M. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn 2021;39:3025-33. [PMID: 32274964 DOI: 10.1080/07391102.2020.1754293] [Cited by in Crossref: 133] [Cited by in F6Publishing: 134] [Article Influence: 66.5] [Reference Citation Analysis]
749 Ucar B, Acar T, Arayici PP, Derman S. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2. Nanotechnology 2021;32. [PMID: 34375967 DOI: 10.1088/1361-6528/ac1c22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
750 Rao S, Baranova A, Cao H, Chen J, Zhang X, Zhang F. Genetic mechanisms of COVID-19 and its association with smoking and alcohol consumption. Brief Bioinform 2021:bbab284. [PMID: 34308962 DOI: 10.1093/bib/bbab284] [